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Zusammenfassung 
 
 
Die vorliegende Dissertation beschreibt fünf miteinander in direktem Zusammenhang 
stehende Projekte. Das Ziel dieser Arbeit war sowohl die Synthese von fluorierten 
Kohlenhydraten als auch die Herstellung fluorierter oder isotopenmarkierter -
Ketocarbonsäuren. Die herausragenden Eigenschaften des chemischen Elements Fluor für 
die Erforschung biologischer Systeme, führten im letzten Jahrzehnt zu enormen Fortschritten 
in der Synthese fluorierter Verbindungen, im speziellen in der Kohlenhydrat Chemie. Als eine 
unverzichtbare Methode zur Analyse enzymkatalysierter Reaktionen erwies sich die 19F-NMR 
Spektroskopie. 
Im ersten Projekt dieser Arbeit wurde eine effiziente und kurze Synthese von 3-Fluor-1-
hydroxyacetonphosphat (FHAP) ausgearbeitet (PART A). FHAP, ein Analogon zu 
Dihydroxyacetonphosphat, diente als neuartiger Donor in Aldolase (aus Kaninchenmuskel 
(RAMA)) katalysierten Aldol Reaktionen zur Synthese fluorierter Kohlenhydrate. Die 
Stereochemie des Aldolprodukts (D-threo) konnte mit Hilfe einer unabhängigen Synthese 
bewiesen werden (PART A und PART C). Darüber hinaus wurde ein sehr schneller RAMA-
katalysierter Proton-Deuterium Austausch von FHAP in D2O und die unterschiedlichen 
Bindungsaffinitäten der gem-Diol- und Keto-Form von FHAP mittels 19F-NMR analysiert. 
In einem Nebenprojekt wurde eine kurze Synthese für Fluorhydroxyaceton (FHA) zur 
Untersuchung organokatalysierter Aldoladditionen entwickelt (PART B). Die Struktur von 
FHA konnte mittels 1H-NMR zweifelsfrei bestimmt werden. Die chemische Instabilität von 
FHA erlaubte keine Isolation und keine Durchführung der geplanten organokatalysierten 
Aldolreaktionen. 
Für die stereochemische Konfigurationsbestimmung des RAMA katalysierten Aldolprodukts 
wurde eine neuartiges -Hydroxyacetylanion Äquivalent zur C-C Kettenverlängerung 
entwickelt (PART C). Zur Synthese substituierter Dihydroxyacetone wurde eine zweistufige 
Sequenz, bestehend aus einer Indium vermittelten Allenylierung von Aldehyden mit 4-Brom-
2-butin-1-ol gefolgt von einer Ozonolyse der resultierenden Allene, verwendet. Die 
Steuerung der Regioselektivität der Indium vermittelten C-C Kettenverlängerung konnte 
über die Hydroxylschutzgruppe erreicht werden und folglich wurden entweder Allene oder 
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Alkine bevorzugt gebildet. Die Vielseitigkeit dieser Synthesestrategie konnte durch eine 
effiziente stereoselektive Synthese von D-erythro-2-Pentulose (D-Ribulose) und 1-Deoxy-D-
ribulose gezeigt werden. 
Aufgrund der erworbenen Expertise während der Dissertation im Bereich nucleophiler 
Fluorierungen wurde eine Synthese für die Herstellung von 4-Fluoro-2-oxobutansäure 
entwickelt. Als Schlüsselschritt wurde eine homoallylische Fluorierung gewählt, welche in 
moderaten bis guten Ausbeuten durchgeführt werden konnte (PART D). Homoallylische 
Fluorierungen gehören zu den am schwersten erzielbaren Fluorierungsmethoden und 
werden daher nur äußerst selten in der organischen Synthese eingesetzt. Die bereits 
literaturbekannte -Ketocarbonsäure galt aufgrund eines Berichts von O-Leary et al. als 
äußerst instabil mit eine Zerfallshalbwertszeit zu 2-Oxo-3-butensäure von 162 Sekunden bei 
pH = 7.0 in D2O. Im Gegensatz zu O’Leary beobachten wir einen langsamen Zerfall von 4-
Fluoro-2-oxobutansäure zu 3-Fluoropropansäure durch den Verlust eines Kohlenstoffatoms 
über zehn Tage. 
Das Ziel des letzten Projekts war die Entwicklung einer isotopenmarkierten Vorstufe für die 
Herstellung selektiv Histidin markierter Proteine. Das häufige Vorliegen der Aminosäure 
Histidine in aktiven Zentren von Enzymen, macht selektiv isotopenmarkiertes Histidin zum 
Studium enzymkatalysierter Reaktionen hochinteressant. Die -Ketocarbonsäure Imidazol-5-
ylpyruvat, normalerweise ein Produkt eines Histidin Abbauweges, wurde als möglicher 
Precursor für die in vivo E. coli vermittelten Synthese von Histidin ausgewählt. Eine 
konvergente Synthesestrategie für Imidazol-5-ylpyruvat, die eine Isotopenmarkierung des 
Imidazolringes und der resultierenden Peptidkette ermöglicht, wurde ausgehend von billigen 
isotopenangereicherten Kohlenstoff (C-13) Quellen untersucht. 
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Abstract 
 
 
The present PhD thesis assembles five closely associated projects for the synthesis of 
fluorinated carbohydrates and fluorinated or isotope labeled -keto acids for protein 
labeling. In the last decade an enormous research effort was directed towards the synthesis 
of fluorinated compounds, especially carbohydrates, due to the favorable properties of 
fluorine for studying biological systems. The 19F-nucleus is an ideally suited reporter for 
visualizing enzyme catalyzed reactions by NMR spectroscopy. 
In the first project, an efficient gram scale synthesis of 3-fluoro-1-hydroxyacetone phosphate 
(FHAP) has been developed (PART A). As a close analog to dihydroxyacetone phosphate 
(DHAP), FHAP was further used as a novel donor substrate for rabbit muscle aldolase 
(RAMA) catalyzed reactions in the synthesis of fluorinated carbohydrates. The 
stereochemistry of the aldol condensation product (D-threo) was confirmed by an 
independent chemical synthesis (PART A and C). In addition, a fast RAMA-catalyzed proton-
deuterium exchange of FHAP with D2O and the different binding affinities of the gem-diol 
and keto form of FHAP were studied by 19F-NMR.  
In a side project a short synthesis for fluorohydroxyacetone (FHA) was developed (PART B). 
The structure of FHA was characterized by NMR spectroscopy in solution, since pure FHA is 
highly instable and cannot be isolated. The initial idea behind this project was to explore the 
organocatalyzed aldol addition of various aldehydes to FHA for the synthesis of fluorinated 
carbohydrates and carbohydrate derived compounds. 
For the determination of the stereochemical configuration of the product from the RAMA 
catalyzed aldol addition, we developed a facile preparation and application of -
hydroxyacetyl anion equivalents for carbon chain elongations (PART C). A two step sequence 
of an indium mediated allenylation of aldehydes with 4-bromo-2-butyn-1-ols followed by 
ozonolysis of the resulting allene was used to generate the desired substituted 
dihydroxyacetone fragments. The regioselectivity of the indium-promoted C-C bond forming 
reaction can be controlled by the hydroxyl-protecting group on 4-bromo-2-butyn-1-ol, 
preferentially yielding either allenes or alkynes. The versatility of this strategy was 
demonstrated by the stereoselective and efficient synthesis of D-erythro-2-pentulose (D-
ribulose), 1-deoxy-D-ribulose. 
Abstract 
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An efficient synthesis of 4-fluoro-2-oxo-butanoic acid has been developed (PART D). In the 
key step of this synthesis the fluorine atom was introduced by a homoallylic fluorination in 
moderate yield. These types of fluorinations are known to be extremely difficult and seldom 
used in organic synthesis. In an earlier report by O’Leary et al., 4-fluoro-2-oxo-butanoic acid 
was claimed to be unstable in D2O solution with a half-life of decomposition to 2-oxo-3-
butenoic acid of 162 s at pH = 7.0. These findings are in contrast to our results since 4-fluoro-
2-oxo-butanoic acid was stable in D2O solutions at pH = 7.0 for several hours. In our hands, 
4-fluoro-2-oxo-butanoic acid decomposed to 3-fluoro-propanoic acid in ten days by loss of 
one carbon atom.  
The aim of the final project was the development of a selectively 13C and deuterium labeled 
precursor compound for the synthesis of histidine labeled proteins (PART E). Histidine is 
frequently found in the active site of enzymes and therefore selectively isotope labeled 
histidine is of high interest for studying enzyme catalyzed reactions. The -keto acid 
imidazol-5-yl pyruvic acid, normally involved in the degradation of histidine, was chosen as a 
possible precursor for the in vivo E. coli mediated synthesis of histidine. A convergent 
synthesis of imidazol-5-yl pyruvic acid was attempted to label the imidazole ring and the 
resulting peptide backbone from cheap carbon-13 enriched precursors.  
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PART A: Synthesis of 3-Fluoro-1-hydroxyacetone Phosphate 
and its Application in Rabbit Muscle Aldolase-Catalyzed 
Aldol Reactions 
 
 
 
A.1. Abstract 
 
An efficient gram scale synthesis of 3-fluoro-1-hydroxyacetone phosphate (FHAP) has been 
developed. As a close analog to dihydroxyacetone phosphate (DHAP), FHAP was further used 
as a novel donor substrate for rabbit muscle aldolase (RAMA) catalyzed reactions in the 
synthesis of fluorinated carbohydrates. The stereochemistry of the aldol condensation 
product (D-threo) was confirmed by an independent chemical synthesis. In addition, a fast 
RAMA-catalyzed proton-deuterium exchange of FHAP with D2O and the different binding 
affinities of the gem-diol and keto form of FHAP were studied by 19F-NMR. Furthermore a 
fast RAMA-catalyzed deuterium incorporation into fructose-1,6-bisphosphate (FBP) was 
examined and the stereochemical configuration of the novel stereogenic center was 
elucidated by NOESY experiments. 
 
 
A.2. Introduction and Background 
 
The construction of carbon-carbon bonds under control of stereochemistry is of outstanding 
importance in organic synthesis. The aldol reaction is one of the most striking methods for 
carbon-carbon-bond formation and the relative and absolute stereochemistry of the formed 
stereogenic centers can be controlled by using stoichiometric chiral starting materials 
(aldehydes or auxiliaries) or chiral catalysts (biochemical catalysts or small chiral molecules 
and metal complexes).1 The most prominent biochemical catalysts for this purpose are 
aldolases, which catalyze reversible asymmetric aldol condensations between an aldehyde 
acceptor and a donor substrate in nature.2 According to their mechanism, aldolases have 
been classified into two categories (Scheme 1).3 
1
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Type I aldolases, which are predominantly found in animals and higher plants, activate the 
donor substrate by forming a Schiff base intermediate in the active site. The Schiff base 
intermediate is generated between the keto functionality of the donor substrate and the 
amino group of a lysine residue in the active site. This activated donor adds 
stereoselectively to the acceptor aldehyde. 
Type II aldolases use a metal cofactor for the activation of the donor substrate. The cofactor 
Zn2+ acts as a Lewis acid and leads to the activation of the donor as a zinc enolate. These 
types of aldolases are mainly found in bacteria and fungi.4 
 
Scheme 1. Two types of aldolase mechanisms1 
 
Aldolases tolerate a broad range of acceptor aldehydes, but on the same time are very 
restrictive towards their donor substrate. Therefore they have been further subdivided 
according to their donor substrate, i.e. DHAP (1), pyruvate/phosphenol pyruvate (PEP), 
glycine and acetaldehyde.5 
 
DHAP-Utilizing Aldolases 
 
In nature, DHAP-dependent aldolases catalyze the reversible enantioselective aldol addition 
of DHAP (1) to an acceptor aldehyde. Fructose-1,6-bisphosphate (FBP)- and Tagatose-1,6-
2
PART A: Synthesis of 3-Fluoro-1-hydroxyacetone Phosphate and its Application in Rabbit Muscle Aldolase-Catalyzed Aldol Reactions 
 
bisphosphate (TBP)-dependent aldolases utilize D-glyceraldehyde-3-phosphate (D-G3P) (2) 
and Fuculose-1-phosphate-(Fuc 1-P), Rhamnose-1-phosphate (Rha 1-P) aldolases utilize L-
lactaldehyde (3) as their acceptor substrate in vivo (Scheme 2). These four enzymes allow 
the stereoselective formation of the four theoretically possible diastereomeric aldol 
products at C3 and C4 (3S, 4R; 3S, 4S; 3R, 4R; 3R, 4S in order as mentioned above). 
 
 
Scheme 2. DHAP dependent aldolases with their natural substrates
1,5 
 
In vivo, two further enzymes catalyze the enantioselective aldol addition of DHAP (1) to 
formaldehyde (8) (D-ketotetrose phosphate aldolase) and to 3-oxopropanoic acid (10) 
(phospho-5-keto-2-deoxygluconate aldolase). 
 
Scheme 3. DHAP dependent aldolases with their natural substrates
1,5
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Fructose-1,6-bisphosphate (FBP) Aldolase (EC.4.1.2.13) 
 
To date, FBP aldolases and especially the commercial available RAMA are the most widely 
used aldolases in organic synthesis. In vivo, FBP aldolases catalyze the reversible aldol 
addition of DHAP (1) to D-G3P (2) under the formation of D-FBP (4) (Scheme 4). The 
equilibrium constant has a value of approximately ~104M-1 and is in favor of FBP formation.  
 
Scheme 4. FBP aldolase with their natural substrate
5 
 
The type I FBP aldolases exist as tetramers (~160 kDa) and feature a high degree of sequence 
homology (< 50%) with the active site residues being highly conserved. Type II FBP aldolases 
exist as dimers of ~80 kDa and possess neither sequence homologies among each other nor 
to type I FBP aldolases. 
 
Rabbit Muscle Aldolase (RAMA) 
 
RAMA is easily isolated from rabbit muscle, not air sensitive, inexpensive and stable for ~2 
days in aqueous solution at pH 7. Therefore, most mechanistic studies have been carried out 
on FBP aldolases from rabbit muscle (RAMA) and X-ray structures have been determined to 
resolution of 1.76 Å (Figure 1).6 
 
Figure 1. X-ray structure of RAMA
6,7 
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Scheme 5. Simplified reaction mechanism of Type I FBP aldolases
5
 
 
A simplified reaction mechanism for Type I FBP aldolases is shown in scheme 5. For simplicity 
only the Schiff-base forming amino acid Lys 229 from the active site is visualized. In the first 
step Lys 229 forms an iminum ion with the keto functionality of DHAP (1), which after 
abstraction of the pro-S hydrogen at C3, forms an enamine intermediate. Then, this enamine 
(or its tautomeric zwitterionic form) can add to D-G3P (2) under formation of D-FBP (4) 
covalently bound to the enzyme via the -amino group of Lys 229. In a subsequent step the 
imine is hydrolyzed by water and D-FBP (4) is liberated. The other amino acids with are 
involved in the active site are shown in Figure 2. For a more detailed discussion of the 
reaction mechanism see Sygusch et al.6 
 
Substrate Specificity 
 
RAMA reliably generates vicinal diols with D-threo configuration with a wide variety of 
acceptor aldehydes (> 100) using DHAP (1) as a donor substrate (Scheme 6).8 In general, 
unhindered aliphatic and -heteroatom substituted aldehydes, aldoses and derivatives  
5
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Figure 2. 2-dimensional (right side) and 3-dimensional (left side) representation of the enamine intermediate trapped in 
the active site of RAMA
6a 
 
Scheme 6. Stereospicifity of RAMA catalyzed aldol reactions
8 
 
thereof are suitable acceptors for RAMA-catalyzed aldol reactions. Sterically hindered, 
aromatic and -unsaturated aldehydes are not accepted by the enzyme.  
In contrast to the acceptor aldehyde, RAMA is much more restricted concerning the donor 
substrate. So far, RAMA tolerates only variations at position C1 of the natural donor DHAP 
(1) (Figure 3) with low catalytic activity (~10 % cf. DHAP (1)). For a more detailed discussion 
of the donor specificity of RAMA see the results section (publication). 
 
Figure 3. Donor substrate analogs
8
  
 
Preparation of Dihydroxyacetone Phosphate (DHAP) 
 
The donor substrate DHAP (1) can be synthesized by enzymatic or classical organic chemical 
approaches (Scheme 7-10). Enzymatic in situ generation of DHAP (1) from D-FBP (4) can be 
achieved by using FBP aldolase in combination with triosephosphate isomerase (TIM). FBP 
6
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aldolase reversibly cleaves D-FBP (4) into DHAP (1) and D-G3P (2), whereas the latter one is 
further converted into DHAP (1) by triosephosphate isomerase (TIM). The external addition 
of aldehydes allows the formation of the desired products, albeit the overall reaction may 
not go to completion depending on the stability of the product compared to D-FBP (4). 
An alternative enzymatic synthesis of DHAP (1) applies glycerol kinase catalyzed 
phosphorylation of dihydroxyacetone (DHA) (8) with ATP. The drawback of this methodology 
lies on the high costs of ATP in large scale synthesis (Scheme 7).9 
 
Scheme 7. Enzymatic synthesis of DHAP (1)
1,5,8 
 
Most chemical synthesis of DHAP (1) rely on the phosphorylation of the ethanol protected 
DHA dimer 16. Phosphorylations have been achieved directly with POCl3
10, (PhO)2P(O)Cl
11, or 
in a two step procedure using (BnO)2PN(iPr)2 and subsequently oxidation by H2O2.
12 In the 
final step the phosphate dimer 17 can be deprotected in acid solution to give DHAP (1) 
(Scheme 8). 
 
Scheme 8. A typical chemical synthesis of DHAP (1) starting from DHA dimer
1,5,8 
 
Alternatively DHAP (1) was efficiently synthesized starting with a copper catalyzed 
regioselective ring opening of benzylglycidol 18 with dibenzylphosphate (Scheme 8).13 The 
resulting secondary alcohol 19 was oxidized with tetrapropylammoniumperruthenate/N-
methylmorpholin-N-oxid (TPAP/NMO) in high yield. DHAP (1) was isolated after deprotection 
with H2 over palladium on carbon in an overall yield of 74 %.  
7
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Scheme 9. Chemical synthesis of DHAP (1) by Meyer et al.
13  
 
Another approach used 1,3-dibromoacetone 20 as a starting material (Scheme 10).14 
Desymmetrization and simultaneous protection of the keto functionality of 20 was achieved 
under basic conditions. After phosphorylation of 21, the benzyl and ketal protecting groups 
were cleaved and the resulting 3-bromo-1-hydroxyacetone phosphate was converted into 
DHAP (1) under basic conditions. 
 
Scheme 10. Chemical synthesis of DHAP (1) by Gefflaut et al.
14 
 
Selected Examples of Use of RAMA in Synthesis 
 
Due to the broad acceptor substrate tolerance, RAMA has been employed for the synthesis 
of nitrogen15 or sulfur-containing, fluoro-, deoxy-, high-carbon16 and 13C-labeled 
carbohydrates.17 Other molecules synthesized by FBP aldolases were various C-glycosides, 
cyclitols,18 spiro compounds and (+)-exo-brevicomin (29) (Figure 4). 
 
Figure 4. Synthesis of various carbohydrates and carbohydrates derived compounds with RAMA
1,5,8 
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A core saccharide of the cell wall of gram-negative bacteria, 3-deoxy-D-manno-oct-2-
ulosonic acid (KDO) and a common component of glycoproteins, the sialic acids were easily 
prepared by RAMA catalyzed aldol addition of DHAP (1) to pentose and hexose phosphates 
31 and 32 (Scheme 11). 
 
Scheme 11. RAMA-catalyzed synthesis of KDO and sialic acid derivatives
1,5,8 
 
RAMA was extensively exerted in the synthesis of nitrogen containing sugars, like the potent 
glycosidase inhibitors deoxynojirimycin (22) and deoxymannojirimycin (36) (Scheme 12).19  
 
Scheme 12. Synthesis of deoxynojirimycin (22) and deoxymannojirimycin (36)
1,5,8
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Deoxy-thio sugars and bioactive five membered pyrrolidine type iminocyclitols have been 
synthesized via similar strategies (Scheme 13 and 14).  
 
Scheme 13. Preparation of deoxy-thio-carbohydrate (23)
1,5,8
 
 
 
Scheme 14. Synthesis of substituted pyrrolidines
1,5,8
 
 
 
10
PART A: Synthesis of 3-Fluoro-1-hydroxyacetone Phosphate and its Application in Rabbit Muscle Aldolase-Catalyzed Aldol Reactions 
 
Concept and Strategy 
 
A substitution of the free hydroxyl group of DHAP (1) by fluorine constitutes the smallest 
possible bioisosteric change (Table 1) at the C3 position (Scheme 15), while simultaneously 
offering a direct access to biological important fluorinated sugars and sugar-derived 
compounds. If FHAP (45) can be efficiently synthesized and is accepted by RAMA, an 
enormous variety of biological interesting compounds should be easily accessible in this 
manner. Since the substitution of the hydroxyl group at C3 by fluorine will interfere with 
hydrogen bonding network in the active site of the enzyme (Figure 2 and 5), the 
stereochemistry of the products at position C3 and C4 have to be determined by an 
independent methodology. 
 
Scheme 15. Strategic concept 
 
Table 1. Steric consequences of fluorine substitution
20
 
Bond Length [Å] Van der Waals 
radius [Å] 
C-H 1.09 1.20 
C=O 1.23 1.50 
C-OH 1.43 1.52 
C-F 1.35 1.47 
O-H 0.96 1.20 
 
Previous Synthesis of FHAP 
 
FHAP (45) was previously synthesized in a laborious sequence by Silverman et al. in low 
overall yield (~1.3 %) and purity (Scheme 16).21 Starting from epichlorohydrin (46), the 
fluorine atom was introduced by a regioselective ring opening of the epoxide in low yield. 
Oxidation of the secondary hydroxyl group of 47 with potassium dichromate followed by 
displacement of the chloride by silver dibenzylphosphate yielded dibenzyl protected FHAP 
11
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49. The deprotection of 49 sluggishly worked with palladium on carbon in methanol under 
an atmosphere of hydrogen. The authors mentioned that the main problem was due to 
ketalisation of the carbonyl moiety of 45. Ethyl acetate or benzene as a solvent gave purer 
compounds but in an even lower yields.  
 
Scheme 16. Silverman’s synthesis of FHAP
21
 
 
Since FHAP is needed in large quantities for the subsequent enzymatic reactions, a novel 
synthesis had to be designed. Silverman’s synthesis of FHAP (45) is afflicted by considerable 
disadvantages. Firstly, potassium dichromate and potassium hydrogen difluoride are toxic 
and the latter one is corrosive. Secondly, the silver (I) dibenzyl phosphate is commercially 
not available. Thirdly the overall yield is very low (< 1.3 %) and the final deprotection step is 
slow and incomplete. 
 
Retrosynthetic Analysis 
 
In our retrosynthetic analysis we considered following points: The fluorine atom has to be 
introduced via a nonhazardous method which is easily scalable. The keto moiety of FHAP 
(45) has to be generated at a late stage of synthesis, since 2-oxo phosphates tend to be 
unstable. Furthermore, the deprotection of the phosphate group should be accomplished by 
a mild methodology. Due to the fact that ketalisation can be prevented by using tert-butanol 
instead of methanol during the hydrogenolysis of benzyl phosphates, we envisaged the same 
final intermediate as Silverman et al. (Scheme 17). 
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Scheme 17. Retrosynthesis of FHAP (45) 
 
The dibenzyl phosphate was planned to be introduced either by a pentavalent phosphorous 
reagent like (BnO)2P(O)Cl or by a much more reactive phosphor(III) species, like PCl3 or 
(BnO)2PN(iPr)2
22 and subsequent oxidation. 
For the introduction of the fluorine atom a halogen-halogen exchange, fluorination of allylic 
alcohol 54 by Ishikawa’s reagent or the Gouverneur’s fluorodesilylation methodology23 could 
be applied (Scheme 18). In our opinion diethylaminosulfur trifluoride (DAST) has to be 
avoided due to its uncontrollable dangerous behavior when used in larger amounts. 
Considering all these facts commercially available triethyl phosphonoacetate (50) (~30 
€/mol) was used as a starting material. 
 
Scheme 18. Retrosynthesis of ethyl 2-(fluoromethyl)acrylate (52) 
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An eﬃcient gram scale synthesis of 3-ﬂuoro-1-hydroxyacetone
phosphate (FHAP) has been developed. As a close analog to
dihydroxyacetone phosphate, FHAP was used as a novel donor
substrate for rabbit muscle aldolase catalyzed reactions. The
diﬀerent binding aﬃnities of the gem-diol and keto form of
FHAP were studied by 19F-NMR.
Rabbit muscle aldolase (RAMA) catalyses the stereospeciﬁc
aldol addition of dihydroxyacetone phosphate (DHAP) to an
aldehyde, thus forming a C–C bond with D-threo conﬁguration.1
The enzyme tolerates a wide variety of functionalized
aldehydes (4100) as acceptor substrates,2 reﬂected by its
applications in numerous syntheses of ketoses, aldoses,
iminosugars and cyclitols.1,3 In contrast to its versatile
acceptor tolerance, RAMA is very restrictive concerning the
nucleophilic donor DHAP, as summarized in Fig. 1.
Variations at position C3 of the donor phosphate are not
tolerated.2a,4,5 The hitherto investigated 3-halo analogs of
DHAP are either competitive (chloride: pH = 7) or irreversible
(iodide; bromide and chloride: pH= 10) inhibitors of RAMA,
acting by oxidizing sulfhydryl groups to disulﬁdes or by
forming stable covalent derivatives with sulfhydryl groups.5
At present, only three analogs of DHAP are established
substrates for RAMA-catalyzed reactions (Fig. 1).2a,6–8
A substitution of the free hydroxyl group of DHAP by
ﬂuorine constitutes the smallest possible bioisosteric change
at the C3 position,9 while simultaneously oﬀering a direct
access to biologically important ﬂuorinated sugars and sugar-
derived compounds.10 3-Fluoro-1-hydroxyacetone phosphate
(FHAP) was previously synthesized in a laborious sequence by
Silverman et al. starting from epichlorohydrin in low overall
yield (B1.3%) and purity.11 Previous studies on the substrate
speciﬁcity of fructose-1,6-bisphosphate aldolase suggested that
FHAP may not act as a substrate for the enzyme,12 which is in
contrast to our recent observations. Additionally, neither
experimental details of the preparation of FHAP and inhibitor
studies nor spectroscopical proof of identity were given.12
Herein, we report on a short and eﬃcient gram scale
synthesis of 1-ﬂuoro-3-hydroxyacetone phosphate and its
application in RAMA-catalyzed aldol reactions. The stereo-
chemistry of the aldol condensation product 8 was proven by
an independent chemical synthesis. Furthermore, a fast
RAMA-catalyzed proton–deuterium exchange of FHAP with
D2O and the diﬀerent binding aﬃnities of the gem-diol and
keto form of FHAP were studied by 19F-NMR.
The synthetic sequence leading to FHAP (5) is outlined in
Scheme 1. Starting from easily accessible ethyl a-ﬂuoromethyl-
acrylate (1),13 allylic ﬂuoride 2 was synthesized by reduction of
the ester moiety with diisobutylaluminium hydride (DIBAL-H).14
The phosphate functionality of FHAP was introduced via
dibenzyl N,N-diisopropylphosphoramidite, followed by a
Fig. 1 Donor substrate variations of DHAP.2a,4–8
Scheme 1 Synthesis of FHAP (5): (a) DIBAL-H, CH2Cl2, 78 1C-
0 1C, 63%; (b) iPr2NP(OBn)2, 1H-tetrazole, CH3CN; then 30% H2O2,
74%; (c) O3, CH2Cl2, 78 1C; (CH3)2S, 95%; (d) iPr2NP(OBn)2,
1H-tetrazole, CH3CN; then O3, CH2Cl2, 78 1C; (CH3)2S, 52%;
(e) H2, 10% Pd/C, tBuOH; 1 N NaOH, lyophilized, 95%.
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stepwise oxidation of the intermediately formed phosphite
with 30% H2O2 to allylic phosphate 3 and ozonolysis of the
double bond in a subsequent step to yield 2-oxo phosphate 4 in
excellent yield. Alternatively a direct oxidation of the double
bond and the phosphite with ozone gave the corresponding
b-keto phosphate 4. The dibenzyl protecting groups were
cleaved by hydrogenolysis over 10% Pd/C in tBuOH,15
thereby preventing a hemiketal formation which was observed
when MeOH was used.11 After conversion into the mono-
sodium salt, lyophilized FHAP (5) was isolated in an overall
yield of 42% over 4 steps (or alternatively in 31% yield over
3 steps) starting from ethyl a-ﬂuoromethylacrylate (1). FHAP
(5) is stable for several months at 20 1C. Suitable crystals
for X-ray diﬀraction were obtained from the biscyclohexyl-
ammonium salt of FHAP, featuring the keto functionality in
its gem-diol (hydrated) form (see ESIw). At neutral pD at
25 1C in D2O,
16 FHAP (5) exists 91% in the gem-diol form
(determined via 19F-NMR), compared to 45% for DHAP.17
In the subsequent enzymatic reactions the 19F nucleus was
used to monitor the reaction progress by 19F-NMR. For all
conversions, spectroscopically pure FHAP (5) (1H- and 19F-
NMR) was essential, since no product formation was detected
with slightly impure substrates. Additionally, the acceptor
substrates investigated showed the highly preferred formation
of one product diastereomer, as judged by 19F-NMR. Our
initial studies focused on the RAMA-catalyzed condensation
of FHAP (5) and chloroacetaldehyde in BIS–TRIS (2-[bis-
(2-hydroxyethyl)amino]-2-(hydroxymethyl)-propane-1,3-diol)
buﬀer (Scheme 2). A slow conversion of FHAP (5) to deoxy-
sugar 6 was observed by NMR (see ESIw). However, all
attempts towards product isolations either as the barium salt
of phosphate 6 or as the dephosphorylated sugar failed
due to the instability of the products. Therefore we used
glycolaldehyde as the acceptor substrate. Good conversion
rates forming derivative 7 were obtained by repeated addition
of RAMA over 3 days. Dephosphorylation with acid
phosphatase and acetylation with acetic anhydride to simplify
isolation and characterization yielded 1,4,5-tri-O-acetyl-3-
deoxy-3-ﬂuoro-D-threo-pent-2-ulose (8) (Scheme 2). The stereo-
chemistry of compound 8 was assigned by an independent
chemical synthesis (Scheme 3). As a prerequisite, the absolute
conﬁguration of allene 9a18 was conﬁrmed by transformation
into D-ribulose (see ESIw). Subsequently, the hydroxyl
functionality of 9a was transformed to the allenylic ﬂuoro
derivative 10a with (diethylamino)sulfur triﬂuoride (DAST) at
78 1C under inversion of the conﬁguration at C3.19
A potential 1,3-neighbouring group participation by the
acetate moiety was ruled out, since using the corresponding
benzyl ether 9b18 instead led to the formation of the same
diastereomer 10b (see ESIw). The syn-relationship was
reﬂected in analogy to literature data20 by the vicinal coupling
constants (10a: 3JH2–H3 = 7.8 Hz; 10b:
3JH2–H3 = 8.0 Hz).
Cleavage of the isopropylidene protecting group and subsequent
acetylation was performed under standard conditions to yield
allene 11a. After ozonolysis of the allene moiety of 11a at
78 1C in CH2Cl2, pentulose 8 was isolated. All spectroscopical
data were identical with the product of the enzymatic synthesis.
As a consequence, the RAMA-catalyzed condensation of FHAP
(5) with glycolaldehyde led to the identical stereochemical
conﬁguration (D-threo) as the one using the natural donor
substrate DHAP.
In concordance with NMR studies of DHAP and RAMA in
D2O,
21 we observed a rapid proton–deuterium exchange for
one of the two enantiotopic protons at the C3 position of
FHAP (5), yielding deuterated FHAP 12 (Scheme 4 and ESIw).
The rate constant determined for the deuteration of 5
(0.03 mmol min1 U1) was signiﬁcantly smaller than the
one reported for the phosphonate analog of DHAP
(0.18 mmol min1 U1) and DHAP (1.2 mmol min1 U1).22
The second C3 proton of FHAP (5) displayed a much slower
exchange rate and a further hydrogen–deuterium exchange at
C1 could only be observed after several hours.23 This ﬁnding is
in contrast to the natural substrate DHAP, where the second
exchange takes place at C1 at a slow rate, followed by an even
slower exchange of the second C3 proton.21 Without the
enzyme FHAP does not exchange its protons for several
months in D2O at pD = 6.9.
Since line width and/or relaxation rates of 19F-NMR resonances
are sensitive to changes in molecular weight (molecular tumbling),
reversible ligand binding processes can easily be analyzed by
changes in signal broadening (ESIw). Such a signiﬁcant change
was only observed for the keto form of FHAP, thus indicating a
speciﬁc binding to RAMA. In contrast, the signal for the gem-diol
Scheme 2 RAMA-catalyzed aldol condensation with chloroacetaldehyde
or glycolaldehyde: (a) RAMA, ClCH2CHO solution (B50 wt. % in
H2O), BIS–TRIS buﬀer, pH = 6.8; (b) RAMA, HOCH2CHO,
BIS–TRIS buﬀer, pH = 6.8; (c) acid phosphatase, pH = 5.1;
(d) Ac2O, DMAP, pyridine, rt (7% over 3 steps).
Scheme 3 Chemical synthesis of 1,4,5-tri-O-acetyl-3-deoxy-3-ﬂuoro-
xylulose (8): (a) NaOMe, MeOH, rt; (b) O3, CH2Cl2, 78 1C; PPh3;
(c) Amberlyst 15 H+, THF/H2O (77% over 3 steps); (d) DAST,
Collidine, CH2Cl2, 78 1C, 35%; (e) Dowex 50 H+, THF/H2O, rt,
80%; (f) Ac2O, Pyridine, DMAP, rt, 95%.
Scheme 4 Deuterium incorporation into FHAP (5).
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form of FHAP remained nearly unchanged after the ﬁrst addition
of enzyme.24 These observations are in agreement with the
proposed enzymatic reaction mechanism for the natural substrate
(DHAP) with RAMA,25 since only the keto form can lead to a
covalent linked Schiﬀ base intermediate with the enzyme. In
analogy to the stereospeciﬁcity of RAMA with DHAP as a
substrate,26 the fast proton–deuterium exchange of the pro-S
hydrogen of FHAP can be assumed.
The low overall yield of the enzymatic aldol addition
requires some comment. Since product formation correlates
with the accessibility of the carbonyl moiety,17a the low
isolated yield may mainly be attributed to the high degree of
hydration (91%) of the keto functionality and to the general
diﬃculties in acetylation of pentuloses.27 Furthermore, the
enamine intermediates of the natural substrates DHAP and
fructose-1,6-bisphosphate are stabilized by a hydrogen bond
between the carboxyl functionality of Asp-33 of the enzyme
and the hydroxyl group at C3 of the substrates.28 The
importance of this crucial interaction was demonstrated by
mutations of Asp-33 into alanine, serine, glutamate and
asparagines, which lowered Vmax of the enzyme dramatically.
29
Our entire ﬁndings point to a similar positioning of FHAP in
the active site of RAMA to that of DHAP. In contrast to
DHAP, FHAP cannot form this seminal interaction with
Asp-33, due to ﬂuorine’s property of lacking hydrogen bond
donor capacities and functioning solely as a hydrogen bond
acceptor.
In summary, we have developed an eﬃcient gram scale
synthesis of FHAP (5). In contrast to earlier reports12 FHAP
could be identiﬁed as a novel donor substrate for RAMA-
catalyzed aldol condensations. This fact was demonstrated in
the synthesis of 1,4,5-tri-O-acetyl-3-deoxy-3-ﬂuoro-D-threo-
pent-2-ulose 8. FHAP is the ﬁrst analog of DHAP with a
modiﬁcation at C3 accepted as a donor substrate by RAMA.
The stereochemical conﬁguration at C3 and C4 (D-threo) of
the aldol condensation product has proven to be identical as
for the natural substrate DHAP, which was conﬁrmed by an
independent chemical synthesis of pentulose 8. Furthermore, a
fast proton–deuterium exchange and the diﬀerent binding
preferences of the gem-diol and keto form of FHAP were
analyzed by 19F-NMR. A direct evolution of aldolases30 might
result in highly eﬃcient catalysts for the aldol condensation of
FHAP with aldehydes, giving access towards a great variety of
ﬂuoro containing carbohydrates with biological and medicinal
relevance.10
We thank Dr Ernst Pittenauer for MS and Prof. Vladimir
Arion for X-ray diﬀraction measurements. We are grateful to
Prof. Robert Konrat and Prof. Fritz Pittner for valuable
discussions.
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PART A: Synthesis of 3-Fluoro-1-hydroxyacetone Phosphate and its Application in Rabbit Muscle Aldolase-Catalyzed Aldol Reactions 
 
Unpublished Work: 
 
Synthesis of Ethyl -fluoromethylacrylate: 
 
Several approaches towards the synthesis of ethyl -fluoromethylacrylate (52) have been 
studied. All of them started from commercially available triethyl phosphonoacetate (53). The 
first approach attempted to introduce the fluorine atom by the electrophilic 
fluorodesilylation methodology of Gouverneur et al. (Scheme 19).23 The silylated precursor 
acrylate 55 was prepared from 53 in two steps in high yield.24 Although we screened several 
reactions conditions, the synthesis of 52 from 55 was unsuccessful using Selectfluor25 or 
NFSI. This observation may be explained by electron withdrawing properties of the ester 
moiety, making the carbon-carbon double bond slightly electron deficient. Therefore a 
nucleophilic attack of the π-system towards an electrophilic fluorine source is not likely 
anymore. Furthermore, to the best of my knowledge Gouverneur et al. never published an 
electrophilic fluorodesilylation of ester substituted carbon-carbon double bonds. 
 
Scheme 19. Attempted synthesis of compound 52 via electrophilic flurodesilylation 
 
In the second approach the fluorine atom was planned to be introduced by a nucleophilic 
substitution of the hydroxyl functionality of compound 54 (Scheme 20). Unfortunately 
applying Ishikawa’s reagent26 the product 57 could be isolated in moderate yield instead. 
Therefore a halogen-halogen exchange was used for the synthesis of 52 form 58.27 
Bromination of 54 with phosphortribromide followed by treatment of 58 with KF in 
methanol yielded ether 59 due to nucleophilic attack of the solvent. For the same reason 
compound 60 was formed applying CsF in nitromethane. The desired product 52 was finally 
obtained by halogen-halogen exchange using tetrabutylammoium fluoride in THF27 or 
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potassium fluoride in acetonitrile with crown ether in good yield (Scheme 21). Due to 
identical Rf-values of 52 and 58, the reaction progress could only be monitored by 
1H-NMR. 
The loss in yield can be explained by co-evaporation of 52 with various solvents used. The 
potassium fluoride system could be up-scaled to 50 gram. 
 
Scheme 20. Synthesis of ethyl -fluoromethylacrylate (52)
27
  
 
 
Scheme 21. Synthesis of ethyl -fluoromethylacrylate (52) 
 
Phosphorylation of Allylic Alcohol 51: 
 
The phosphorylation of allylic alcohol 51 proved to be complicated (Scheme 22). In analogy 
to the synthesis of DHAP (1), various methods for phosphorylation of 51 were tested. The 
pentavalent phosphorous reagent (BnO)2P(O)Cl (62) seemed to be too unreactive. Dibenzyl 
phosphoryl chloride (62) was synthesized by conversion of dibenyzlphosphite 63 with 
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trichlorocyanuric acid 64 in excellent yield (Scheme 23).28 POCl3, which was successfully used 
by Effenberger10 for the synthesis of DHAP (1), did not give any product.  
 
Scheme 22. Phosphorylation of allylic alcohol 51 
 
 
Scheme 23. Synthesis of dibenzylphosphoryl chloride (62)
28
 
 
Enzymatic Reactions of FHAP with D-Glyceraldehyde: 
 
Whitesides et al. demonstrated that glyceraldehyde is a good acceptor substrate for RAMA-
catalyzed aldol reactions.8 To facilitate the final purification it was planned to perform the 
enzymatic aldol condensation with D-glyceraldehyde since theoretically only one product 
was expected. 1,2-O-Isopropylidene-D-glyceraldehyde (65) was synthesized starting from D-
mannitol (66) by standard procedures.29 The cleavage of the acetonide protecting group was 
performed by hydrolysis under acidic conditions in a THF/water mixture and monitored by 
TLC. After removal of the THF by evaporation, the crude product was used for the RAMA 
catalyzed aldol reaction with FHAP (45). Unfortunately the desired 3-deoxy-3-fluoro-D-
fructose 67 could not be isolated (Scheme 24). 
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Scheme 24. Attempted synthesis of 3-deoxy-3-fluoro-D-fructose-1-phosphate (67) 
 
Catalytic Role of Asp-33 of RAMA: 
 
Tolan et al. have demonstrated the critical role of Asp33 in catalytic mechanism of RAMA by 
site-directed mutagenesis.30 Aspartic acid 33 was changed to alanine, serine and glutamic 
acid, resulting in the mutant proteins, D33A, D33S and D33E, respectively. By analyzing the 
kinetic properties of the recombinant rabbit aldolases A using FBP (4), they showed that 
mutating the aspartate residue to alanine clearly had the most severe effect on Vmax of the 
enzyme. The Vmax of D33A, where the mutant residue is most dissimilar to the original 
enzyme, was 5600 times slower than wild-type. The D33S had a Vmax 3600 and the D33E a 
Vmax 960 times slower than wild type.  
In 2007, Sygusch et al. showed that numerous interactions with active side residues stabilize 
the covalent intermediate, which was trapped by freezing a WT aldolase crystal in the 
presence of DHAP (1) (Fig 2).6 As visible in Figure 5, the above mentioned Asp33 stabilizes 
the enamine intermediate by hydrogen bonding with DHAP C3 hydroxyl. 
Assuming that FHAP (45) forms a similar placed covalent intermediate with the enzyme, at 
least this interaction is disturbed. Since the fluorine atom in FHAP (45) can only act as a 
hydrogen bond acceptor, a productive interaction with Asp33 is not possible anymore. Of 
course, this hypothesis can only be proved without a doubt by comparison of the X-ray 
structure of covalently linked FHAP (45) and DHAP (1) to RAMA. Maybe this disturbed 
interaction has an influence on the catalytic turnover of FHAP (45) by RAMA, which is 
reflected in the low yield of the enzymatic reactions.  
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Figure 5. Catalytic role of Asp-33 with FBP (4)
6c
  
 
Miscellaneous Experiments: 
 
Type I FBP Aldolase from Spinach and Type II FBP Aldolases from E. Coli, Thermotoga 
Maritime and Thermoanaerobacter Ethanolicus: 
 
In addition to RAMA another commercial Type I FBP dependent aldolase from spinach31 was 
tested in the aldol reaction between glycolaldehyde and FHAP (45). Similar to the reaction 
with RAMA, FHAP (45) was a bad substrate. The 19F-NMR spectra showed that the reaction 
was even slower compared to RAMA catalyzed ones and therefore more side products were 
produced. Furthermore, we obtained four Type II aldolases from the company DSM, which 
were overexpressed in various bacteria. Two rhamnulose 1-phosphate aldolases from E. coli 
and Thermotoga maritime and two fuculose 1-phosphate aldolases from E. coli and 
Thermoanaerobacter ethanolicus were tested as catalysts for the aldol addition. Freshly 
distilled acetaldehyde (68) and 2-hydroxypropanal (71) were used as acceptor substrates 
(Scheme 25 and 26). Unfortunately no reaction progress could be observed under 19F-NMR 
monitoring. The racemic aldehyde 71 was synthesized in two different sequences as outlined 
in Scheme 27 and 28, to exclude that impurities from the synthesis of 2-hydroxypropanal 
(71) were responsible for enzyme inhibition. The published reaction yields from Wong et al. 
could not be realized.32 The deprotection of 71 was monitored by TLC and 1H NMR and the 
aldehyde 71 was directly subjected to the enzymatic reactions after removal of amberlyst 15 
H+. 
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Scheme 25. Reagents and conditions: a) Rhamnulose 1-phosphate aldolases from E. coli (at rt) or Rhamnulose 1-
phosphate aldolases from Thermotoga maritime (at 50°C) in BIS-TRIS buffer, pH = 6.8, rt; b) fuculose 1-phosphate 
aldolases from E. coli (at rt) and Thermoanaerobacter ethanolicus (at 50°C) in BIS-TRIS buffer, pH = 6.8, rt. 
 
 
Scheme 26. Reagents and conditions: a) Rhamnulose 1-phosphate aldolases from E. coli (at rt) or Rhamnulose 1-
phosphate aldolases from Thermotoga maritime (at 50°C) in BIS-TRIS buffer, pH = 6.8, rt; b) fuculose 1-phosphate 
aldolases from E. coli (at rt) and Thermoanaerobacter ethanolicus (at 50°C) in BIS-TRIS buffer, pH = 6.8, rt. 
 
 
Scheme 27. Synthesis of 2-hydroxypropanal (71)32 
 
 
Scheme 28 Synthesis of 2-hydroxypropanal (71) via ozonolysis32 
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RAMA-Catalyzed Incorporation of Deuterium into Fructose-1,6-bisphosphate (FBP): 
 
Since RAMA catalyzes a slow incorporation of deuterium into DHAP (1) at the position C1 we 
speculated that a hydrogen-deuterium exchange may be possible for the C1 position of D-
FBP (4) as well. Indeed this exchange reaction was observed after addition of RAMA to FBP 
(4) in D2O at pD = ~7 (Scheme 29). Interestingly only one deuterium was incorporated, 
according to the integration of the 1H-NMR signals. The sight of exchange (C1) was 
undoubtedly determined by a combination of NMR methods (COSY, TOCSY, HSQC and 
HMBC) and ESI-MS2 analysis of the fragmentation patterns. The stereochemistry of the novel 
stereogenic center at C1 was elucidated by comparison of NOESY crosspeaks of 
diisopropylidene protected, deuterium labeled fructose 80 and diisopropylidene protected 
fructose 8133 (Figure 6).  
Our findings were in accordance with Lowe and Pratt, which were found after excessive 
literature researches.34 Only the pro-S hydrogen was selectively exchanged by RAMA. A 
degradation of deuterium labeled fructose 79 to S-[2-D]glycolic acid, according to the 
procedure Rose et al. described for a identical tritrium labeled fructose, was 
unsuccessfully.35 
 
 
Scheme 29 Synthesis of selectively deuterium labeled 1,2,4,5-O-diisopropylidene-D-fructose (80) 
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Figure 6. Determination of stereochemistry at C1 – the most important NOESY crosspeaks are visualized 
 
 
A.4. Experimental Procedures 
 
Published work: 
 
Gram Scale Synthesis of 3-Fluoro-1-hydroxyacetone Phosphate: A Novel Donor 
Substrate in Rabbit Muscle Aldolase-Catalyzed Aldol Reactions 
Michael Fischer, Hanspeter Kählig, Walther Schmid, Chem. Commun. 2011, 47, 6647-6649. 
 
Supporting Information: 
http://www.rsc.org/suppdata/cc/c1/c1cc11579k/c1cc11579k.pdf 
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General Considerations. Anhydrous THF was distilled from potassium under argon, anhydrous 
CH3CN was distilled of CaH2. 1H and 13C NMR spectra were recorded on either 400 MHZ or 600 
MHz spectrometer. Unless otherwise stated, all NMR spectra were measured either in CDCl3 
solutions and referenced to the residual CHCl3 signal (1H, δ=7.26 ppm; 13C, δ=77.16 ppm) or in 
D2O solutions (HDO, 1H, δ=4.79 ppm). All 1H and 13C shifts are given in ppm. Flash 
chromatography was performed using silica gel 60 (0.004-0.063 mm). TLC monitoring was done 
on silica plates (silica gel 60 F254), compounds were visualized by treatment with a solution of 
(NH4)6Mo7O24.4H2O (48g) and Ce(SO4)2 (2g) in 10% H2SO4 (1L), followed by heating, or with an 
aqueous KMnO4-solution. Ethyl α-bromomethylacrylate was synthesized according to a literature 
procedure.1 pH and pD measurements were accomplished using a glass electrode (pD = pH + 0.4).2 
RAMA (lyophilized powder) and acid phosphatase (Type XA: from Sweet Potato) were purchased 
by Sigma Aldrich. 
 
Ethyl α-fluoromethylacrylate (1): 
 
 
To a solution of ethyl α-bromomethylacrylate (48.3 g, 0.25 mol) in dry CH3CN (200 mL), KF 
(43.6 g, 0.75 mol) and 18-crown-6 (1 g, 3.75 mmol) were added under argon. The mixture was 
refluxed until NMR monitoring (small aliquots were taken and measured in CDCl3) showed 
complete consumption of the starting material (up to 3 days). The reaction was cooled to 0°C and 
quenched by addition of ice-cold water (75 mL). The aqueous phase was separated and the organic 
phase was extracted with water (2 x 50 mL). The combined aqueous phases were re-extracted with 
ether (150 mL) and the combined organic phases were dried over MgSO4, filtered and concentrated 
under reduced pressure (22°C, 50 Torr). The product was purified by vacuum distillation over a 
vigreux column to yield ethyl α-fluoromethylacrylate (1) (19.8 g, 60 %). 
The moderate yield was due to co-evaporation of ethyl α-fluoromethylacrylate (1) with CH3CN 
and CH2Cl2. Spectroscopical data were in accordance with Villieras et al.2  
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2-(Fluoromethyl)prop-2-en-1-ol (2): 
 
 
To a solution of ethyl α-fluoromethylacrylate (1) (5.28 g, 0.04 mol) in dry CH2Cl2 (200 mL) at 
−78°C, DIBAL-H (1M in Hexan, 83.2 mL) was slowly added over 45 min under argon. After 
stirring the reaction mixture for 2 ½ hours at −65°C and for 45 min at room temperature the 
mixture was again cooled to −20°C. A saturated solution of Na2SO4 (2 mL) was slowly added and 
the reaction mixture was warmed up to 0°C. After addition of an ice cold saturated solution of 
NH4Cl (50 mL) at 0°C, a white  precipitate formed at room temperature, which was diluted with 
CH2Cl2 (100 mL) and filtered. The filtrate was carefully washed with CH2Cl2, the phases were 
separated and the combined organic phases were dried over MgSO4, filtered and concentrated at 
reduced pressure (40°C, 750 Torr). The crude product was purified by flash chromatography 
(gradient: pentan/ether : 15:1→1:1) to yield 2-(fluoromethyl)prop-2-en-1-ol (2) (2.27 g, 63 %). The 
moderate yield was due to co-evaporation of 2-(fluoromethyl)prop-2-en-1-ol (2) with various 
solvents used. IR (film, cm-1): ν = 3317, 2927, 1438, 1211, 1025; 1H NMR (400 MHz, CDCl3): 
δ = 5.29 (m, 1H), 5.24 (m, 1H), 4.93 (m, J = 47.2 Hz, 2H), 4.23 (s, 2H), 1.58 (bs, 1OH). 13C NMR 
(400 MHz, CDCl3): δ = 144.13 (d, J = 14.6 Hz), 114.5 (d, J = 9.8 Hz), 83.8 (d, J = 165.0 Hz), 
63.33 (d, J = 2.9 Hz). 19F NMR (600 MHz, CDCl3, coupled): δ = −218.04 (dt, J = 47.2, 3.4 Hz). 
HRMS (EI) calcd for C4H7O (M-F): 71.0497, found 71.0495. 
 
(Dibenzyl (2-(fluoromethyl)allyl) phosphate (3): 
 
 
 
To a solution of 2-(fluoromethyl)prop-2-en-1-ol (2) (1.23 g, 13.65 mmol) in dry CH2Cl2 (50 mL), 
dibenzyl N,N-diisopropylphosphoramidite (6.60 g, 19.11 mmol) was added under argon. The 
Electronic Supplementary Material (ESI) for Chemical Communications
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reaction mixture was cooled to -5°C and tetrazole (~0.45 M in CH3CN, 51 mL, 22.9 mmol) was 
added slowly. A white solid precipitated and after the solution was stirred for 10 min at room 
temperature, a H2O2 solution (30% in H2O, 3.1 mL, 30 mmol) was added. After TLC monitoring 
(hexane/EtOAc = 2/1) showed complete consumption of the intermediate phosphite (~20 min), 
H2O (20 mL) and CH2Cl2 (20 mL) was added. The organic phase was separated and the aqueous 
phase was extracted with CH2Cl2 (3 x 20 mL). The combined organic phases were dried over 
MgSO4, filtered and evaporated. The crude material was purified by flash chromatography 
(hexane/EtOAc = 2/1) to yield dibenzyl (2-(fluoromethyl)allyl) phosphate (3) (3.53 g, 74 %). IR 
(film, cm-1): ν = 2927, 1456, 1272, 1012, 738, 696; 1H NMR (400 MHz, CDCl3): 
δ  = 7.37−7.30 (m, 10H), 5.30−5.25 (m, 2H), 5.06 (dd, J = 11.8, 8.4 Hz, 2H), 5.04 (dd, J = 11.8, 8.4 
Hz, 2H), 4.82 (m, J = 46.9 Hz, 2H), 4.52 (d, J = 7.3 Hz, 2H). 13C NMR (600 MHz, CDCl3) 
δ = 139.5, 135.9 (d, JCF = 6.7 Hz), 128.7, 128.1, 117.3  (d, JCF = 9.5 Hz), 82.7  (d, JCF = 167.0 Hz), 
69.6  (d, JCP = 5.5 Hz), 67.1  (dd, JCP = 5.5 Hz, JCF = 2.8 Hz). 19F NMR (600 MHz, CDCl3, 
coupled): δ = −219.26 (dt, J = 46.9, 3.3 Hz). HRMS (ESI) calcd for C18H21O4FP (M+H): 351.1162, 
found 351.1167. 
 
Dibenzyl (3-fluoro-2-oxopropyl) phosphate (4): 3 → 4 
 
 
 
Ozone was bubbled through a solution of compound 3 (3.50 g, 9.99 mmol) in dry CH2Cl2 (25 mL) 
at -78°C until the color of the mixture turned blue. Dry air was bubbled through the solution until 
the blue color disappeared. After addition of (CH3)2S (0.87 g, 14 mmol), the mixture was allowed 
to reach room temperature by stirring overnight. The solvent was removed under reduced pressure 
to yield dibenzyl (3-fluoro-2-oxopropyl) phosphate (4) (3.34 g; 95 %). IR (film, cm-1): 
ν = 2927, 1751, 1271, 1009, 737, 696. 1H NMR (400 MHz, CDCl3): δ = 7.40−7.28 (m, 10H), 5.13 
(dd, J = 11.7, 8.6 Hz, 2H) 5.09 (dd, J = 11.7, 9.1 Hz, 2H), 4.89 (d, J = 47.0 Hz, 2H), 4.70 (dd, J = 
9.7, 1.7 Hz, 2H). 13C NMR (400 MHz, CDCl3): δ = 199.9 (dd, J = 19.0, 5.9 Hz, 1C), 135.6 (d, J = 
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6.5 Hz, 2C), 128.9 (2C), 128.8 (4C), 128.3 (4C), 84.3 (d, J = 182.5 Hz, 1C), 70.0 (d, J = 5.8 Hz, 
2C), 69.3 (dd, J =5.6, 2.6 Hz, 1C). 19F NMR (600 MHz, CDCl3, coupled): δ = −237.3 (tt, J = 47.0, 
1.7 Hz).  HRMS (EI) calcd for C17H19O5PF (M+H): 353.0954, found 353.0945. 
 
Dibenzyl (3-fluoro-2-oxopropyl) phosphate (4): 2 → 4 
 
 
 
To a solution of 2-(fluoromethyl)prop-2-en-1-ol (2) (0.45 g, 5 mmol) in dry CH2Cl2 (20 mL), 
dibenzyl N,N-diisopropylphosphoramidite (2.42 g, 7 mmol) was added under argon. The reaction 
mixture was cooled to -5°C and tetrazole (~0.45 M in CH3CN, 18.6 mL) was added slowly. A 
white solid precipitated and the solution was stirred for 15 min at room temperature. Ozone was 
bubbled through this solution at -78°C until the color of the mixture turned blue. Dry air was 
bubbled through the solution until the blue color disappeared. After addition of (CH3)2S (0.43 g, 7 
mmol), the mixture was allowed to reach room temperature by stirring overnight. The solvent was 
removed under reduced pressure and the crude material was purified by flash chromatography 
(toluol/EtOAc = 1/1) to yield dibenzyl (3-fluoro-2-oxopropyl) phosphate (4) (914 mg, 52 %).  
 
3-Fluoro-1-hydroxyacetone phosphate mono sodium salt (5): 
 
 
Compound 4 (2.04 g, 5.79 mmol) was dissolved in tBuOH (60 mL) and hydrogenated in the 
presence of 10% palladium-on-charcoal (308 mg) with a balloon of hydrogen. After TLC 
monitoring (tolulol/EtOAc = 1/1) showed consumption of the starting material, the catalyst was 
removed by filtration and the filter was rinsed with water (30 mL). After addition of NaOH (0.1 M, 
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5.79 mL,) the solution (pH = 6.5-6.8) was concentrated under reduced pressure (not to dryness), 
water added and concentrated again to remove tBuOH (not to dryness). The mono sodium salt of 3-
fluoro-1-hydroxyacetone phosphate (5) (1.06 g, 95 %) was obtained after lyophilisation. 1H NMR 
(400 MHz, D2O): δketo = 5.30 (d, J = 46.5 Hz, 2H), 4.63 (d, J = 7.4 Hz, 2H); δhydrate = 4.40 (d, J = 
46.6 Hz, 2H), 3.86 (dd, J = 5.9, 2.2 Hz, 2H) . 13C NMR (400 MHz, D2O): δhydrate = 93.5 (dd, J = 
19.2, 7.7 Hz, 1C), 84.0 (d, J = 172.3 Hz, 1C), 66.4 (dd, J = 5.0, 1.8 Hz, 1C);  δketo = 207.3 (from 
HMBC, 1C), 85.0 (d, J = 176.8 Hz, 1C), 67.9 (from HMBC, 1C); 19F NMR (600 MHz, D2O, 
coupled): δhydrate = −230.9 (tt, J = 1.9, 46.6 Hz); δketo = −237.1 (t, J = 46.7 Hz). HRMS (ESI-neg. 
mode) calcd for C3H5O5FP (M-H): 170.9859 found, 170.9856. 
 
19F-NMR study of RAMA with chloroacetaldehyde in H2O: 5-Chloro-3,5-dideoxy-3-fluoro-D-
threo-pent-2-ulose-1-phosphate (6): 
 
 
Good resolved 19F-NMR spectra for compound 6 were obtained by using a BIS-TRIS buffer (2-
[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol). To a solution of FHAP (5) (42.5 
mg, 0.219 mmol) in H2O (2 mL), chloroacetaldehyde (~ 50% in H2O; 33 µL, 0.255 mmol) and 
BIS-TRIS (2 mg, 0.01 mmol) was added and the pH was adjusted with small quantities of 1 M 
NaOH solutions to pH = 6.8. RAMA (43.6 U) was added (SI, Figure 3). After slow stirring over 
night, RAMA (19 U) was repeatedly added (SI, Figure 4). 
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19F- and 1H-NMR study of RAMA with glycolacetaldehyde in D2O: 3-deoxy-3-fluoro-D-threo-
pent-2-ulose-1-phosphate (7): 
 
 
 
To a solution of FHAP (5) (4 mg; 0.021 mmol) in D2O (0.6 mL), glycolaldehyde (1.3 mg, 0.021 
mmol) was added and the pD was adjusted with small quantities of 1M NaOD or DCl solutions to 
pD = 7.3. RAMA (2U) was added and the reaction progress was monitored by 1H-NMR and 19F-
NMR (SI, Figure 5).  
 
Enzymatic synthesis of 1,4,5-tri-O-acetyl-3-deoxo-3-fluoro-D-threo-pent-2-ulose (8): 
 
 
 
To a solution of FHAP mono sodium salt (100 mg, 0.52 mmol) in H2O (30 mL), glycolaldehyde 
(36 mg, 0.6 mmol) and BIS-TRIS (31 mg, 0.15 mmol) was added. After the pH was adjusted with 
small quantities of 1 M NaOH solutions to pH = 6.8, RAMA (95 U) was added. The solution was 
slowly stirring over night and RAMA (47.5 U) was added again. After 2 days the pH was adjusted 
to pH = 5.1 with 1 N HCl solution, acid phosphatase (110 U) was added. The reaction mixture was 
slowly stirred over night and the pH was adjusted to 6.85 with 1N NaOH. After lyophilization the 
crude product was purified by flash chromatography (CHCl/MeOH = 9/1). Since a structural 
determination was not possible, the fractions with Rf between 0.56 and 0.30 were pooled together, 
evaporated and suspended in dry pyridine (2 mL). Dimethylaminopyridine (11 mg, 0.09 mmol) was 
added and the solution was cooled to 0°C under argon. Acetanhydride (191 mg, 1.87 mmol) was 
added and the solution was stirred over night. The reaction mixture was quenched by the addition 
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of H2O (1 mL) at 0°C and the aqueous phase was extracted with EtOAc (3 x 5ml). The combined 
organic phases were washed with brine, dried over MgSO4, filtered and evaporated in vacuo. The 
product was purified by flash chromatography (hexane/EtOAc = 4/1) to yield 1,4,5- tri- O-acetyl-3-
deoxy-3-fluoro-D-threo-pent-2-ulose (8) (10 mg, 7 %).  = -24.5 (c 0.5, CH2Cl2); IR (film, cm-
1): ν = 2925, 2855, 1744, 1372, 1227, 1048; 1H NMR (400 MHz, CDCl3,): δ = 5.48 (ddt, J = 27.8, 
6.5, 2.4 Hz, 1H), 5.14 (dd, J = 47.5, 2.5 Hz, 1H), 5.05 (dd, J = 18.2, 2.1 Hz, 1H) 4.92 (dd, J = 18.2, 
2.1 Hz, 1H), 4.31 (dd, J = 11.4, 6.6 Hz, 1H), 4.24 (ddd, J = 11.5, 6.2, 1.0 Hz, 1H), 2.17 (s, 3H), 
2.12 (s, 3H), 2.08 (s, 3H). 13C NMR (400 MHz, CDCl3): δ = 199.6 (d, J = 26.5 Hz), 170.3, 170.1, 
170.0, 93.3 (d, J = 191.3 Hz), 69.7 (d, J = 17.8 Hz), 67.2 (d, J = 4.6 Hz), 60.6 (d, J = 6.0 Hz), 20.7, 
20.6, 20.5. 19F NMR (600 MHz, CDCl3, coupled): δ = −215.12 (ddt, J = 47.3, 27.8, 2.4 Hz).  
HRMS (ESI) calcd for C11H15O7FNa (M+Na): 301.0700, found 301.0695. 
 
Determination of the absolute stereochemistry of compound 9a: 
 
O
HO OH
OH
OH
D-ribulose
AcO O
OH
O•
HO O
OH
O•
HO O
OH
OONaOMe
MeOH
1. O3, 78°C
2. PPh3, DCM
9a 13 14
see ref.3
 
 
To a suspension of compound 9a3 (9 mg, 0.037 mmol) in dry MeOH under argon, NaOMe (0.5 mg, 
9 µmol) was added at 0°C. The reaction mixture was stirred at room temperature until TLC 
monitoring (H/EtOAC = 1/1) showed conversion of the starting material. Then Dowex 50 H+ was 
added and the mixture was stirred for 5 min. After neutralization the resin was removed by 
filtration, washed in with MeOH and the filtrate concentrated in vacuo to yield compound 13.3 The 
crude material was dissolved in dry CH2Cl2 (1 mL) and cooled to −78°C. Ozone was bubbled 
through this solution at -78°C until the color of the mixture turned blue. Dry air was bubbled 
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through the solution until the blue color disappeared. After addition of PPh3 (12 mg, 0.044 mmol), 
the mixture was allowed to reach room temperature by stirring overnight. The solvent was removed 
under reduced pressure and the crude material was purified by flash chromatography 
(hexane/EtOAc = 1/1) to yield 4,5-Odiisopropylidine-D-erythro-pent-2-ulose (14) (6.4 mg, 91 %).3 
Compound 14 was transformed in D-ribulose as previously published.3 The spectroscopical data for 
D-ribulose were identical with those reported.4  
 
(2R,3R)-4-(Acetyloxymethyl)-3-fluoro-1,2-O-isopropylidene-hexa-4,5-dien-1,2-diol (10a): 
 
 
 
To a suspension of compound 9a3 (34 mg, 0.14 mmol) in dry CH2Cl2 (4 mL) under argon, collidine 
(34 mg, 0.281 mmol) was added and the reaction mixture cooled to −78°C. After dropwise addition 
of DAST (95 %) (47 mg, 0.281 mmol) the solution was stirred for 15 min at −78°C and then 
warmed up to −30°C. After TLC monitoring showed conversion of the starting material, the 
reaction was quenched by the addition of a NaHCO3-solution (10%, 0.5 mL). The solution was 
brought to room temperature and the aqueous phase was extracted with CH2Cl2 (3 x 2 mL). The 
combined organic phases were dried over MgSO4, filtered and evaporated in vacuo. Flash 
chromatography on silica gel in hexane/EtOAc = 8/1 afforded compound 10a (12 mg, 35 %).  
= +35.1 (c = 0.2, CH2Cl2); IR (film, cm-1): ν = 2935, 1963, 1745, 1365, 1225; 1H NMR (400 MHz, 
CDCl3): δ = 5.1−5.0 (m, 2H), 4.88 (ddt, J = 48.7, 7.8, 1.5 Hz, 1H), 4.69−4.64 (m, 2H), 4.47−4.34 
(m, 1H), 4.06 (ddd, J = 8.8, 6.9, 2.1 Hz, 1H), 3.69 (ddd, J = 8.6, 6.6, 0.9 Hz, 1H), 2.08 (s, 3H), 1.47 
(s, 3H), 1.39 (s, 3H). 13C NMR (400 MHz, CDCl3): δ = 208.1 (d, J = 8.5 Hz), 170.5, 110.7, 97.2 (d, 
J = 21.3 Hz), 91.8 (d, J = 180.5 Hz) 79.5 (d, J = 2.7 Hz), 76.5 (d, J = 20.0 Hz), 65.7 (d, J = 5.9 Hz), 
61.7 (d, J = 0.7 Hz), 26.7, 25.4, 21.0. 19F NMR (600 MHz, CDCl3, coupled): δ = −182.0 (dm, J = 
48.8 Hz).  HRMS (EI) calcd for C11H14O4F (M-CH3): 229.0876, found 229.0875. 
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(2R,3R)-4-(Benzylloxymethyl)-3-fluoro-1,2-O-isopropylidene-hexa-4,5-dien-1,2-diol (10b): 
 
 
 
To a suspension of compound 9b3 (73 mg, 0.25 mmol) in dry CH2Cl2 (6 mL) under argon, collidine 
(61 mg, 0.5 mmol) was added and the reaction mixture cooled to −78°C. After dropwise addition of 
DAST (95 %) (84 mg, 0.5 mmol) the solution was stirred for 15 min at −78°C and then warmed up 
to −30°C. After TLC monitoring showed conversion of the starting material, the reaction was 
quenched by the addition of a NaHCO3-solution (10%, 1 mL). The solution was brought to room 
temperature and the aqueous phase was extracted with CH2Cl2 (3 x 3 mL). The combined organic 
phases were dried over MgSO4, filtered and evaporated in vacuo. Flash chromatography on silica 
gel in hexane/EtOAc = 8/1 afforded compound 10b (18 mg, 25 %). IR (film, cm-1): 
ν = 2988, 2924, 2854, 1958,  1372, 1069, 740, 699; 1H NMR (400 MHz, CDCl3): δ = 7.33−7.27 
(m, 5H), 5.04−4.82 (m, 2H), 4.92 (ddt, J = 49.1, 8.0, 1.3 Hz, 1H), 4.54 (d, J = 11.5 Hz, 1H), 4.51 
(d, J = 11.8 Hz, 1H), 4.51−4.40 (m, 1H), 4.14-4.11 (m, 2H), 4.03 (ddd, J = 8.6, 7.0, 2.2 Hz, 1H), 
3.67 (ddd, J = 8.6, 6.6, 1.1 Hz, 1H), 1.46 (s, 3H), 1.38 (s, 3H). 13C NMR (400 MHz, CDCl3): 
δ = 208.3 (d, J = 8.5 Hz), 137.9, 128.6, 127.97, 127.96, 110.5, 98.0 (d, J = 21.0 Hz), 92.2 (d, J = 
179.2 Hz), 78.3 (d, J = 2.9 Hz), 76.6 (d, J = 20.2 Hz), 72.5, 67.9, 65.8 (d, J = 6.4 Hz), 26.8, 25.5. 
19F NMR (600 MHz, CDCl3, coupled): δ = −180.2 (dm, J = 49.2 Hz).  HRMS (EI) calcd for 
C16H18O3F (M-CH3): 277.1240, found 277.1233. 
 
(2R,3R)-1,2-Di-O-acetyl-4-(acetyloxymethyl)-3-fluoro-hexa-4,5-dien-1,2-diol (11a): 
 
AcO OAc
F
OAc•
11a  
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To a suspension of compound 10a (11 mg, 0.045 mmol) in 2 mL of a mixture of water/THF (2:1), 
10 mg of Amberlyst 15 (H+-form) were added and the mixture was stirred at room temperature. 
After TLC monitoring showed conversion of the starting material (~4 h), the resin was removed by 
filtration, washed with methanol and the solvent was removed under reduced pressure. The crude 
product was suspended in dry pyridine (0.5 mL), dimethylaminopyridine (0.5 mg, 4 µmol) was 
added and the solution was cooled to 0°C under argon. Acetanhydride (18 mg, 0.176 mmol) was 
added and the solution was stirred over night. The reaction mixture was quenched by addition of 
H2O (200 µL) at 0°C and the aqueous phase was extracted with EtOAc (3 x 1ml). The combined 
organic phases were washed with brine, dried over MgSO4, filtered and evaporated in vacuo. The 
product was purified by flash chromatography (hexane/EtOAc = 4/1) to yield (2R,3R)-3-fluoro-
1,2,5-O-triacetyl-4-vinylidene-pentan-1,2,5-triol (11a) (10 mg, 80 %).  = +28.0 (c 0.1, 
CH2Cl2); IR (film, cm-1): ν = 2922, 1973, 1744, 1374, 1222, 1047; 1H NMR (400 MHz, CDCl3): 
δ = 5.39 (dddd, J = 17.8, 5.7, 3.9, 1.9 Hz, 1H), 5.14 (ddt, J = 47.2, 5.9, 1.7 Hz, 1H), 5.10−5.03 (m, 
2H), 4.67 (m, 2H), 4.36 (dd, J = 11.9, 3.8 Hz, 1H), 4.16 (dd, J = 12.0, 5.9 Hz, 1H) 2.12 (s, 3H) 2.09 
(s, 3H) 2.02 (s, 3H). 13C NMR (400 MHz, CDCl3): δ = 208.06 (d, J = 8.0 Hz), 170.60, 170.59, 
170.2, 96.4 (d, J = 22.0 Hz), 88.8 (d, J = 182.0 Hz), 79.7 (d, J = 1.8 Hz), 70.8 (d, J = 20.9 Hz), 
62.33 (d, J = 6.0 Hz), 61.6 (d, J = 1.7 Hz), 21.0, 20.9, 20.8. 19F NMR (600 MHz, CDCl3, coupled): 
δ = −191.7 (ddt, J = 46.9, 17.5, 7. 8 Hz).   HRMS (ESI) calcd for C13H17O6FNa (M+Na): 311.0907, 
found 311.0912. 
 
Chemical synthesis of 1,4,5-tri-O-acetyl-3-deoxy-3-fluoro-D-threo-pent-2-ulose (8): 
 
 
 
Ozone was bubbled through a solution of compound 11a (3 mg, 10.4 µmol) in dry CH2Cl2 (1.5 mL) 
at -78°C until the color of the mixture turned blue. Dry air was bubbled through the solution until 
the blue color disappeared. After addition of PPh3 (4 mg, 15 µmol), the mixture was allowed to 
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reach room temperature by stirring overnight. The solvent was removed under reduced pressure 
and the crude material was purified by flash chromatography (hexane/ethyl acetate = 3:1) to yield 
compound 8 (2.7 mg; 95 %).  = -26.5 (c 0.15, CH2Cl2). Spectroscopical data were identical 
with the data obtained from the enzymatic synthesis. 
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2-(Fluoromethyl)prop-2-en-1-ol (2): 
2.02.53.03.54.04.55.05.56.06.57.0 ppm
1.
58
4.
23
4.
87
4.
87
4.
99
4.
99
5.
24
5.
24
5.
24
5.
24
5.
25
5.
29
5.
29
7.
26
1.
27
1.
81
0.
97
1.
00
0.
94
0.
99
F OH
2
220 200 180 160 140 120 100 80 60 40 20 0 ppm
63
.
32
63
.
35
7
6.
85
7
7.
16
7
7.
48
82
.
95
84
.
59
11
4.
48
11
4.
58
14
4.
06
14
4.
20
F OH
2
 
Electronic Supplementary Material (ESI) for Chemical Communications
This journal is © The Royal Society of Chemistry 2011
38
S14 
 
 
Dibenzyl (2-(fluoromethyl)allyl) phosphate (3): 
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Dibenzyl (3-fluoro-2-oxopropyl) phosphate (4): 
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1H-NMR: FHAP (5) 
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(2R,3R)-4-(Acetyloxymethyl)-3-fluoro-1,2-O-isopropylidene-hexa-4,5-dien-1,2-diol (10a):  
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(2R,3R)-4-(Benzyloxymethyl)-3-fluoro-1,2-O-isopropylidene-hexa-4,5-dien-1,2-diol (10b): 
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(2R,3R)-1,2-Di-O-acetyl-4-(acetyloxymethyl)-3-fluoro-hexa-4,5-dien-1,2-diol (11a): 
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13C NMR (JMOD): For the quaternary carbon of compound 11a see above. 
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1,4,5-Tri-O-acetyl-3-deoxy-3-fluoro-D-threo-pent-2-ulose (8): 
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13C-NMR: 
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Figure 1. Crystal structure of biscyclohexylammonium salt of FHAP (5): The keto functionality is 
hydrated)5 
 
Fluorine: green 
Oxygen: red 
Phosphor: orange 
Nitrogen: blue 
Carbon: black 
Hydrogen: gray-white 
 
CCDC-809382 contains the supplementary crystallographic data for this paper. These data can be 
obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
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Figure 2. 19F-NMR spectrum (decoupled): FHAP (5) in D2O 
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19F-NMR spectrum (coupled): FHAP (5) in D2O 
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Figure 3. 19F-NMR spectra: RAMA catalyzed formation of 5-chloro-3,5-dideoxy-3-fluoro-D-threo-
pentulose 1-phosphate (6) in H2O after 20 hours. 
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Figure 4. 19F-NMR spectra (coupled): RAMA catalyzed formation of 5-chloro-3,5-dideoxy-3-
fluoro-D-threo-pentulose 1-phosphate (6) in D2O after repeated addition of RAMA over 3 days. 
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Figure 5. 19F-NMR spectra: RAMA catalyzed reaction of FHAP with glycolaldehyde in D2O: 3d 
after repeated addition of RAMA 
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Figure 6. 1H-NMR (CD3OD): RAMA catalyzed reaction of FHAP with glycolaldehyde in D2O 
after dephosphorylation with acid phosphatase.  
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Figure 7. 19F-NMR (decoupled; CD3OD): RAMA catalyzed reaction of FHAP with glycolaldehyde 
in D2O after dephosphorylation with acid phosphatase.  
-195.3 ppm
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Figure 8. 19F-NMR spectra: RAMA catalyzed incorporation of deuterium from D2O into 
FHAPa
 
 
aexperimental conditions: A solution of FHAP mono sodium salt (4 mg, 0.021 mmol) in D2O (0.6 
mL) was adjusted with small quantities of 1M NaOD to pD = 7.3. RAMA (4 U) was added and the 
reaction progress was monitored by 1H-NMR and 19F-NMR. (S)-3-D-FHAP: 1H NMR (CDCl3, 400 
MHz): δketo 5.32 (d, J = 46.4 Hz, 1H) 4.53 (d, J = 7.0 Hz, 2H) δhydrate 4.36 (d, J = 46.8 Hz, 1H) 3.84 
(dd, J = 8.1, 2.2 Hz, 2H). 19F NMR: δhydrate −230.7 (dt, J = 46.7, 6.3 Hz); δketo −237.5 (dt, J = 46.4, 
6.3 Hz). HRMS (ESI-neg. mode) calcd for C3H3O5D2FP (M-D): 172.9984 found, 172.9988 
(Sample was measured in D2O). 
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Figure 9. 1H NMR: RAMA catalyzed incorporation of deuterium from D2O into FHAP: 2h 17’ 
after addition of RAMA 
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Figure 10. 19F-NMR (coupled): RAMA catalyzed incorporation of deuterium from D2O into 
FHAP: 2h 7’ after addition of 
RAMA
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Figure 11. 19F-NMR (decoupled): RAMA catalyzed incorporation of deuterium from D2O into 
FHAP: 2h 17’ after addition of RAMA 
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Figure 12. 19F-NMR (coupled): RAMA catalyzed incorporation of deuterium from D2O into 
FHAP: 23h 33’ after addition of RAMA 
-230 -231 -232 -233 -234 -235 -236 -237 -238 ppm
-
23
7.
55
-
23
7.
53
-
23
7.
52
-
23
7.
46
-
23
7.
45
-
23
7.
44
-
23
7.
43
-
23
5.
80
-
23
5.
7
9
-
23
5.
7
1
-
23
1.
28
-
23
0.
7
2
-
23
0.
64
-
23
0.
56
-
23
0.
09
0.
13
0.
02
0.
04
1.
00
-237.4 ppm
0.
13
2
F O
P
O
DO OD
DO OD
D
F O
P
O
DO OD
DO OD
F O
P
O
DO OD
DO OD
D D
F O
P
O
DO ODD
O
F O P
O
OD
OD
DO OD
HD DH
 
Electronic Supplementary Material (ESI) for Chemical Communications
This journal is © The Royal Society of Chemistry 2011
58
S34 
 
Figure 13. 19F-NMR (decoupled): RAMA catalyzed incorporation of deuterium from D2O into 
FHAP: 3 days after repeated addition of RAMA 
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Figure 14. 19F-NMR spectra (decoupled): 19F-NMR binding study of FHAP with RAMA: Change 
of line width of 19F NMR signalsa 
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aexperimental conditions: FHAP (0.7 mg, 3.6 µmol) was dissolved in 450 µL H2O and 50 µL D2O 
and the pH was adjusted to 7.3 by 1 M NaOH (black line). RAMA was repeatedly added [1st 
addition: 1.2 mg, 14 U, in 70 µL D2O; 2nd addition: 4.3 mg, 49 U in 100 µL D2O; 3rd addition: 6.2 
mg, 71 U, in 150 µL D2O (red line)] 
 
 
19F-NMR binding study of FHAP with RAMA: Changes in line width (LW) of 19F-NMR 
resonances – graphical representation of data from table 1 
 
Electronic Supplementary Material (ESI) for Chemical Communications
This journal is © The Royal Society of Chemistry 2011
60
S36 
 
Table 1. 19F-NMR binding study of FHAP with RAMA: Change of line width of 19F NMR signalsa 
FHAP (mg) RAMA (µM) Line width (Hz) ΔLW (%) Line width (Hz) ΔLW (%)
   FHAP (gem-diol)  FHAP (keto)    
0,7 0 9,0 - 4,3 - 
0,7 13 13,9 54 8,5 98 
0,7 51 13,8 53 10,3 140 
0,7 88 13,3 48 14,2 230 
 
 
References: 
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2 T. H. Fife, T. C. Bruice, J. Phys. Chem. 1961, 65, 1079−1080. 
3 The spectroscopical data were identical with those reported previously: Fischer, M; Schmölzer, 
S.; Nowikow, T.; Schmid., W. Eur. J. Org. Chem. 2011, 9, 1645−1651. 
4 1H-NMR, 13C-NMR and HRMS were in full agreement with previously published data: a) T. 
Vuorinen, A. S. Serianni, Carbohydr. Res. 1990, 209, 13–31. b) D. de Wit, F. van Rantwijk, L. 
Maat, A. P. G. Kieboom, Recl. Trav. Chim. Pays-Bas 1991, 110, 271–274. 
5 Crystal Structure Visualisation: “Mercury CSD 2.0 - New Features for the Visualization and 
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Unpublished work: 
 
Following compounds were synthesized according to literature procedures: 
 Ethyl 2-(hydroxymethyl)acrylate (54)27 
 Ethyl 2-((trimethylsilyl)methyl)acrylate (55)24 
 Ethyl 2-(diethoxyphosphoryl)-3-(trimethylsilyl)propanoate (56)24 
 Ethyl 2-(bromomethyl)acrylate (58)27 
 Dibenzyl phosphorylchloride (62)28 
 1,2-O-Isopropylidine-D-glyceraldehyde (64)29 
 1,1-Dimethoxypropan-2-one (74)32a 
 1,1-Dimethoxypropan-2-ol (75)32a 
 2-Hydroxypropanal (76)32a 
 But-3-en-2-ol (77)32b 
 1,2,4,5-Di-O-isopropylidene--D-fructose (82)33 
 
 
Ethyl 2-(methoxymethyl)acrylate (59): 
 
Ethyl 2-(bromomethyl)acrylate (58) (60 mg, 0.31 mmol) was dissolved in dry methanol (3 mL) 
and cesium fluoride (94 mg, 0.93 mmol) was added. The reaction flask was heated at 70°C 
until TLC monitoring showed complete consumption of the starting materials (~ 28 hours). 
The reaction mixture was quenched by addition of water (1 mL) and the aqueous phase was 
extracted with dichloromethane (5 x 3 mL). The combined organic phases were dried over 
MgSO4, filtered and concentrated under reduced pressure to give ethyl 2-(methoxymethyl)-
acrylate (59) (20 mg, 45 %). 1H-NMR (400 MHz, CDCl3):  = 6.29 (m, 1H, CH) 5.83 (m, 1H, CH) 
4.21 (q, J = 7.1 Hz, 2H, CH2) 4.13 (t, J = 1.4 Hz, 2H, CH2) 3.39 (s, 3H, CH3) 1.30 (t, J = 7.1 Hz, 3H, 
CH2); 
13C-NMR (400 MHz, CDCl3):  =166.0, 137.5, 125.7, 70.9, 60.8, 58.7, 14.3. 
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Ethyl 2-methylene-4-nitrobutanoate (60): 
 
 
Ethyl 2-(bromomethyl)acrylate (58) (2 g, 0.01 mol) was dissolved in nitromethane (30 mL) 
and potassium fluoride (1.2 g, 0.02 mol) was added. After addition of water (~0.5 mL), the 
reaction mixture was heated at 70°C until TLC monitoring showed complete consumption of 
the starting materials (~ 14 hours). The reaction mixture was quenched by addition of water 
(20 mL) and the aqueous phase was extracted with dichloromethane (3 x 15 mL). The 
combined organic phases were dried over MgSO4, filtered and concentrated under reduced 
pressure to give ethyl 2-methylene-4-nitrobutanoate (60) (1.64 g, 92 %). 1H-NMR (250 MHz, 
CDCl3):  = 6.30 (s, 1H, CH) 5.72 (m, 1H, CH) 5.58 (t, J = 6.8 Hz, 2H, CH2) 4.24 (q, J = 7.1 Hz, 2H, 
CH2) 2.99 (dt, J = 3.5 Hz, J = 0.87 Hz, 2H, CH2) 1.32 (t, J = 7.1 Hz, 3H, CH2). 
 
[(S)-1-H2]-1,2,4,5-di-O-isopropylidene--D-fructose (80): 
 
Fructose-1,6-bisphosphate monocalcium salt (75%, 252 mg, 0.5 mmol) was dissolved in D2O 
(5 mL) and amberlyst 15 H+ was added. After 1.5 hours, the resin was filtrated, rinsed with 
D2O and the pD was adjusted to pD = 7 with a 1 M NaOD solution. RAMA (3.7 U) was added 
and the reaction mixture was slowly stirred over night. Since the fructose-1,6-bisphosphate 
was not fully converted to deuterated fructose-1,6-bisphosphate (monitored by 1H-NMR 
spectroscopy), RAMA (7.2 U) was added again and the reaction mixture stirred over night. 
After full conversion, acid phosphatase (11 U) was added over two days in equal portions 
(the reaction progress was monitored by TLC). Then the pH was readjusted to pH = 6.8 and 
the solvent was removed under reduced pressure. The crude product was purified by anion 
exchange chromatography (dowex 50 Cl-). The deuterated fructose was eluted with H2O and 
concentrated under reduced pressure (the unreacted deuterated fructose-1,6-bisphosphate 
with a 3 M HCl solution). The deuterated fructose fraction was dissolved in dry acetone (2.6 
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mL) and conc. H2SO4 (13 µL) was added. After stirring the reaction mixture over night, the pH 
was adjusted to pH = 9-10 with an ice-cold aqueous solution of NaOH (2 M). The acetone 
was removed under reduced pressure and the aqueous phase was extracted with CHCl3 (3 x 
5 mL). The combined organic layers were washed with H2O (1 mL), dried over MgSO4 and 
concentrated. The crude product was recrystallized in a mixture of diethyl ether and hexane 
(1/1) to give [(S)-1-H2]-1,2,4,5-di-O-isopropylidene--D-fructose (80) (39 mg, 30%). 1H-NMR 
(400 MHz, CDCl3):  = 4.20 (dd, J = 5.8 Hz, J = 2.3 Hz, 1H, CH) 4.15-4.08 (m, 2H, CH, CH2) 4.03-
3.84 (m, 2H, CH2, CHD) 3.66 (dd, J = 8.1 Hz, J = 6.9 Hz, 1H, CH) 1.96 (d, J = 8.3 Hz, 1H, OH) 
1.53 (s, 3H , CH3) 1.51 (s, 3H , CH3) 1.44 (s, 3H , CH3) 1.37 (s, 3H , CH3); 
13C-NMR (400 MHz, 
CDCl3):  = 111.9, 109.6, 104.7, 77.4, 73.6, 72.3 (t, J = 23.0 Hz) 70.7, 61.1, 28.2, 26.7, 26.5, 
26.2.  
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Selected spectra:  
 
1H-NMR spectra of [1-2H]-D-FBP (78) and D-FBP (4):  
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MS-and Ms2-Spectra of 1D-FBP (78): 
 
 
  
66
PART A: Synthesis of 3-Fluoro-1-hydroxyacetone Phosphate and its Application in Rabbit Muscle Aldolase-Catalyzed Aldol Reactions 
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Comparison of 1H-NMR spectra of [(S)-1-H2]-1,2,4,5-di-O-isopropylidene--D-fructose (80) 
with 1,2,4,5-di-O-isopropylidene--D-fructose (81): 
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Comparison of 13C-NMR spectra of [(S)-1-H2]-1,2,4,5-di-O-isopropylidene--D-fructose (80) 
with 1,2,4,5-di-O-isopropylidene--D-fructose (81): 
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Part B: Preliminary Experiments Regarding the Synthesis of 
Fluorohydroxyacetone for Organocatalyzed Aldol Reactions 
 
 
 
B.1. Abstract 
 
A short synthesis for fluorohydroxyacetone (FHA) was developed. The structure of FHA was 
characterized by NMR spectroscopy in solution, since pure FHA is highly instable and cannot 
be isolated. The initial idea behind this project was to explore the organocatalyzed aldol 
addition of various aldehydes to FHA for the synthesis of fluorinated carbohydrates and 
carbohydrate derived compounds. 
 
 
B.2. Introduction and Background 
 
Asymmetric Organocatalysis 
 
Although the Hajos-Parrish-Eder-Sauer-Wiechert reaction was known for over 30 years,36 
asymmetric organocatalysis only recently emerged into a rapidly expanding and exciting field 
of organic chemistry.37 After the seminal publication of B. List et al. in year 2000,38 an 
enormous research effort arose in the organic synthetic community.39 An experimentally 
simple proline-catalyzed asymmetric aldol reaction between acetone and various aldehydes 
was used for the synthesis of -hydroxyketones with high enantiomeric excess (Scheme 30, 
entry 1). An historical overview over the organocatalyzed aldol reaction and frequently 
applied organocatalyst are depicted in scheme 30 and figure 7 respectively. Shortly after, 
hydroxyacetone (91) was shown to regioselectively add to various aldehydes under proline-
catalysis to give anti-configurated -dihydroxyketones with high diastereo- and 
enantioselectivities (Scheme 30, entry 2).40 The diastereoselectivity of this reaction can be 
changed to the syn-products by applying catalyst 85 (Scheme 30, entry 5). Like 
hydroxyacetone, fluoroacetone (92) regioselectively reacted with aldehydes under the 
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formation of -hydroxy--fluoroketones, albeit in lower yield, diastereo- and 
enantioselectivities (Scheme 30, entry 3).41 Cyclic derivatives of DHA like 93 proved to be 
superior for asymmetric aldol additions in terms of yield, enantio- and diastereoselectivities 
compared to the DHA (15) and non-cyclic protected DHA derivatives 94 (Scheme 30, entries 
4,6-10).42 Interestingly only the cyclic DHA derivatives were reactive under proline catalysis 
and exclusively yielded anti-configurated products. DHA (15) and non-cyclic protected DHA 
derivatives gave under the catalysis of 87 and 88 the syn-aldol products, proline (82) was not 
a catalyst for these donor substrate.43 It has to be emphasized that all reaction procedures 
mentioned strongly depend on the aldehyde and are not generally applicable to every 
acceptor substrate. The most consistent results were published from Enders et al. and will 
be discussed in more detail (Scheme 31). Enders et al. used the more complex D-
glyceraldehyde (65) and L-Garner’s aldehyde (95) as acceptor aldehydes in proline catalyzed 
aldol additions.44 L-Proline (82) was the catalyst of choice for the synthesis of protected 5-
amino-5-deoxy-L-psicose (96) from L-garner aldehyde (95) in high yield, excellent anti/syn 
selectivity and high ee values (matched case). 5-Amino-5-deoxy-L-tagatose (96) could be 
obtained using D-proline in high ee and de values (mismatched case), however in lower yield. 
Consequently, D-proline was the appropriate catalyst for D-glyceraldehyde 65 (matched case, 
Scheme 31).  
 
Figure 7. Selected amine- and organo-catalysts for asymmetric aldol reactions 
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Scheme 30. Organocatalyzed aldol reactions - historical overview38
-44  
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Scheme 30. Organocatalyzed aldol reactions - historical overview (continued).
38,40,44
 
 
 
Scheme 31. Proline-catalyzed asymmetric aldol reaction of dioxanone with L-garneraldehyde (95) and D-glyceraldehyde 
(65) by Enders et al.44 
 
In the year 2008 Mahrwald et al. found that tertiary amines like cinchonine are capable of 
catalyzing the asymmetric addition of DHA (15) to D-glyceraldehyde (65) to yield D-fructose 
in high yield, enatio- and diastereoselectivity (Scheme 32).45 By using non chiral bases like 
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DBU and TBDMS-protected (S)-lactate, a one to one mixture of L-rhamnulofuranose (101) 
and 6-deoxy-L-sorbose (102) was isolated. 
 
Scheme 32. Amine-catalyzed aldol addition by Mahrwald et al. 
45
 
 
As a consequence of these research efforts, every desired D-hexopyranose (103-106) can be 
synthesized from D-glyceraldehyde (65) by choosing the right catalyst (Scheme 33).46  
 
Deoxofluoro Carbohydrates 
 
The importance of deoxyfluoro carbohydrates is reflected by their manifold applications for 
studying biological systems.47 The ability of fluorine to mimic hydrogen or hydroxyl groups 
made it a perfect tool for medicinal diagnostics, since many fluorinated metabolites 
especially deoxofluoro carbohydrates are processed by the same transporting pathways as 
their unfluorinated counterparts. These properties, combined with the artificial isotope 
fluorine-18, made the positron emission tomography (PET)48 to one of the most powerful 
probes in medicinal diagnostics of cancer, Parkinson and Alzheimer’s diseases by using 2-
deoxy-2-[18F]-fluoro-glucose as reporter.49 In addition, deoxyfluoro sugars have been used 
for the elucidation of enzyme mechanisms50 and for mapping of subsides of monoclonal 
anti-carbohydrate antibodies.51 Gylcosylfluorides52 are well established glycosyldonors for 
the synthesis of oligo-, polysaccacharides and glycans. These carbohydrates are essential in 
many biological processes like cell-cell interaction/adhesion,53 inflammation, blood group 
determination,54 energy metabolism and storage. The synthesis of fluorinated carbohydrates 
is often hampered by the difficulties in stereoselective incorporation of fluorine at specific 
position of the carbohydrate skeleton.55 Often numerous side reactions56 can occur and 
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therefore multistep procedures applying numerous protection- and deprotection steps are 
necessary (for representative example see Scheme 34). 
Scheme 33. De novo synthesis of carbohydrates by Mahrwald et al.
46
 
 
 
Scheme 34. Synthesis of 3-deoxy-3-fluoro-D-fructose (114)
57 
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Concept and Strategy  
 
Besides FHAP (45) for enzyme catalyzed aldol addition, FHA (115) would be a highly desirable 
donor substrate for organo-, antibody- and fructose 6-phosphate aldolase-catalyzed aldol 
additions.58 If FHA (115) can be efficiently synthesized, an enormous variety of biological 
interesting compounds should be easily accessible by the strategy depicted in scheme 35. An 
organocatalytic approach towards 3-deoxy-3-fluoro-uloses and/or 1-deoxy-1-fluoro-uloses 
would be highly desirable, since laborious protecting and deprotection steps could be 
avoided. In addition, the regioselectivity of these reactions may provide information on the 
relative nucleophilic behavior of -fluoro to -hydroxyl carbanions. If the diastereo- and 
enantioselectivity can be controlled by the organocatalyst or tertiary amine base, all 
theoretically possible diastereomers are synthesizable in analogy to the work of Barbas, 
Enders, and Mahrwald et al. with DHA (15). 
 
Scheme 35. Strategy for the organocatalytic synthesis of fluorinated ketoses 
 
Previous Synthesis of FHA (115) 
 
The first synthesis of FHA (115) was reported by Fondy et al.,59 starting from 3-fluoropropan-
1,2-diol (116) (Scheme 36). After regioselective protection of the primary hydroxyl group 
with benzoylchloride, the secondary alcohol 117 was oxidized by a Pfitzner-Moffatt 
oxidation.60 In the subsequent step the keto functionality of 118 was protected as dimethoxy 
ketal to enable the alkaline removal of the benzoyl protecting group. An isolation of FHA 
(115) was not possible due to the instability of FHA (115) which was obtained after acidic 
deketalisation of 120. The main drawback of this synthesis is the usage of only in milligram 
quantities available expensive diol 116 (153 € / 250 mg) as starting material.61  
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Scheme 36. Synthesis of FHA (115) by Fondy et al.
59 
 
Kozarich et al. reported a very concise synthesis of FHA (115) (Scheme 37).62 Starting from 
commercially available 3-fluoropyruvic acid (121), the -keto acid functionalities were 
simultaneously protected as dimethyl ketal and methyl ester using trimethylorthoformate. 
After reduction of the ester 122 with LiAlH4, Fondy’s final intermediate 120 was isolated in 
high yield. Again FHA (115) was only obtained in solution after acid catalyzed deketalisation. 
An obvious drawback of this elegant synthesis is the expensive starting material 3-
fluoropyruvic acid (147 €/g). 
 
Scheme 37. Synthesis of FHA (115) by Kozarich et al. 
62 
 
Retrosynthetic Analysis 
 
Ideally the hydroxyl and the keto functionalities of FHA (115) are generated at a late stage of 
the synthesis, since free -hydroxy ketones tend to be unstable.63 Therefore we thought that 
a simultaneous liberation of these functionalities should be possible by ozonolysis of the -
lactone 123 (Scheme 36). The fluorine atom should be introduced by a halogen-halogen 
exchange with allylic bromide 124 or by fluorination of allylic alcohol 125. As starting 
material 3,3-dimethylacrylic acid (126) (0.27 €/g) or dihydroxyacetone (15) (0.28 €/g) can be 
used. This strategy would allow a short, cheap and protecting group free synthesis of FHA 
(115).  
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Scheme 38. Retrosynthetic analysis of FHA (115). 
 
 
B.4. Results and Discussion 
 
To avoid dangerous DAST, the halogen-halogen exchange approach was investigated first. 
3,3-dimethylacrylic acid 126 was converted into furanone 124 by radical di-bromination of 
the allylic methyl groups with two equivalents of N-bromsuccinimid (NBS) followed by 
alkaline workup.64 All attempts to displace the bromine of 124 either by nucleophilic fluorine 
reagent (CsF, TBAF, KF) or by electrophilic fluorine source (Selectfluor, NFSI) after halogen 
metal exchange65 failed (Scheme 39). The corresponding iodo furanone 127, which was 
obtained after halogen-halogen exchange with sodium iodide in acetone, was unreactive as 
well. After these disappointing results we decided to further elaborate the DAST mediated 
fluorination. A direct conversion of allylic bromide 124 into allylic alcohol 125 with KOH in 
DMF was unsuccessfully. The desired hydroxy furanone 125 was finally obtained after 
displacement of allylic bromide with ammonium acetate followed by acid catalyzed cleavage 
of the acetyl group in moderate yield (Scheme 40).66  
Since this sequence was inefficient, the allylic alcohol 125 was prepared by two slightly 
different strategies starting from DHA (15) (Scheme 41).66,67 A Wittig reaction of DHA (15) 
with phosphor ylid 129 in dichloromethane afforded 125 in moderate yield. Alternatively 
DHA (15) was acetylated with acetanhydride, followed by the same Wittig reaction. The 
furanone 125 was obtained after acid catalyzed cleavage of the acetyl protecting groups and 
lactonisation. The ylid 129 was prepared from ethyl bromoacetate (132) and 
triphenylphosphine (Scheme 42).69  
78
Part B: Preliminary Experiments Regarding the Synthesis of Fluorohydroxyacetone for Organocatalyzed Aldol Reactions 
 
 
Scheme 39. Halogen-halogen exchange approach for the synthesis of furanone 123
66,68
 
 
 
Scheme 40. Synthesis of allylic alcohol 125
66
 
 
 
Scheme 41. DAST-mediated synthesis of furanone 123.
67
 
 
79
Part B: Preliminary Experiments Regarding the Synthesis of Fluorohydroxyacetone for Organocatalyzed Aldol Reactions 
 
 
Scheme 42. Ylid formation
69
 
 
To circumvent the ylide formation a Horner-Wadsworth Emmons (HWE) reaction between 
DHA (15) and trietyhlphosphonoacetate (53) was attempted (Scheme 43). Interestingly, DHA 
(15) was completely unreactive under these conditions.  
 
Scheme 43. Unsuccessful HWE reaction 
 
The fluorination with DAST at -5°C worked smoothly to afford the desired fluoro furanone 
123 in good yield.67a Surprisingly the double bond of 123 could not be ozonized under 
standard conditions using dichloromethane or methanol at -78°C or methanol at -30°C 
(Scheme 44). Only unreacted starting material could be isolated although the inlet time of 
ozone was prolonged substantially and the color of the reaction mixture was deep blue for 
several minutes. Alternatively the double bond was tried to oxidize by a Lemieux-von-
Rudloff-Oxidation. Again only unreacted starting material could be isolated. Finally FHA (115) 
was observed as mixture of several compounds via careful ozonolysis of 123 at -15°C in 
methanol. Elevating the temperature to -5°C and the exposure of the reaction mixture to a 
diluted aqueous HCl solution, after destroying the ozonides and peroxides with 
triphenylphosphine gave cleaner spectra. All effort to isolate FHA (115) or to purify the crude 
product by silica chromatography were unsuccessful and can be attributed to its inherent 
instability as published by Fondy and Kozarich et al.59,62 A precise determination of the FHA 
(115) yield was yet not possible and a more reproducible procedure has to be elaborated for 
performing the reaction on a larger scale. For these reasons the planned organocatalytic 
aldol additions were not implemented.  
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Scheme 44. Synthesis of FHA (115) by ozonolysis of furanone 123 
 
 
B.4. Experimental Procedures 
 
Following compounds were synthesized according to literature procedures: 
 4-(Fluoromethyl)furan-2(5H)-one (123)67a: 
Spectroscopical data: 1H-NMR (400 MHz):  = 6.09-6.05 (m, 1H, CH,) 5.31 (dm, JH-F = 46.1 
Hz, 2H, CH2) 4.88-4.85 (m, 2H, CH2); 
13C-NMR (400 MHz):  = 172.6, 163.6 (d, J = 20.3 Hz) 
116.5 (d, J = 6.4 Hz) 78.2 (d, J = 169.8 Hz) 70.5 (d, J = 5.7 Hz); 19F-NMR (600 MHz):  = -
226.2 (t, J = 46.1 Hz). 
 4-(Bromomethyl)furan-2(5H)-one (124)64 
 4-(Hydroxymethyl)furan-2(5H)-one (125)67a 
 Ethyl (triphenylphosphoranyliden)acetate (129)69 
 1,3-Dihydroxyacetone diacetate (130)67b 
 Ethyl 4-acetyloxy-3-(acetyloxy)methyl-but-2-enoate (131)67a 
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4-(Iodomethyl)furan-2(5H)-one (127): 
 
 
4-(Bromomethyl)furan-2(5H)-one (124) (100 mg, 0.56 mmol) was dissolved in dry acetone (3 
mL) and to secure absoluteness molecular sieve (3Å) was added. After ten minutes, sodium 
iodide (169 mg, 1.13 mmol) were added and the reaction mixture was refluxed until 1H-NMR 
monitoring showed consumption of the starting material. The reaction mixture was 
quenched by addition of H2O (2 mL) and extracted with diethyl ether (2 x 3 mL). The 
combined organic phases were washed with aqueous NaHSO3 solution (2 %) and dried over 
MgSO4. After filtration and removal of the solvent under reduced pressure 4-
(iodomethyl)furan-2(5H)-one (127) was isolated (80 mg, 63 %). 1H-NMR (250 MHz, CDCl3):  
= 6.13-6.09 (m, 1H, CH,) 5.02-4.98 (m, 2H, CH2) 4.17-4.12 (m, 2H, CH2); 
13C-NMR (400 MHz, 
CDCl3):  = 165.0, 117.7, 72.4, -8.1.  
 
4-Acetyloxymethylfuran-2(5H)-one (128): 
 
 
4-(Bromomethyl)furan-2(5H)-one (124) (50 mg, 0.28 mmol) was dissolved in dry acetonitrile 
(2 mL) and ammonium acetate (26 mg, 0.35 mmol) was added. Since TLC monitoring showed 
unconsumed starting materials after 24 hours, ammonium acetate (13 mg, 0.175 mmol) was 
added again and the reaction mixture was stirred for another 12 hours. The reaction was 
quenched by addition of H2O (1 mL) and diethyl ether (2 mL). The phases were separated 
and the organic layer was extracted with diethyl ether (2 x 5 mL). The combined organic 
phases were dried over MgSO4, concentrated and purified by silica chromatography 
(toluene/hexane = 3/1) to yield 4-(acetyloxy methyl)furan-2(5H)-one (128) (19 mg, 43%). The 
spectroscopical data were identical with those reported.66  
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Fluorohydroxyacetone (115): 
 
 
Ozone was bubbled through a solution of 4-(Fluoromethyl)furan-2(5H)-one (123) (29 mg, 25 
mmol) in dry methanol (2.5 mL) at -5°C for seven minutes . Dry air was bubbled through the 
solution (~ 4 minutes) and PPh3 (82 mg, 0.31 mmol) was added. The mixture was allowed to 
reach room temperature by stirring over night. To remove the methanol, D2O (1 mL) was 
added and the solvent was evaporated under reduced pressure (not to dryness!). After 
repeating this procedure once again, the white solid was removed by filtration over 
absorbent cotton, rinsed with D2O and the aqueous solution was acidified by addition of a 
DCl solution (1 M). After heating the reaction mixture over night at 40°C, 
Fluorohydroxyacetone (115) could be identified by 1H-NMR in good purity. The 
spectroscopical data were identical with those reported.62 
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Selected spectra:  
 
4-(Fluoromethyl)furan-2(5H)-one (123):  
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1H-NMR of FHA (115): 
  
19F-NMR (decoupled) of FHA (115): 
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19F-NMR (coupled) of FHA (115): 
 
 
 
-222 -224 -226 -228 -230 -232 -234 -236 -238 ppm
-
2
3
4
.
7
3
-
2
2
8
.
6
1
-
2
2
7
.
7
3
-
2
2
3
.
6
8
-
2
2
0
.
9
8
0
.2
6
1
.0
0
-234.7 -234.8 ppm-228.6 ppm
F
OD
OD
DO
F
O
OD
86
PART C: Indium-Mediated Allenylation of Aldehydes with 4-Bromo-2-butyn-1-ols: Versatile -Hydroxyacetyl Anion Equivalents 
 
PART C: Indium-Mediated Allenylation of Aldehydes with 
4-Bromo-2-butyn-1-ols: Versatile -Hydroxyacetyl Anion 
Equivalents  
 
 
 
C.1. Abstract 
 
We developed a facile and convenient preparation and application of -hydroxyacetyl anion 
equivalents for carbon chain elongations. A two-step sequence of an indium mediated 
allenylation of aldehydes with 4-bromo-2-butyn-1-ols followed by ozonolysis of the resulting 
allene was used to generate the desired substituted dihydroxyacetone fragments. The 
regioselectivity of the indium-promoted C-C bond forming reaction can be controlled by the 
hydroxyl protecting group on 4-bromo-2-butyn-1-ol, preferentially yielding either allenes or 
alkynes. Compared to established protocols, the necessary amount of indium for the 
allenylation was decreased by a factor of two to four. The versatility of this strategy was 
demonstrated by the stereoselective and efficient synthesis of D-erythro-2-pentulose (D-
ribulose) and 1-deoxy-D-ribulose. 
 
 
C.2. Introduction and Background 
 
The concept of reactivity “umpolung” proved to be a significant advancement in organic 
synthesis.70 Among acyl anion equivalents, -hydroxyacetyl anions are of increasing interest, 
although mild chemical methods for creating them are relatively scarce so far.71,72 The 
addition of -hydroxyacetyl anion equivalents to aldehydes and ketones gives access to a 
variety of natural products, like keto sugars, cortical steroids and anthracycline antibiotics.73 
Recently, indium-mediated reactions of substituted propargyl bromides with aldehydes have 
been established for the regioselective formation of either homopropargylic or allenylic 
alcohols.74,75 Especially -hydroxy allenes have proven to be valuable synthetic inter-
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mediates due to their variability in chemical applications.76 Following the previous synthetic 
employed -hydroxyacetyl anion equivalents, the mechanism and application of indium-
mediated allenylation/propargylation reactions will be discussed. 

-Hydroxyacetyl Anion Equivalents 
 
Since decades organic chemists search for efficient methods which permit a direct 
interconversion of aldoses into the C2 elongated ketose homologues. 2-Nitroethanol was 
one of the first -hydroxyacetyl anion equivalents used for this purpose. In 1950 Swoden et 
al.71h,77 condensed arabinose 133 with 2-nitroethanol 134 under basic conditions and after 
addition of sulfuric acid (Nef reaction) D-gluco- and D-manno-heptulose (135 and 136) were 
isolated in low yield (Scheme 45). 
 
Scheme 45. 2-Nitroethanol as -hydroxyacetyl anion equivalent
77
 
 
In 1971 Paulsen et al. published a simple synthesis of pillarose, using the dianion of 1,3-
dithian-2-methanol as an -hydroxyacetyl anion equivalent.71e,78 The dithiane was 
desulfuricated by borontrifluoride in presence of mercury oxide in low yield (Scheme 46). 
 
Scheme 46. 1,3-Dithian-2-methanol dianion (138) as -hydroxyacetyl anion equivalent
71e,78
 
 
In 1981 Mukaiyma et al. described an efficient method for the synthesis of D-erythro-2-
pentulose (141) by a stereoselective addition of 2-furyllithium (142) to 2,3-O-isopropylidene-
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D-glyceraldehyde (65) (Scheme 47).71a The intermediate furfurylalcohol (143) was converted 
into the desired pentulose by a bromination/ozonolysis sequence. 
 
Scheme 47. 2-Furyllithium (142) as -hydroxyacetyl anion equivalents
71a
  
 
Dihydro-1,4-dioxin-2-yl lithium (146) was used for the synthesis of various -
dihydroxyketones by Fetizon et al. (Scheme 48).71b The hydroxy intermediate 147 was 
converted to the desired substituted dihydroxyacetone 149 by an oxidation/reduction 
sequence. 
 
Scheme 48. Dihydro-1,4-dioxin-2-yl lithium (146) as -hydroxyacetyl anion equivalent
71b
  
 
In 1990 Ito et al. reported a facile samarium(II)iodide coupling of 152 with aldehydes and 
ketones (Scheme 49).72c,d The resulting imines were hydrolyzed under acidic conditions to 
give various substituted 1-O-benzyl-protected dihydroxyacetones 153. This strategy was 
used in the short synthesis of D-erythro-2-pentulose. 
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Scheme 49. Samarium(II)iodide coupling of aldehydes with 152
77c,d 
 
All approaches for the generation of an -hydroxyacetyl anion equivalent mentioned above 
suffer either from low yield or from harsh reaction conditions, which are not applicable to 
unprotected carbohydrates.  
In nature, the transfer of an -hydroxyketone subunit from one substrate to another is 
catalyzed by transketolases in presence of thiamine pyrophosphate and magnesium ions. 
Synthetically -hydroxypyruvic acid (HPA) 154 is used as a ketol donor, making the reaction 
irreversible due to decarboxylation of 154. The isolated yields differ strongly with respect to 
the acceptor aldehydes (Scheme 50).72 
 
Scheme 50. Transketolase catalyzed synthesis of substituted dihydroxyacetones
72
 
 
Indium-Mediated Allenylation/Propargylation of Aldehydes with Substituted Alkynes 
 
Albeit one example of an indium mediated propargylation was already mentioned in the 
seminal publication on indium mediated allylations of carbonyl compounds by Araki et al.,79 
it took another seven years until the first preparatively useful study on indium-mediated 
couplings of aldehydes with propargyl bromides was published.80 Substituted 
propargylbromides preferentially yielded the allene products, whereas unprotected 
propargylbromides gave the alkyne products (Scheme 51). Trialkysilyl propargylbromides 
afforded mixtures of regioisomers under aqueous reaction conditions. In 2003 Loh et al. 
showed that the regioselectivity of propargylbromides can be controlled by employing 
trimetylsilyl or bulkier triisopropylsilyl propargylbromides under Lewis acid catalysis.81 The 
change in regioselectivity was attributed to chelation of silicon to the reactive indium 
90
PART C: Indium-Mediated Allenylation of Aldehydes with 4-Bromo-2-butyn-1-ols: Versatile -Hydroxyacetyl Anion Equivalents 
 
intermediate, which is not possible for sterical reasons for the triisopropylsilyl 
propargylbromides.  
 
Scheme 51. Indium-Mediated Allenylation/Propargylation of Aldehydes with Substituted Alkynes
80-82,85,88 
 
The active intermediate of indium-mediated allenylation/propargylation in solution is still a 
matter of debate.82 Chan et al. observed an indium(I) species in aqueous solution and a 
mixture of indium(I) and indium(III) species in tetrahydrofuran (Scheme 50).82a The system 
(1H-spectra) was further complicated by the substituent on the propargylbromides. For 
unsubstituted prop-2-ynyl bromides the allenylindium structures dominated, due to their 
higher stability. This result was verified by either HF or B3LYP calculations. After addition of 
p-chlorobenzaldehyde, the corresponding homopropargylic alcohol was isolated. 
Substituents at the alkyne strongly influenced the equilibrium between the allenyl and the 
alkenylindium species, favoring the latter one due to steric repulsion. Addition of p-
chlorobenzaldehyde to these systems yielded allenylic alcohols. All findings were in 
agreement with an SE2’ reaction, a pathway generally observed by addition of 
allenyl/propargyl organometallics to carbonyl compounds (Figure 8).  
 
Scheme 52. Mechanism of the indium-mediated propargylation/allenylation of aldehydes with substituted 
propargylbromides by Chan et al.82  
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Figure 8. Possible transition states for the allenylation (A) and propargylation reaction (B) 
 
In 2006 Hammond et al. crystallographically characterized the first In-C-CC complex (Figure 
9).83 Two alkynyl ligands, one bromine and two molecules of DMSO coordinated to central 
indium atom. By reaction of similar substituted complexes with electrophiles, they 
demonstrated that the ratio of allene to alkyne products solely depend on the reactivity of 
the electrophile (Scheme 53). 
 
Figure 9. Crystal structure of first In-C-CC complex
83
 
 
 
Scheme 53. Indium-mediated difluroallenylation and propargylation
83
 
 
Recently allenes have been established as versatile synthetic intermediates.84 Especially 
transition metal catalyzed cyclizations by gold or platinum are synthetically valuable 
transformations. Lee et al. published two consecutive papers on combining indium mediated 
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allenylations with gold-catalyzed cyclizations (Scheme 54 and 55).85 Alternatively the allenes 
can be further converted to other synthetically useful intermediates by Diels-Alder reactions 
or by Lewis acid catalysis. 
 
Scheme 54. Allenes as synthetic intermediates
85 
 
 
Scheme 55. Allenes as synthetic intermediates
85
 
 
The conversion of allenes into ketones by ozonoylsis86 is straight forward and was reported 
for the synthesis of 1-deoxy-heptuloses by Whitesides et al.87 and the natural product (+)-
goniofufurone (170) by Li et al. (Scheme 56 and 57).88 
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Scheme 56. Synthesis of 1-deoxy-heptuloses by Whitesides et al.87 
 
 
Scheme 57. Synthesis of (+)-goniofufurone by Li et al.88 
 
Concept and Strategy 
 
The idea of this project was the conversion of aldoses into ketoses by a C2 elongation. 
Ideally, naturally occurring aldoses are used to avoid the normally necessary protection and 
deprotection steps in carbohydrate chemistry. A novel equivalent to an -hydroxyacetyl 
anion had to be designed for this transformation, since no general applicable method existed 
for this C2 synthon. Our retrosynthetic considerations directed us to 4-bromo-2-butin-1-ol 
for a synthetic equivalent for an -hydroxyacetyl anion (Figure 10). For this substituted 
propargylbromide we expected that allenes 173 are formed by an indium-mediated 
allenylation reaction with aldehydes. Ozonolysis of the allene moiety of 173 afforded the 
desired C2 elongated ketoses (Scheme 58). 
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Figure 10. 4-bromo-2-butin-1-ols as -hydroxyacetyl anion equivalents. 
 
 
Scheme 58. Retrosynthetic analysis. 
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C.3. Results and Discussion 
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Indium-Mediated Allenylation of Aldehydes and Its Application in
Carbohydrate Chemistry: Efficient Synthesis of D-Ribulose and
1-Deoxy-D-ribulose
Michael Fischer,[a] Christoph Schmölzer,[a] Christina Nowikow,[a] and Walther Schmid*[a]
Keywords: Indium / Allenes / Carbohydrates / Acyl anion / Water chemistry
A two-step reaction sequence starting with the indium-medi-
ated allenylation of aldehydes with 4-bromo-2-butyn-1-ols
and subsequent ozonolysis of the resulting allenylic product
was developed to generate a variety of dihydroxyacetone de-
rivatives. The regioselectivity of the indium-promoted C–C
bond-forming reaction can be manipulated through hydroxy
protecting groups on 4-bromo-2-butyn-1-ol, yielding either
Introduction
Indium-mediated reactions, such as the addition of sub-
stituted propargyl bromides to aldehydes, have gained sub-
stantial interest in synthetic organic chemistry.[1,2] This re-
action enables the regioselective formation of either homo-
propargylic or allenylic alcohols, the latter being extremely
valuable synthetic intermediates due to their variability in
chemical applications.[3] Suitably substituted propargyl bro-
mides can be retrosynthetically seen as a source of α-hy-
droxyacetyl anion equivalents (Scheme 1), which play im-
portant roles in the concept of “umpolung” reactivity in
synthetic strategies.[4] However, simple and mild methods
for generating α-hydroxyacetyl anions are relatively
scarce[5,6] although their application in the synthesis of a
variety of natural products,[7] like cortical steroids, anthra-
cycline antibiotics, or keto sugars, have impressively demon-
strated their synthetic potential.
This publication reports on a facile synthetic sequence,
generating an α-hydroxyacetyl anion equivalent from 4-
bromo-2-butyn-1-ols and utilizing this synthon in an in-
dium-mediated allenylation reaction of various aldehydes.
The resulting allenes are converted into keto moieties by
ozonolysis, thus forming the desired substituted dihydroxy-
acetone derivative. Because the regioselectivity of the in-
dium-mediated reaction can be manipulated by the nature
of the hydroxy protecting group of 4-bromo-2-butyn-1-ol,
the ratio of the allene and alkyne products can be influ-
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allenes or alkynes as preferred products. Compared to estab-
lished protocols, the necessary amount of indium for this type
of allenylation can be decreased by a factor of two to four.
The versatility of this strategy was demonstrated in the
stereoselective and straightforward synthesis of D-ribulose
and 1-deoxy-D-ribulose.
Scheme 1. Retrosynthetic concept.
enced within a certain range. We used this strategy for a
stereoselective and efficient synthesis of d-erythro-2-pent-
ulose (d-ribulose) and its 1-deoxy-d-erythro-2-pentulose
analogue.
Results and Discussion
Our initial studies focused on the addition of 1-(benz-
yloxy)-4-bromo-2-butyne (2) to 2,3-O-isopropylidene-d-
glyceraldehyde[8] (1) under indium promotion. Compound
1 was used as the starting aldehyde due to its synthetic im-
portance as a starting material in carbohydrate chemistry
and total syntheses.[9] The yields obtained are summarized
in Table 1.
Reaction of 1 with the in situ generated organoindium
reagent in water or THF did not yield significant amounts
of products (Table 1, Entries 1 and 2).[10] In contrast, by
addition of LiI or LiCl in THF the reaction proceeded
smoothly and afforded good yields of desired allene 3a
(Table 1, Entries 3 and 8).[11,12] The use of THF/water mix-
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Table 1. Indium-mediated reactions of 2,3-O-isopropylidene-d-
glyceraldehyde (1) with 1-(benzyloxy)-4-bromo-2-butyne (2).
Entry[a] Indium Additive Solvent Yield 3a/3b[c]
[equiv.] [equiv.] [%][b]
1 1.0 H2O 0 nd
2 1.0 THF ca. 5 nd
3 1.0 LiI (1.0) THF 74 73:27
4 1.0 LiI (1.0) THF/H2O 58 52:48
5 1.0 LiI (3.0) DMF 70 52:48
6 1.0 LiI (2.0) THF 71 69:31
7 1.0 LiBr (2.0) THF 46 70:30
8 1.0 LiCl (2.0) THF 84 70:30
9 1.0 LiF (2.0) THF 0 nd
10 0.55 LiI (1.0) THF 69 78:22
11 0.55 LiCl (2.0) THF nd[d] nd
12 1.0 nBu4NI (1.0) THF 58 69:31
13 1.0 nBu4NCl (1.0) THF 0 nd
14 1.0 LiNO3 (2.0) THF 0 nd
15 1.0 NaCl (2.0) THF 35 68:32
[a] Except where indicated, all reactions were carried out on 0.5-
mmol scale with aldehyde/bromide/indium = 1:1:1 under ultrasonic
conditions. [b] Isolated combined yields of allenes and alkynes.
[c] nd = not determined. [d] Starting materials were not fully con-
sumed.
tures or DMF as solvent led to a decrease in the combined
yields and regioselectivity (Table 1, Entries 4 and 5). The
best results were obtained by addition of 1 to a suspension
of indium (1 equiv.), propargyl bromide 2 (1 equiv.), and
either LiI (1 equiv.) or LiCl (2 equiv.) in anhydrous THF
under ultrasonic conditions (Table 1, Entries 3 and 8).[13]
However, nearly half of the metallic indium remained un-
changed in the reaction mixture after consumption of start-
ing materials 1 and 2.[14] Reducing the amount of indium
to 0.55 equiv. resulted in nearly the same combined yields
of allene 3a and alkyne 3b (Table 1, Entry 10), whereas the
regioselectivity shifted towards desired allene 3a. In this
case, by substituting LiI with LiCl (Table 1, Entry 11) only
trace amounts of products were observed. Additionally, a
further decrease in the amount of indium to 0.2 equiv. led
to incomplete consumption of starting materials 1 and 2.
For practical reasons, we used the optimized reaction con-
ditions of Entry 10 (Table 1) for further studies.
Interestingly, the allenylation of 1 was highly diastereo-
selective (96%de), whereas the propargylation gave mix-
tures of diastereomers ranging from 4:1 to 2:1
(erythro/threo).[15] The configuration of the stereocenter
formed in product 3a was unambiguously assigned by
transformation of the allenylic alcohol into the correspond-
ing d-erythro-2-pentulose (25).[16] The observed anti rela-
tionship between the newly generated hydroxy group and
the C2 hydroxy group of starting aldehyde 1 can be easily
rationalized by the Felkin–Anh model.[17]
www.eurjoc.org © 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Eur. J. Org. Chem. 2011, 1645–16511646
The organoindium species involved in this type of reac-
tion was the subject of numerous investigations.[18,19] The
data summarized in Table 1 suggest some basic mechanistic
considerations. In general, propargyl iodides proved to be
more reactive than bromides, albeit leading to lower
yields.[20] The addition of LiI to the reaction mixtures ac-
celerated the formation of the reactive organoindium spe-
cies, presumably by in situ generation of the corresponding
propargyl iodides.[21] The addition of LiCl instead of LiI
beneficially influenced the combined yield of alkyne- and
allene-type products (Table 1, Entries 6 and 8).[22] However,
only in the case where LiI was applied could the amount of
indium be decreased significantly (Table 1, Entries 10 and
11). Using tetrabutylammonium salts instead of lithium
salts only in the case of nBu4NI led to product formation
(Table 1, Entries 12 and 13).[23] In general, Grignard-type
reaction conditions were superior to Barbier-type ones.[12b]
Because indium chelates to oxygen functionalities,[24] we
hypothesized that the hydroxy protecting group of com-
pound 2 is crucial for the regioselective formation of 3a and
3b (Scheme 2).[25] The results are summarized in Table 2. In
analogy to the investigations of Lin et al. on siliconated
propargyl bromides,[2a] we observed that bulky protecting
groups favor the formation of the allenylic alcohols (i.e., 3a
and 8a; Table 2, Entries 1 and 6) presumably via intermedi-
ate B (Scheme 2). As expected, changing the protecting
group from benzyl to methyl decreased the regioselectivity
for the formation of 4a while increasing the combined yield
(Table 2, Entry 2). Unprotected 4-bromo-2-butyn-1-ol (5;
Table 2, Entry 3) reversed the regioselectivity of the reaction
presumably by formation of intermediate A (Scheme 2),
thus yielding mainly homopropargylic alcohol 5b. In ad-
dition, acetyl- or Cbz-protected 4-bromo-2-butyn-1-ol may
stabilize allenylic intermediate C by formation of a six-
membered transition state, thus yielding propargylic deriva-
tives (i.e., 6b and 7b; Table 2, Entries 4 and 5) preferentially.
Further evidence for intermediate C was obtained by the
following observations: Compounds with an oxygen atom
too distant for chelating the allenylic intermediate or lack-
ing an oxygen atom (Table 2, Entries 7 and 8) almost exclu-
sively gave allenylic products 9a and 10a.
These results led us to examine the relative reactivity of
1-(benzyloxy)-4-bromo-2-butyne (2) towards a variety of
different aldehydes (Table 3). In summary, citronellal gave
lower yields than aromatic and α,β-unsaturated aldehydes
(Table 3, Entries 1–4). 2-Phenylpropionaldehyde and the
serine-derived “Garner aldehyde” gave good to excellent
diastereoselectivity (Table 3, Entries 5 and 6).[26] As ob-
served for 4-hydroxybenzaldehyde, a free hydroxy group is
tolerated in carbonyl substrates (Table 3, Entry 3).
Furthermore, we examined the potential reactivity of 1-
(benzyloxy)-4-bromo-2-butyne (2) towards water-soluble
substrates (Table 3, Entries 7–11). In these cases, we added
an aqueous solution of the corresponding aldehydes to the
preformed indium intermediate, resulting in THF/water
mixtures of 2:1. As depicted in Table 3, a freshly prepared
solution of formaldehyde reacted smoothly with 2, yielding
compound 17a in excellent yield. In analogy, aqueous solu-
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Scheme 2. Allenylation vs. propargylation: influence of hydroxy
protecting groups on regioselectivity. The corresponding organo-
indium(III) species are not shown.[19]
Table 2. Indium-mediated reactions of 2,3-O-isopropyliden-d-glyc-
eraldehyde (1) with substituted propargyl bromides.
Entry[a] BrCH2CCR1, R1 = Yield [%][b] Allene/Alkyne
1 CH2OCH2Bn (2) 69 78:22 (3a/3b)
2 CH2OCH3 (4) 80 60:40 (4a/4b)
3 CH2OH (5) 70 28:72 (5a/5b)
4 CH2OAc (6) 70 45:55 (6a/6b)[c]
5 CH2OCbz (7) 65 49:51 (7a/7b)
6 CH2OTBDPS (8) 48 67:33 (8a/8b)
7 CH3 (9) 75 98:2 (9a/9b)
8 CCCH2OH (10) 40 99:1 (10a/10b)
[a] All reactions were carried out on 0.5-mmol scale with aldehyde/
bromide/LiI/indium = 1:1:1:0.55 under ultrasonic conditions.
[b] Isolated combined yield. [c] Partial acetyl migration in allenylic
product 6a was observed (1-OAc/3-OAc = 56:44).
tions of glycolaldehyde and chloroacetaldehyde were used
and again satisfactory yields were obtained (Table 3, En-
tries 8 and 9). With unprotected d-glyceraldehyde, the syn
allenylation product was obtained in high diastereoselectiv-
ity (Table 3, Entry 10).[27] Unprotected d-arabinose pro-
duced an inseparable mixture of corresponding allene 21a
and alkyne 21b in low yield (Table 3, Entry 11).[28] The
change in regioselectivity of Garner’s aldehyde and d-
glyceraldehyde (Table 3, Entries 6 and 10) in comparison to
the other aldehydes used is remarkable, although we do not
have a satisfactory explanation of this phenomenon at the
moment.
Subsequently, as proof of concept for the present meth-
odology, allene 3a was converted into corresponding pent-
ulose 25 (Scheme 3). Ozonolysis of the allene functionality
of 3a at –78 °C in dichloromethane gave 2-keto derivative
22 in excellent yield. Deprotection of the benzyl and acet-
onide protecting groups was achieved by standard pro-
cedures to yield d-erythro-2-pentulose (25).[29]
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Table 3. Indium-mediated allenylation of aldehydes with 1-(benz-
yloxy)-4-bromo-2-butyne (2).
[a] Except where indicated, all reactions were carried out on 1.0-
mmol scale with aldehyde/bromide/LiI = 1:1:1 under ultrasonic
conditions. Solvents: THF (Entries 1–6), THF/H2O = 2:1 (En-
tries 7–11). [b] Isolated combined yield. [c] Yield is adjusted to ac-
count for recovered starting materials. [d] Diastereomeric ratios of
allenylic products (anti/syn): 15a (1:10), 16a (40:1), 20a (1:8), and
21a (1:20). [e] Cinnamyl aldehyde only gave regiospecific 1,2-ad-
dition products. [f] Chloride was substituted by iodide in a ratio of
1:3 in the allenylic products. [g] Instead of LiI, LiCl (2 equiv.) was
used.
The versatility of the present methodology was further
demonstrated by an efficient synthesis of 1-deoxy-d-rib-
ulose (29).[30,31] In a three-step synthesis, 29 was obtained
in an overall yield of 51% starting from 1 and by using 1-
bromo-2-butyne as an acetyl anion equivalent.[32] In com-
parison to the literature,[33] when adding LiI the applied
quantities of 1-bromo-2-butyne and indium were decreased
by a factor of two and four, respectively. Because 3a is a
fully orthogonally protected precursor, the sequence of de-
protection steps can be easily altered, giving rise to various
derivatives of pentulose (24, 26, and 28).
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Scheme 3. Synthesis of d-erythro-2-pentulose (25) and 1-deoxy-d-
erythro-2-pentulose (29).
Conclusions
Hydroxy-protected 4-bromo-2-butyn-1-ols (i.e., 2, 4, 6–
8) are versatile synthetic equivalents for α-hydroxyacetyl
anions. This fact is demonstrated by their application in a
short and efficient indium-mediated synthesis of d-erythro-
2-pentulose (25) in 32% overall yield. The regioselectivity
of the indium-promoted C–C bond-forming reaction can be
influenced by the protecting group on 4-bromo-2-butyn-1-
ol (for 2, 4–8). Due to chelation control, the addition of
unprotected 4-bromo-2-butyn-1-ol (5) to aldehydes yields
mainly alkyne-type products, whereas the addition of 1-
(benzyloxy)-4-bromo-2-butyne (2) leads to allene-type de-
rivatives preferentially. Compared to established synthetic
protocols, the amount of indium was decreased by a factor
of two to four. Furthermore, the reaction presented toler-
ates aqueous reaction conditions, thus significantly broad-
ening the scope of this method. The applicability of this
concept is further demonstrated by a three-step synthesis of
1-deoxy-d-erythro-2-pentulose (29).
Experimental Section
General Considerations: All allenylations were carried out in oven-
dried Erlenmeyer flasks under an argon atmosphere. Ultra-
sonication was performed in a conventional ultrasound cleaning
bath at room temperature. Indium (powder, 100 mesh) was pur-
chased by Sigma–Aldrich. Anhydrous THF was distilled from po-
tassium under an atmosphere of argon. 1H and 13C NMR spectra
were recorded with either a Bruker Avance DRX 400 MHz or
www.eurjoc.org © 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Eur. J. Org. Chem. 2011, 1645–16511648
DRX 600 MHz spectrometer. Unless otherwise stated, all NMR
spectra were measured either in CDCl3 solutions and referenced to
the residual CHCl3 signal (1H, δ = 7.26 ppm; 13C, δ = 77.16 ppm)
or in D2O solutions (HDO, 1H, δ = 4.79 ppm). High-resolution
mass spectrometry (HRMS) was performed with a Finnigan MAT
900 with resolution of 10000. Optical rotations were measured with
a P341 Perkin–Elmer polarimeter. Flash chromatography was per-
formed by using Merck silica gel 60 (0.004–0.063 mm). TLC moni-
toring was done on Merck plates (silica gel 60 F254), and com-
pounds were visualized by treatment with a solution of (NH4)6-
Mo7O24·4H2O (48 g) and Ce(SO4)2 (2 g) in 10% H2SO4 (1 L), fol-
lowed by heating, or with an aqueous KMnO4 solution. 2,3-O-
Isopropylidene-d-glyceraldehyde and O-protected 4-bromobut-2-
yn-1-ol were prepared by following literature procedures.[8,25] For
the preparation of the formalin solution, paraformaldehyde (1.08 g,
36 mmol) was heated at reflux in water (20 mL) containing concen-
trated H3PO4 (200 μL) for 1.5 h until a clear solution was obtained.
Standard Conditions for Allenylation (Method A): Synthesis of Com-
pounds 3a–21a and 3b–21b
Representative Procedure of the Reaction of Aldehydes with Indium
and Substituted Propargyl Bromides: To a suspension of powdered
indium (32 mg, 0.275 mmol) and LiI (67 mg, 0.5 mmol) in dry THF
(4 mL) was added 1-(benzyloxy)-4-bromo-2-butyne (2; 120 mg,
0.5 mmol). After the mixture was sonicated for 20 min under an
argon -atmosphere, 2,3-O-isopropylidene-d-glyceraldehyde (1;
65 mg, 0.5 mmol) was added. The reaction mixture was further
sonicated until TLC monitoring (hexane/ethyl acetate = 3:2)
showed complete consumption of the starting material. The reac-
tion was quenched by the addition of a saturated solution of
NaHCO3 (5 mL). The aqueous phase was separated and extracted
with ethyl acetate (315 mL). The combined organic layers were
washed with thiosulfate solution (2%) and brine, dried with
MgSO4, filtered, and concentrated. The regioisomers were sepa-
rated by silica gel column chromatography (hexane/ethyl acetate =
5:1) to yield 3a (78 mg, 54%) and 3b (22 mg, 15%). The yield of
the reaction was not decreased by scaling up to 2 mmol.
1-O-Benzyl-2-deoxy-2-C-ethenylidene-4,5-O-isopropylidene-D-erythro-
pentitol (3a): [α]D20 = +20.2 (c = 1.0, CH2Cl2). 1H NMR (400 MHz,
CDCl3): δ = 7.38–7.27 (m, 5 H, Ar-H), 4.97–4.93 (m, 2 H, CH2),
4.56 (d, 2J = 11.9 Hz, 1 H, CH2), 4.53 (d, 2J = 11.9 Hz, 1 H, CH2),
4.36–4.30 (m, 1 H, CH), 4.26 (dt, 2J = 11.3 Hz, 5J = 2.2 Hz, 1 H,
CH2), 4.22 (m, 1 H, CH), 4.14 (dt, 2J = 11.3 Hz, 5J = 1.8 Hz, 1 H,
CH2), 4.05 (dd, 2J = 8.4 Hz, 3J = 6.3 Hz, 1 H, CH2), 4.01 (dd, 2J
= 8.4 Hz, 3J = 6.1 Hz, 1 H, CH2), 2.64 (d, 3J = 4.4 Hz, 1 H, OH),
1.43 (s, 3 H, CH3), 1.35 (s, 3 H, CH3) ppm. 13C NMR (400 MHz,
CDCl3): δ = 207.2 (C), 137.8 (C), 128.6 (2 CH), 128.1 (2 CH), 128.0
(CH), 109.4 (C), 100.4 (C), 77.9 (CH2), 77.5 (CH), 72.5 (CH2), 71.2
(CH), 69.8 (CH2), 65.8 (CH2), 26.7 (CH3), 25.3 (CH3) ppm. IR
(film): ν˜ = 3433, 2931, 1957, 1062, 738, 698 cm–1. HRMS (ESI):
calcd. for C17H22O4Na [M + Na]+ 313.1416; found 313.1411.
(2R)-7-(Benzyloxy)-1,2-O-isopropylidenehept-5-yne-1,2,3-triol (3b):
Mixture of two diastereomers: major/minor = 2.8:1.0. 1H NMR
(400 MHz, CDCl3, major isomer): δ = 7.37–7.27 (m, 5 H, Ar-H),
4.59 (s, 2 H, CH2), 4.19–4.15 (m, 2 H, CH2), 4.11–4.04 (m, 2 H,
CH2), 4.01–3.94 (m, 1 H, CH), 3.80–3.74 (m, 1 H, CH), 2.63–2.48
(m, 2 H, CH2), 1.42 (s, 3 H, CH3), 1.36 (s, 3 H, CH3) ppm. 13C
NMR (400 MHz, CDCl3, major isomer): δ = 137.6 (C), 128.6 (2
CH), 128.2 (2 CH), 128.0 (CH), 109.5 (C), 82.3 (C), 79.2 (C), 77.5
(CH), 71.9 (CH2), 70.4 (CH), 66.0 (CH2), 57.8 (CH2), 26.8 (CH3),
25.3 (CH3), 24.1 (CH2) ppm. IR (film): ν˜ = 3377, 2825, 2240, 1062,
747. 699 cm–1. HRMS (ESI): calcd. for C17H22O4Na [M + Na]+
313.1416; found 313.1406.
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Typical Procedure for Ozonolysis (Method B): Synthesis of Com-
pounds 22, 23, and 28
1-O-Benzyl-4,5-O-isopropylidene-D-erythro-2-pentulose (22): Ozone
was bubbled through a solution of compound 3a (145 mg,
0.5 mmol) in CH2Cl2 (25 mL) at –78 °C until the color of the mix-
ture turned blue. Dry air was bubbled through the solution until
the blue color disappeared. After addition of PPh3 (157 mg,
0.6 mmol), the mixture was allowed to reach room temperature by
stirring overnight. The solvent was removed under reduced pres-
sure, and the crude material was purified by flash chromatography
(hexane/ethyl acetate = 4:1) to yield compound 22 (133 mg; 95%).
[α]D20 = –57.3 (c = 0.3, CH2Cl2).1H NMR (400 MHz, CDCl3): δ =
7.39–7.26 (m, 5 H, Ar-H), 4.62 (s, 2 H, CH2), 4.57 (d, 2J = 18.2 Hz,
1 H, CH2), 4.29 (d, 2J = 17.9 Hz, 1 H, CH2), 4.17 (dd, 2J = 6.7 Hz,
3J = 6.4 Hz, 1 H, CH2), 4.12–3.93 (m, 3 H, 2 CH, CH2), 3.29 (d,
3J = 5.8 Hz, 1 H, OH), 1.42 (s, 3 H, CH3), 1.33 (s, 3 H, CH3) ppm.
13C NMR (400 MHz, CDCl3): δ = 208.0 (C), 137.1 (C), 128.7 (2
CH), 128.3 (CH), 128.2 (2 CH), 110.4 (C), 76.2 (CH), 75.3 (CH),
73.7 (CH2), 73.6 (CH2), 67.1 (CH2), 26.7 (CH3), 25.2 (CH3) ppm.
IR (film): ν˜ = 3386, 2934, 1729, 1067, 739, 698 cm–1. HRMS (ESI):
calcd. for C15H20O5Na [M + Na]+ 303.1208; found 303.1206.
1-Deoxy-4,5-O-isopropylidene-D-erythro-2-pentulose (23):
Method B was applied to compound 9a (92 mg, 0.5 mmol) for
ozonolysis to yield product 23 (68 mg; 78%). [α]D20 = –90.6 (c = 0.5,
CH2Cl2). 1H NMR (400 MHz, CDCl3): δ = 4.14–4.01 (m, 3 H, CH
CH2), 3.95–3.87 (m, 1 H, CH), 3.47 (d, 3J = 5.4 Hz, 1 H, OH), 2.3
(s, 3 H, CH3), 1.49 (s, 3 H, CH3), 1.35 (s, 3 H, CH3) ppm. 13C
NMR (400 MHz, CDCl3): δ = 209.1 (C), 110.4 (C), 77.6 (CH), 76.4
(CH), 67.5 (CH2), 27.7 (CH3), 26.8 (CH3), 25.4 (CH3) ppm. IR
(film): ν˜ = 3424, 2989, 1716, 1069 cm–1. HRMS (ESI): calcd. for
C8H14O4Na [M + Na]+ 197.0790; found 197.0794.
4,5-O-Isopropylidene-D-erythro-2-pentulose (24): Pentulose deriva-
tive 22 (21 mg, 0.075 mmol) was dissolved in ethanol (2 mL) and
hydrogenated in the presence of 10% palladium-on-charcoal (1 mg)
with a balloon of hydrogen. The catalyst was removed by filtration,
and the solvent was removed under reduced pressure to yield com-
pound 24 (10 mg, 72%). [α]D20 = –71.5 (c = 0.5, CH2Cl2). 1H NMR
(400 MHz, CDCl3): δ = 4.68 (dd, 2J = 20.1 Hz, 3J = 5.0 Hz, 1 H,
CH2), 4.40 (dd, 2J = 20.0 Hz, 3J = 3.5 Hz, 1 H, CH2), 4.24 (dd, 3J
= 7.7 Hz, 3J = 5.2 Hz, 1 H, CH), 4.14 (dd, 2J = 8.9 Hz, 3J = 6.3 Hz,
1 H, CH2), 4.07 (dd, 2J = 8.9 Hz, 3J = 5.0 Hz, 1 H, CH2), 3.99
(ddd, 3J = 7.8 Hz, 3J = 6.3 Hz, 3J = 5.1 Hz, 1 H, CH), 3.24 (d, 3J
= 5.4 Hz, 1 H, OH), 3.05 (t, 3J = 4.9 Hz, 1 H, OH), 1.49 (s, 3 H,
CH3), 1.36 (s, 3 H, CH3) ppm. 13C NMR (400 MHz, CDCl3): δ =
210.7 (C), 110.6 (C), 76.0 (CH), 75.4 (CH), 67.6 (CH2), 67.3 (CH2),
26.7 (CH3), 25.1 (CH3) ppm. IR (film): ν˜ = 3411, 2925, 1726,
1066 cm–1. HRMS (EI): calcd. for C7H11O6 [M – CH3]+ 175.0606;
found 175.0610.
Typical Procedure for Isopropylidine Cleavage of Ketoses
(Method C): Synthesis of Compounds 25, 28, and 29
D-erythro-2-Pentulose (25): To a suspension of 4,5-O-isopropylid-
ene-d-erythro-2-pentulose (24; 9 mg, 0.047 mmol) in water/THF
(1:1, 0.8 mL) was added Amberlyst 15 (H+ form, 6 mg), and the
mixture was stirred at room temperature. After TLC monitoring
showed conversion of the starting material, the pH of the solution
was adjusted to 7 by addition of 0.05 n NaOH. The resin was re-
moved by filtration and washed with water, and the solvent was
lyophilized. The crude product was purified by flash chromatog-
raphy over silica gel (ethyl acetate/MeOH = 8:1) to yield 25 (6.1 mg,
86%). Equilibrium of three compounds: α/β/open = 58:24:18.
[α]D20 = –14.0 (c = 0.25, H2O). The spectroscopic data were identical
with those reported.[16]
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Typical Procedure for Isopropylidine Cleavage of Allenes
(Method D): Synthesis of Compounds 26 and 27
1-O-Benzyl-2-deoxy-2-C-ethenylidene-D-erythro-pentitol (26): To a
suspension of compound 3a (34 mg, 0.117 mmol) in water/THF
(1:1, 2 mL) was added Amberlyst 15 (H+ form, 40 mg), and the
mixture was stirred at room temperature. After TLC monitoring
showed conversion of the starting material, the resin was removed
by filtration and washed with methanol, and the solvent was re-
moved under reduced pressure to yield compound 26 (28 mg; 97%).
[α]D20 = +14.8 (c = 0.25, MeOH). 1H NMR (400 MHz, D2O): δ =
7.58–7.36 (m, 5 H, Ar-H), 5.12 (s, 2 H, CH2), 4.64 (s, 2 H, CH2),
4.27–4.13 (m, 3 H, CH, CH2), 3.89–3.77 (m, 2 H, CH2), 3.73–3.61
(m, 1 H, CH2) ppm. 13C NMR (400 MHz, D2O): δ = 207.0 (C),
137.1 (C), 128.8 (2 CH), 128.7 (2 CH), 128.4 (CH), 100.4 (C), 78.7
(CH2), 73.2 (CH), 71.8 (CH2), 70.5 (CH), 67.9 (CH2), 62.5 (CH2)
ppm. IR (film): ν˜ = 3377, 2926, 1956, 1055, 745, 698 cm–1. HRMS
(ESI): calcd. for C14H18O4Na [M + Na]+ 273.1103; found 273.1099.
(2R,3S)-4-Methylhexa-4,5-dien-1,2,3-triol (27): Method D was ap-
plied to compound 9a (46 mg, 0.25 mmol) for deprotection to yield
product 27 (35 mg, 98%). [α]D20 = +25.9 (c = 0.35, MeOH). 1H
NMR (400 MHz, D2O): δ = 4.88–4.80 (m, 2 H, CH2), 4.08 (dt, 3J
= 7.5 Hz, 5J = 1.4 Hz, 1 H, CH), 3.85 (dd, 2J = 11.7 Hz, 3J =
2.78 Hz, 1 H, CH2), 3.81–3.74 (m, 1 H, CH), 3.66 (dd, 2J =
11.7 Hz, 3J = 6.6 Hz, 1 H, CH2), 1.75 (t, 5J = 3.22 Hz, 3 H, CH3)
ppm. 13C NMR (600 MHz, D2O): δ = 206.9 (C), 98.5 (C), 76.0
(CH2), 73.4 (CH), 72.7 (CH), 63.0 (CH2), 14.0 (CH3) ppm. IR
(film): ν˜ = 3317, 2926, 1961, 1035 cm–1. HRMS (ESI): calcd. for
C7H12O3Na [M + Na]+ 167.0684; found 167.0680.
1-O-Benzyl-D-erythro-2-pentulose (28): Method C was applied to
compound 22 (39 mg, 0.139 mmol) for deprotection to yield prod-
uct 28 (27 mg; 81%), or compound 26 (25 mg, 0.1 mmol) was ozon-
ized in a mixture of MeOH/CH2Cl2 (9:1) according to method B
to yield product 28 (21.6 mg; 90%). Equilibrium of three com-
pounds: α/β/open = 62:25:13. [α]D20 = –20.7 (c = 2.25, MeOH). 1H
NMR (600 MHz, CD3COCD3+D2O, α-isomer): δ = 7.39–7.23 (m,
5 H, Ar-H), 4.65–4.46 (m, 2 H, CH2), 4.22–4.17 (m, 1 H, CH), 4.06
(d, 3J = 5.3 Hz, 1 H, CH), 3.92 (dd, 2J = 9.4 Hz, 3J = 5.3 Hz, 1 H,
CH2), 3.78 (dd, 2J = 9.3 Hz, 3J = 3.6 Hz, 1 H, CH2), 3.52 (d, 2J =
10.6 Hz, 1 H, CH2), 3.44 (d, 2J = 10.2 Hz, 1 H, CH2) ppm. 1H
NMR (600 MHz, CD3COCD3+D2O, β-isomer): δ = 7.39–7.23 (m,
5 H, Ar-H), 4.65–4.46 (m, 2 H, CH2), 4.45–4.38 (m, 1 H, CH), 4.04
(dd, 2J = 8.9 Hz, 3J = 6.3 Hz, 1 H, CH2), 3.97 (d, 3J = 5.3 Hz, 1
H, CH), 3.71 (d, 2J = 10.2 Hz, 1 H, CH2), 3.64 (dd, 2J = 8.9 Hz,
3J = 4.7 Hz, 1 H, CH2), 3.58 (d, 2J = 10.2 Hz, 1 H, CH2) ppm. 1H
NMR (600 MHz, CD3COCD3+D2O, open isomer): δ = 7.71–7.55
(m, 2 H, Ar-H), 7.64–7.60 (m, 1 H, Ar-H), 7.57–7.51 (m, 2 H, Ar-
H), 4.65–4.46 (m, 4 H, 2 CH2), 4.23 (d, 3J = 5.7 Hz, 1 H, CH),
3.89–3.84 (m, 1 H, CH), 3.66 (dd, 2J = 11.0 Hz, 3J = 5.3 Hz, 1 H,
CH2), 3.59 (dd, 2J = 11.2 Hz, 3J = 5.9 Hz, 1 H, CH2) ppm. 13C
NMR (600 MHz, CD3COCD3+D2O, α-isomer): δ = 139.3 (C),
129.0 (2 CH), 128.2 (2 CH), 128.1 (CH), 103.3 (C), 73.8 (CH2),
72.2 (CH2), 71.9 (CH2), 71.8 (CH), 71.2 (CH) ppm. 13C NMR
(600 MHz, CD3COCD3+D2O, β-isomer): δ = 139.2 (C), 128.5
(CH), 128.4 (2 CH), 128.1 (2 CH), 106.1 (C), 76.9 (CH), 74.0
(CH2), 72.3 (CH2), 71.9 (CH2), 71.6 (CH) ppm. 13C NMR
(600 MHz, CD3COCD3+D2O, open isomer): δ = 209.7 (C), 139.5
(C), 132.9 (2 CH), 132.6 (2 CH), 132.5 (CH), 77.0 (CH), 74.4
(CH2), 74.2 (CH), 73.3 (CH2), 62.9 (CH2) ppm. HRMS (ESI):
calcd. for C12H16O5Na [M + Na]+ 263.0895; found 263.0893.
1-Deoxy-D-erythro-2-pentulose (29):Method C was applied to com-
pound 23 (10 mg, 0.057 mmol) for deprotection to yield product 29
(7 mg; 91%). Equilibrium of three compounds: α/β/open =
102
M. Fischer, C. Schmölzer, C. Nowikow, W. SchmidFULL PAPER
14:14:72. [α]D20 = –30 (c = 0.3, H2O). The spectroscopic data were
identical with those reported.[30,31] HRMS (ESI): calcd. for C5H9O4
[M – H]– 133.0501; found 133.0504. HRMS (EI): calcd. for C5H8O3
[M – H2O]+ 116.0473; found 116.0476.
Supporting Information (see footnote on the first page of this arti-
cle): Experimental and spectroscopic details for compounds 6–8,
10, 4a–21a, 4b–21b, 30a, 30b, 31a, and 31b and 1H and 13C NMR
spectra of compounds 6–8, 10, 22–29, 3a, 3b, 4a–21a, 21b, 30a, 30b,
31a, and 31b.
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Unpublished Work: 
 
Indium-Mediated Allenylation/Propargylation of Arabinose (122) with 1-(Benzyloxy)-4-
bromo-2-butyne (171a):  
 
The indium-mediated allenylation of arabinose was attempted by various procedures as 
depicted in table 2. Arabinose was the carbohydrate of choice since it is known to be a very 
reactive aldose for indium-mediated allylation reactions (Scheme 59). The first eight 
procedures were performed before the crucial addition of either LiI or LiCl for these type of 
reactions was recognized. It was supposed that solvent systems, which are suitable for 
indium-mediated allylation reactions of aldoses, are applicable for indium-mediated 
allenylations as well (entries 1-7). An acceleration of the reaction by diluted hydrochloric 
acid (entries 1, 6 and 12) or by a saturated ammonium chloride solution (entry 5) was not 
successful. The addition of tetrabutylammonium iodide, a phase transfer catalyst and a 
reaction promoter (iodide), did not yield any product either (entry 8). The reaction 
conditions, which have been effective for various aldehydes, were unproductive for 
unprotected arabinose (entries 7-12). Only by addition of lithium chloride, traces of product 
could be observed on TLC plates (entries 13-15). These compounds were isolated in the case 
of entry 15 and identified as the desired products 173a and 174. Obviously arabinose (133) 
was not reactive enough for indium-mediated allenylations with 1-(benzyloxy)-4-bromo-2-
butyne (171a). The best result (5% yield) was obtained by using two equivalents of arabinose 
(133) and LiCl and one equivalent of indium and 1-(benzyloxy)-4-bromo-2-butyne (171a) in a 
THF/water mixture (1/1). 
 
Scheme 59. Indium-mediated allenylation/propargylation of arabinose with 1-(benzyloxy)-4-bromo-2-butyne 
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Table 2. Indium-mediated allenylation/propargylation of arabinose with 1-(benzyloxy)-4-bromo-2-butyne – applied 
conditions 
entry arabinose 
[equiv.] 
indium 
[equiv.] 
1-(benzyloxy)-4-
bromo-2-butyne 
[equiv.] 
additive 
[equiv.] 
solvent yield 
(allene / 
alkyne) 
1 1 2 2  0.1 N HCl/EtOH = 
1/9 
0 
2 1 2 2  EtOH/H2O = 4/1 0 
3 1 2 2  THF/H2O 0 
4 1 2 2  THF/H2O/DMF 0 
5 1 2 2  THF/NH4Clsat = 1/5 0 
6 1 2 3  0.1 N HCl/EtOH = 
1/10 
0 
7 1 2 2 Bu4NI THF/H2O = 1/10 0 
8 1 2 3 LiI [1] DMFabs 0 
9 1 1 1 LiI [1] THFabs 0 
10 1 1 1 LiI [1] THF/H2O 0 
11 1 1 1 LiCl [2]/  
LiI [1] 
THF/H2O 0 
12 1.2 1 1 LiCl [2] THF/0.1 N HCl 0 
13 1.2 1 1 LiCl [2] THF/H2O = 1/4 <5 % (nd.) 
14 2 1 1 LiCl [2] THF/H2O = 1/1 <5 % (nd.) 
15 2 1 1 LiCl [2] THF/H2O = 2/1 5 % (1/1) 
 
Indium-Mediated Allenylation/Propargylation of Aldehydes with Dibenzyl (4-bromobut-2-
yn-1-yl) Phosphate (171b): 
 
Starting from 2-butyn-1,4-diol, dibenzyl (4-bromobut-2-yn-1-yl) phosphate (171b) was 
synthesized in two steps (Scheme 60). The dibenzyl phosphate was prepared by 
phosphorylation of one hydroxyl group with dibenzyl phosphorylchloride, followed by 
displacement of the other hydroxyl group by bromine via an Appel reaction. The indium-
mediated allenylation of 1,2-O-isopropylidene-D-glyceraldehyde or freshly prepared 
formaldehyde with alkyne 171b were unsuccessful and did not yield the product 173b and 
173c, a potential precursor for DHAP (1). 
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Scheme 60. Attempted indium-mediated allenylation of aldehydes with dibenzyl (4-bromobut-2-yn-1-yl) phosphate 
(171b) 
 
Reactivity of Alkynyl Bromide 171a vs. Allenyl Bromide 176: 
 
During the preparation of alkyne 171a, a substantial amount (1.89 g, 16%) of allenyl bromide 
176 was isolated (Scheme 61). Allene 176 was only formed, when the starting material for 
the Appel reaction, 4-(benzyloxy)-but-2-yn-1-ol was not purified by vacuum distillation.  
 
Scheme 61. Synthesis of allenylbromide 176 
 
Subsequently, the reactivity of the alkynylbromide 171a and the allenylbromide 176 was 
compared via the indium-mediated allenylation/propargylation of benzaldehyde. 
Alkynylbromide reacted substantially faster than allenylbromide 176 (Figure 11). In addition, 
it was demonstrated that the preformation of the reactive indium species (Grignard 
conditions) was superior to Barbier additions (allene 176 was unreactive applying Barbier 
conditions). 
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Figure 11. Reactivity of alkyne 171a and allene 176 and comparison of Grignard with Barbier conditions 
 
Proof of Stereochemistry: 
 
An initial major problem of indium-mediated allenylation reactions with 1,2-O-
isopropylidene-D-glyceraldehyde was the assignment of the stereochemistry of the novel 
formed stereocenter at C3 of allene 173d. All primarily attempted conversions of allene 
173d into known pentuloses 177 were unsuccessful (which was later done as published). 
Even the literature known benzyl cleavage did not yield any assignable structure.71c 
Therefore, we attempted to determine the stereochemistry via some further derivatized 
structures of compound 173d either by NOESY experiments or X-ray diffraction (Figure 12).  
 
Figure 12. Possible strategies to assign the novel stereocenter at C3 of allene 173d 
 
The acetonide protecting group of allene 173d was quantitatively removed under aqueous 
acidic conditions. Surprisingly, the protection of the 1,2,3-triol with a benzylidene group 
exclusively gave five membered 1,2-protected triols 181 and 182 and no 1,3-protected triol 
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178 was formed (Scheme 62). Usually, benzylidene protecting groups favor the formation of 
1,3-dioxane rings under thermodynamic control.89 A stereochemical determination at C3 
was not possible by NOE experiments for the dioxolane rings 181 and 182.  
This strategy was efficient for compound 173e, which was synthesized by the indium-
mediated allenylation of glyceraldehyde 65 with 1-bromo-2-butyne (Scheme 63). By 
assignment of the NOESY crosspeaks, the stereocenter at C3 was determined to be S-
configurated. The same result was later obtained by conversion of 173d into D-erythro-pent-
2-ulose (see publication). 
 
Scheme 62. Formation of dioxolane 181 and 182 
 
Scheme 63. Determination of the stereochemistry of C3 of compound 183 by NOESY crosspeaks. 
 
All derivatized compounds for X-ray diffraction did not yield any suitable crystals for this 
methodology. Phenyl hydrazones, well known for their beneficial properties for 
crystallization, either did not yield any crystals (Scheme 64) or could not be synthesized at all 
(Scheme 65). 
 
Scheme 64. Hydrazone formation of compound 184 
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Scheme 65. Attempted hydrazone formation of compound 187. 
 
A para-nitrobenzoyl protection of compound 189 or 194 again gave no suitable crystals for 
X-ray diffraction (Scheme 66 and 67). Only the primary hydroxyl group of allene 189 reacted 
with para-nitrobenzoyl chloride. During the acid catalyzed removal of the acetonide 
protecting group of 173f, a partial cleavage of the silyl protecting group was observed. The 
product 190 was converted into the corresponding pentulose by ozonolysis. A precise 
determination of the pentulose was not possible, due to impurities. Alternatively, the silyl 
protecting group of 173f was selectively removed with TBAF. A benzylidene protection of the 
free hydroxy groups yielded 1,3-dioxane 193. Unfortunately, in this case an assignment of 
the stereochemistry at C3 was not reasonable, because the two six-membered rings 193a 
and 193b could not be distinguished by NOESY experiments (Figure 13).  
 
Scheme 66. p-Nitrobenzoyl protection of 189, ozonolysis of 190 and 1,3-dioxan formation of 192. 
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Figure 13. Unfeasible determination of the stereocenter at C3 for compound 193 by NOE experiments. 
 
 
Scheme 67. 3-Chloro-4-nitrobenzoyl protection of compound 194. 
 
Miscellaneous Experiments: 
 
The free hydroxyl group of allene 173d is suitable positioned for a 5-endo-dig ring closing 
reaction with the neighboring terminal allene moiety (Scheme 68). Nevertheless, the initial 
gold catalyzed cyclization failed under standard conditions (dichloromethane as solvent).84 
Using THF as solvent, the desired dihydrofuran 195 was isolated in 30 % yield. Primarily 
experiments for an iodine- or Selectfluor-catalyzed ring closing reaction for the synthesis of 
compounds 196 and 197 were unsuccessful. Further studies towards these directions have 
to be pursued. 
 
 
Scheme 68. Various conditions for 5-endo-dig cyclizations. 
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C.4. Experimental Procedures 
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Indium-mediated Allenylation of Aldehydes and its Application in Carbohydrate 
Chemistry: Efficient Synthesis of D-Ribulose and 1-Deoxy-D-ribulose 
M. Fischer, C. Schmölzer, C. Nowikow, W. Schmid, Eur. J. Org. Chem. 2011, 1645-1651. 
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 Experimental and spectroscopical data for compounds 6-8, 10; 4a-21a, 4b-21b, 30a, 30b, 31a, 31b. 
 
 1H and 13C NMR spectra of compounds 6-8; 10, 22-29; 3a, 3b; 4a-21a, 21b, 30a, 30b, 31a, 31b. 
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2-Deoxy-2-C-ethenylidene-4,5-O-isopropylidene-1-O-methyl-D-erythro-pentitol (4a): Analogously to method 
A, 2,3-O-isopropylidene-D-glyceraldehyde 1 (65 mg, 0.5 mmol) was added to a suspension of LiI (67 mg, 0.5 
mmol), indium (32 mg, 0.275 mmol) and 1-(methoxy)-4-bromo-2-butyne 4 (82 mg, 0.5 mmol) in THF (4 mL). 
The crude product was separated by silica gel column chromatography (hexane/ethyl acetate = 4/1) to yield 2-
deoxy-2-C-ethenylidene-4,5-O-isopropylidene-1-O-methyl-D-erythro-pentitol 4a (51 mg, 48%) and 7-(methoxy)-
1,2-O-isopropylidenehept-5-yne-1,2,3-triol 4b (34 mg, 32 %). (4a):  = +20.0° (c 0.5, EtOAc); 
1
H NMR (400 
MHz; CDCl3): =4.95–4.91 (m, 2H; CH2) 4.28 (dt, 
3
J = 5.3 Hz, 
5
J = 1.9 Hz, 1H; CH) 4.25-4.18 (m, 1H; CH) 4.14 
(dt, 
2
J = 11.2 Hz, 
5
J = 2.2 Hz, 1H; CH2) 4.05 (dd, 
2
J = 8.5 Hz, 
3
J = 6.4 Hz, 1H; CH2) 4.01 (dt, 
2
J = 11.1 Hz, 
5
J = 
1.9 Hz, 1H; CH2) 4.00 (dd, 
2
J = 8.4 Hz, 
5
J = 6.0 Hz, 1H; CH2) 3.35 (s, 3H; CH3) 1.43 (s, 3H; CH3) 1.35 (s, 3H; 
CH3); 
13
C NMR (400 MHz; CDCl3): =207.0 (C), 109.4 (C), 100.3 (C), 77.8 (CH2), 77.5 (CH), 72.1 (CH2), 71.2 
(CH), 65.7 (CH2), 58.2 (CH3), 26.7 (CH3) 25.3 (CH3); IR (film) 3411, 2937, 1962, 1067 cm
-1
; HRMS (EI): 
m/z:[M-CH3]
+
 calcd for C10H15O4: 199.0970, found: 199.0975. 
4a 
 
(2R)-7-(Methoxy)-1,2-O-isopropylidenehept-5-yne-1,2,3-triol (4b): Mixture of diastereomeres: major : minor = 
4.0 : 1; 
1
H-NMR (400 MHz; CDCl3): 
major
=4.11-4.05 (m, 4H; 2xCH2) 4.10-3.93 (m, 1H; CH) 3.81-3.73 (m, 1H; 
CH) 3.37 (s, 3H; CH3) 2.64-2.46 (m, 2H; CH2) 2.15 (d, 
3
J = 4.3 Hz, 1H; OH) 1.42 ( s, 3H; CH3) 1.36 (s, 3H; 
CH3) ; 
13
C NMR (400 MHz; CDCl3): 
major
=109.6 (C), 81.8 (C), 81.3 (C), 77.5 (CH), 70.5 (CH), 66.1 (CH2), 57.8 
(CH3), 51.4 (CH2), 25.3 (CH3), 24.1 (CH2); IR (film) 3407, 2935, 1066 cm
-1
; HRMS (EI): m/z:[M-CH3]
+
 calcd for 
C10H15O4: 199.0970, found: 199.0973. 
4b 
 
2-Deoxy-2-C-ethenylidene-4,5-O-isopropylidene-D-erythro-pentitol (5a): Analogously to method A, 2,3-O-
isopropylidene-D-glyceraldehyde 1 (65 mg, 0.5 mmol) was added to a suspension of LiI (67 mg, 0.5 mmol), 
indium (32 mg, 0.275 mmol) and 4-bromo-2-butyn-1-ol 5 (75 mg, 0.5 mmol) in THF (4 mL). The crude product 
was separated by silica gel column chromatography (hexane/ethyl acetate = 1/1) to yield compounds 5a (20 mg, 
20 %) and 5b (51 mg, 51 %). (5a):  = +24.4° (c 0.25, CH2Cl2); 
1
H NMR (400 MHz; CDCl3): =5.00-4.97 (m, 
2H; CH2) 4.39-4.32 (m, 1H; CH) 4.30-4.24 (m, 2H; CH2) 4.24–4.18 (m, 1H; CH) 4.09 (dd, 
2
J = 8.6 Hz, 
3
J = 6.6 
Hz, 1H; CH2) 4.01 (dd, 
2
J = 8.4 Hz, 
3
J = 6.2 Hz, 1H; CH2) 2.49 (t, 
3
J = 5.4 Hz, 1H; OH) 2.42 (d, 
3
J = 4.0 Hz, 1H; 
OH) 1.45 (s, 3H; CH3) 1.36 (s, 3H; CH3); 
13
C NMR (400 MHz; CDCl3): =205.4 (C), 109.6 (C), 103.9 (C), 79.3 
(CH2), 77.9 (CH), 71.2 (CH), 65.9 (CH2), 62.6 (CH2), 26.6 (CH3), 25.2 (CH3); IR (film) 3411, 2934, 1962, 
1067cm
-1
; HRMS (EI): m/z: [M-CH3]
+
 calcd for C9H13O4: 185.0814, found: 185.0812. 
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5a 
 
(2R)-1,2-O-Isopropylidenehept-5-yne-1,2,3,7-tetrol (5b): Mixture of diastereomeres: major:minor = 3.5:1; 
1
H-
NMR (400 MHz; CDCl3): 
major
=4.65 (t, 
5
J = 2.0 Hz, 2H; CH2) 4.10-4.02 (m, 2H; CH2) 4.01-3.94 (m, 1H; CH) 
3.80-3.71 (m, 1H; CH) 2.57 (ddt, 
2
J = 17.0 Hz, 
3
J = 4.7 Hz, 
5
J = 2.3 Hz, 1H; CH2) 2.49 (ddt, 
2
J = 17.2 Hz, 
3
J = 
6.5 Hz, 
5
J = 2.1 Hz, 1H; CH2) 2.48 (bs, 1H; OH) 2.04 (bs, 1H; OH) 1.41 (s, 3H; CH3) 1.35 (s, 3H; CH3) ; 
13
C 
NMR (400 MHz; CDCl3) 
major
=109.6 (C), 81.8 (C), 81.3 (C) 77.5 (CH), 70.5 (CH), 66.1 (CH2), 51.4 (CH2), 26.8 
(CH3), 25.3 (CH3) 24.1 (CH2); IR (film) 3369, 2924, 1063 cm
-1
; HRMS (EI): m/z: [M-CH3]
+
 calcd for C9H13O4: 
185.0814, found: 185.0812. 
 
5b 
 
Typical procedure for bromination of mono oxygen substituted 2-butyne-1,4-diol (Method E) – synthesis of 
compounds 6-8: 1-O-Acetyl-4-bromo-but-2-yn-1-ol (6): To a solution of 4-O-acetyl-but-2-yne-1,4-diol
[1]
 (1.28 
g, 0.01 mol) in anhydrous CH2Cl2 (30 mL), CBr4 (3.32 g, 0.01 mol) was added and cooled to 0°C. In small 
portions PPh3 (2.63 g, 0.01 mol) was added over a period of 30 minutes and the reaction mixture was further 
stirred at room temperature until TLC monitoring showed conversion of the starting material. MeOH (5mL) was 
added and the solvent were evaporated under reduced pressure. The crude product was purified by silica gel 
column chromatography (hexane/ethyl acetate = 6/1) to yield 1-O-acetyl-4-bromo-but-2-yn-1-ol 6 (1.8 g, 95 %). 
1
H NMR (400 MHz; CDCl3): =4.72 (t, 
5
J = 2.0 Hz, 2H; CH2) 3.92 (t, 
5
J = 2.0 Hz, 2H; CH2) 2.09 (s, 3H; CH3); 
13
C NMR (400 MHz; CDCl3): =170.2 (C), 81.8 (C), 80.8 (C), 52.3 (CH2), 20.8 (CH3), 13.8 (CH2); HRMS (EI): 
m/z: [M-CH3]
+
 calcd for C6H7BrO2: 189.9629, found: 189.9625. 
6 
 
1-O-Acetyl-2-deoxy-2-C-ethenylidene-4,5-O-isopropylidene-D-erythro-pentitol (6a): Analogously to method A, 
2,3-O-isopropylidene-D-glyceraldehyde 1 (65 mg, 0.5 mmol) was added to a suspension of LiI (67 mg, 0.5 mmol), 
indium (32 mg, 0.275 mmol) and 1-O-acetyl-4-bromo-but-2-yn-1-ol 6 (96 mg, 0.5 mmol) in THF (4 mL). The 
crude product was separated by silica gel column chromatography (hexane/ethyl acetate = 3/1) to yield 
compounds 6a (21 mg, 17 %), 6b (47 mg, 39 %) and 6c (17 mg, 14 %). (6a):  = +38.0° (c 0.2, CH2Cl2); 
1
H-
NMR (400 MHz; CDCl3): =5.00–4.98 (m, 2H; CH2) 4.73 (dt, 
2
J = 12.1 Hz, 
5
J = 2.3 Hz, 1H; CH2) 4.65 (dt, 
2
J = 
12.3 Hz, 
5
J = 2.2 Hz, 1H; CH2) 4.32-4.26 (m, 1H; CH) 4.23-4.16 (m, 1H; CH) 4.04 (dd, 
2
J = 8.46 Hz, 
3
J = 6.44 
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Hz, 1H; CH2) 3.98 (dd, 
2
J = 8.5 Hz, 
3
J = 6.2 Hz, 1H; CH2) 2.40 (d, 
3
J = 3.8 Hz, 1H; OH) 2.07 (s, 3H; CH3) 1.43 (s, 
3H; CH3) 1.35 (s, 3H; CH3); 
13
C NMR (400 MHz; CDCl3): =206.8 (C), 170.9 (C), 109.4 (C), 100.6 (C), 79.5 
(CH2), 77.7 (CH), 70.0 (CH), 65.5 (CH2), 62.7 (CH2), 26.6 (CH3), 25.2 (CH3), 21.1 (CH3); IR (film) 3434. 2988, 
1956, 1738, 1373, 1260 cm
-1
; HRMS (EI): m/z: [M-CH3]
+
 calcd for C11H15O5: 227.0919, found: 227.0911. 
6a  
 
(2R)-7-O-Acetyl-1,2-O-isopropylidene-5-heptyne-1,2,3,7-tetrol (6b):
 
Mixture of diastereomeres: 
1
H-NMR (400 
MHz; CDCl3): 
major
=4.65 (t, 
5
J = 2.1 Hz, 2H; CH2) 4.09-4.00 (m, 2H; CH2) 3.99-3.90 (m, 1H; CH) 3.78-3.70 (m, 
1H; CH) 2.56 (ddt, 
2
J = 17.0 Hz, 
3
J = 4.7 Hz, 
5
J = 2.3 Hz, 1H; CH2) 2.48 (ddt, 
2
J = 17.0 Hz, 
3
J = 6.7 Hz, 
5
J = 2.2 
Hz, 1H; CH2) 2.30 (d, 
3
J = 4.7 Hz, 1H; OH) 2.07 (s, 3H; CH3) 1.39 (s, 3H; CH3) 1.34 (s, 3H; CH3); 
13
C NMR (400 
MHz; CDCl3): 
major
=170.5 (C), 109.5 (C), 83.0 (C), 77.5 (CH), 77.1 (C), 70.3 (CH), 66.0 (CH2), 52.7 (CH2), 26.8 
(CH3), 25.3 (CH3), 24.1 (CH2), 20.9 (CH3); IR (film) cm
-1
 3386. 2927, 1726, 1380, 1230, 1027 cm
-1
; HRMS (EI): 
m/z: [M-CH3]
+
 calcd for C11H15O5: 227.0919, found: 227.0912. 
 
6b 
 
3-O-Acetyl-2-deoxy-2-C-ethenylidene-4,5-O-isopropylidene-D-erythro-pentitol (6c): 
1
H-NMR (400 MHz; 
CDCl3): =5.26 (dt, 
3
J = 6.1 Hz, 
5
J = 1.8 Hz, 1H; CH), 5.05–4.92 (m, 2H; CH2) 4.36-4.28 (m, 1H; CH) 4.22-4.12 
(m, 2H; CH2) 4.08 (dd, 
2
J = 8.66 Hz, 
3
J = 6.50 Hz, 1H; CH2) 3.89 (dd, 
2
J = 8.64 Hz, 
3
J = 5.7 Hz, 1H; CH2) 
2.52-2.42 (m, 1H; OH) 2.09 (s, 3H; CH3) 1.42 (s, 3H; CH3) 1.35 (s, 3H; CH3); 
13
C NMR (400 MHz; CDCl3): 
=206.7 (C), 170.6 (C), 110.0 (C), 102.5 (C), 79.5 (CH2), 76.5 (CH), 72.0 (CH), 66.3 (CH2), 62.0 (CH2), 26.6 
(CH3), 25.3 (CH3), 21.1 (CH3); HRMS (EI): m/z: [M-CH3]
+
 calcd for C11H15O5: 227.0919, found: 227.0913. 
6c 
 
1-O-Benzyloxycarbonyl-4-bromo-but-2-yn-1-ol (7): To a solution of 2-butyne-1,4-diol (5 g, 0.058 mol) in 
anhydrous CH2Cl2 (100 mL) and pyridine (14.2 mL), dimethylaminopyridine (DMAP) (0.35 g, 2.9 mmol) was 
added and the mixture was cooled to 0°C. Benzyl chloroformate (Cbz-Cl) (13.8 g, 0.082 mol) was added slowly 
under string and after 2 hours the reaction was quenched by addition of a saturated aqueous NH4Cl solution (100 
mL). The aqueous phase was separated and extracted with ethyl acetate (3 x 100 mL). The combined organic 
layers were washed with brine, dried over MgSO4 and evaporated. The crude product was separated by silica gel 
117
Supporting Information - Eur. J. Org. Chem.
column chromatography to yield 4-O-benzyloxycarbonyl-but-2-yne-1,4-diol (7.55 g, 59%). Analogous to method 
E, to a solution of 4-O-benzyloxycarbonyl-but-2-yne-1,4-diol (7.55 g, 0.034 mol) in anhydrous CH2Cl2 (50 mL), 
CBr4 (13.65 g, 0.041 mol) and PPh3 (10.79 g, 0.0419) were added. The crude product was purified by silica gel 
column chromatography (hexane/ethyl acetate = 8/1) to yield 1-O-benzyloxycarbonyl-4-bromo-2-butyn-1-ol 7 
(9.3 g, 95 %).
 1
H NMR (400 MHz; CDCl3): =7.42-7.30 (m, 5H; ArH) 5.19 (s, 2H; CH2) 4.79 (t, 
5
J = 2.0 Hz, 2H; 
CH2) 3.92 (t, 
5
J = 2.0 Hz, 2H; CH2); 
13
C NMR (400 MHz; CDCl3): =154.6 (C), 135.0 (C), 128.8 (CH), 128.7 
(2xCH), 128.5 (2xCH), 82.6 (C), 80.0 (C), 70.2 (CH2), 55.7 (CH2), 13.8 (CH2); IR (film) 3034, 1751, 1262, 616 
cm
-1
; HRMS (EI): m/z: [M]
+
 calcd for C12H11O3Br: 281.9882, found: 281.9885. 
7 
 
1-O-Benzyloxycarbonyl-2-deoxy-2-C-ethenylidene-4,5-O-isopropylidene-D-erythro-pentitol (7a): 
Analogously to method A, 2,3-O-isopropylidene-D-glyceraldehyde 1 (65 mg, 0.5 mmol) was added to a 
suspension of LiI (67 mg, 0.5 mmol), indium (32 mg, 0.275 mmol) and 1-O-benzyloxycarbonyl-4-bromo-but-2-
yn-1-ol 7 (142 mg, 0.5 mmol) in THF (4 mL). The crude product was separated by silica gel column 
chromatography (hexane/ethyl acetate = 5/1) to yield compounds 7a (53 mg, 32%) and 7b (55 mg, 33 %). (7a): 
 = +9.0° (c 0.74, EtOAc); 
1
H NMR (400 MHz; CDCl3): =7.40-7.28 (m, 5H; ArH) 5.16 (s, 2H; CH2) 
5.00-4.97 (m, 2H; CH2) 4.80 (dt, 
2
J = 12.1 Hz, 
5
J = 2.2 Hz, 1H; CH2)
 
4.72 (dt, 
2
J = 11.9 Hz, 
5
J = 2.1 Hz, 1H; 
CH2)
 
4.38-4.27 (m, 1H; CH) 4.22-4.15 (m, 1H; CH) 4.03 (dd, 
2
J = 8.4 Hz, 
3
J = 6.2 Hz, 1H; CH2) 3.96 (dd, 
2
J = 
8.4 Hz, 
3
J = 6.2 Hz, 1H; CH2) 2.43 (s, 1H; OH) 1.42 (s, 3H; CH3), 1.33 (s, 3H; CH3); 
13
C NMR (400 MHz; 
CDCl3): =206.9 (C), 155.0 (C), 135.2 (C), 128.7 (3xCH), 128.4 (2xCH), 109.4 (C), 100.1 (C), 79.6 (CH2), 77.7 
(CH), 69.9 (CH), 69.8 (CH2), 66.1 (CH2), 65.4 (CH2), 26.6 (CH3), 25.1 (CH3); IR (film) 3445, 2986, 1957, 1743, 
1240, 753, 696 cm
-1
; HRMS (ESI): m/z: [M+Na]
+
 calcd for C18H22O6Na: , 357.1314 found: 357.1299. 
7a 
 
(2R)-7-O-Benzyloxycarbonyl-1,2-O-isopropylidene-5-heptyne-1,2,3,7-tetrol (7b): Mixture of diastereomeres: 
major: minor = 4.8:1; 
1
H NMR (400 MHz; CDCl3): 
major
=7.38-7.26 (m, 5H; ArH) 4.59 (s, 2H; CH2) 4.19-4.15 (m, 
2H; CH2) 4.10-4.04 (m, 2H; CH2) 4.01-3.93 (m, 1H; CH) 3.81-3.73 (m, 1H; CH) 2.63-2.47 (m, 2H; CH2) 2.15 (d, 
3
J = 4.7 Hz, 1H; OH) 1.42 (s, 3H; CH3), 1.36 (s, 3H; CH3); 
13
C NMR (400 MHz; CDCl3): 
major
=155.3 (C), 137.1 
(C), 128.6 (2xCH), 128.2 (2xCH), 128.1 (CH), 109.2 (C), 82.1 (C), 79.1 (C), 77.5 (CH), 71.9 (CH2), 70.4 (CH), 
66.1 (CH2), 57.8 (CH2), 26.8 (CH3), 25.3 (CH3), 24.1 (CH2); IR (film) 3317, 2924, 1747, 1241, 756, 697 cm
-1
; 
HRMS (ESI): m/z: [M+Na]
+
 calcd for C18H22O6Na: , 357.1314 found: 357.1230. 
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7b 
 
1-O-tert-Butyldiphenylsilyl-4-bromobut-2-yn-1-ol (8): Analogous to method E, to a solution of 4-O-tert-
butyldiphenylsilylbut-2-yne-1,4-diol
[2]
 (1.45 g, 5 mmol) in anhydrous CH2Cl2 (20 mL), CBr4 (1.66 g, 5 mmol) and 
PPh3 (1.31 g, 5 mmol) were added. The crude product was purified by silica gel column chromatography 
(toluol/ethyl acetate = 20/1) to yield 1-O-tert-butyldiphenylsilyl-4-bromobut-2-yn-1-ol 8 (1.84 g, 95 %). 
1
H NMR 
(400 MHz; CDCl3): =7.77-7.67 (m, 4H; ArH) 7.52-7.34 (m, 6H; ArH) 4.39 (t, 
5
J = 2.0 Hz, 2H; CH2) 3.91 (t, 
5
J = 
2.0 Hz, 2H; CH2) 1.09 (s, 9H; CH3); 
13
C NMR (400 MHz; CDCl3): =135.8 (4xCH), 133.1 (2xC), 130.0 (2xCH), 
127.9 (4xCH), 85.4 (C), 80.3 (C), 52.9 (CH2), 26.9 (CH3), 19.3 (C), 14.7 (CH2); IR (film) 3072, 2932, 1112, 701, 
612 cm
-1
; HRMS (EI): m/z: [M]
+
 calcd for C20H23BrOSi: 386.0702, found: 386.0707. 
8 
 
1-O-tert-Butyldiphenylsilyl-2-deoxy-2-C-ethenylidene-4,5-O-isopropylidene-D-erythro-pentitol (8a): 
Analogously to method A, 2,3-O-isopropylidene-D-glyceraldehyde 1 (65 mg, 0.5 mmol) was added to a 
suspension of LiI (67 mg, 0.5 mmol), indium (32 mg, 0.275 mmol) and 1-O-tert-butyldiphenylsilyl-4-bromobut-2-
yn-1-ol 8 (194 mg, 0.5 mmol) in THF (4 mL). The crude product was separated by silica gel column 
chromatography (hexane/ethyl acetate = 6/1) to yield compounds 8a (70 mg, 32 %) and 8b (35 mg, 16 %). (8a): 
 = +23.1° (c 0.3, CH2Cl2); 
1
H NMR (400 MHz; CDCl3): =7.77–7.62 (m, 4H; ArH) 7.48–7.34 (m, 6H; ArH) 
4.88–4.83 (m, 2H; CH2) 4.45–4.35 (m, 2H; CH, CH2) 4.34–4.23 (m, 2H; CH, CH2) 4.08-3.98 (m, 2H; CH2) 2.82 
(d, 
3
J = 4.0 Hz, 1H; OH) 1.43 (s, 3H; CH3) 1.35 (s, 3H; CH3) 1.07 (s, 9H; CH3); 
13
C NMR (400 MHz; CDCl3): 
=206.1 (C), 135.7 (4xCH), 133.0 (2xC), 130.0 (CH), 129.9 (CH), 127.9 (2xCH), 127.8 (2xCH), 109.3 (C), 102.6 
(C), 78.2 (CH2), 77.5 (CH), 71.1 (CH), 65.7 (CH2), 64.1 (CH2), 26.9 (3xCH3), 26.7 (CH3), 25.3 (CH3), 19.3 (C); 
IR (film) 3452, 3051, 2932, 1961, 1112, 702, 611 cm
-1
; HRMS (ESI): m/z: [M+Na]
+
 calcd for C26H34O4SiNa: 
461.2124, found: 461.212. 
8a 
 
(2R)-7-O-tert-Butyldiphenylsilyl-1,2-O-isopropylidenehept-5-yne-1,2,3,7-tetrol (8b): Mixture of 
diastereomeres: major: minor = 5:1: 
1
H NMR (400 MHz; CDCl3): 
major
=7.76–7.64 (m, 4H; ArH) 7.48–7.33 (m, 
6H; ArH) 4.35 (s, 2H; CH2) 4.06–3.87 (m, 3H; CH2, CH) 3.69–3.52 (m, 1H; CH) 2.52-2.34 (m, 2H; CH2) 1.98 (d, 
3
J = 5.1 Hz, 1H; OH) 1.41 (s, 3H; CH3) 1.35 (s, 3H; CH3) 1.06 (s, 9H; 3xCH3); 
13
C NMR (400 MHz; CDCl3): 
major=135.7 (4xCH), 133.4 (2xC), 130.0 (2xCH), 127.8 (4xCH), 109.5 (C), 81.7 (C), 80.9 (C), 77.4 (CH), 70.4 
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(CH), 66.1 (CH2), 53.0 (CH2), 26.83 (3xCH3), 26.82 (CH3), 25.3 (CH3), 24.1 (CH2), 19.3 (C); HRMS (ESI): m/z: 
[M+Na]
+
 calcd for C26H34O4SiNa: 461.2124, found: 461.211. 
 
8b 
 
(2R,3S)-1,2-O-Isopropylidene-4-methylhex-4,5-dien-1,2,3-triol (9a): Analogously to method A, 2,3-O-
isopropylidene-D-glyceraldehyde 1 (65 mg, 0.5 mmol) was added to a suspension of LiI (67 mg, 0.5 mmol), 
indium (32 mg, 0.275 mmol) and 1-bromobut-2-yne 9 (67 mg, 0.5 mmol) in THF (4 mL). The crude product was 
purified by silica gel column chromatography (hexane/ ethyl acetate = 4:1) to yield compound 9a (68 mg, 74 %) 
and 9b (1 mg, 1 %).  = +26.8 (c=1.0, CH2Cl2);
1
H NMR (400 MHz; CDCl3): =4.79-4.69 (m, 2H; 2xCH) 
4.17-4.08 (m, 2H; CH2) 3.98 (dd, 
2
J = 7.28 Hz, 
3
J = 7.28 Hz, 1H; CH2) 3.92 (dd, 
2
J = 7.14 Hz, 
3
J = 7.14 Hz, 1H; 
CH2), 2.42 (s, 1H; OH) 1.72 (t, 
5
J = 3.2 Hz, 3H; CH3) 1.39 (s, 3H; CH3) 1.31 (s, 3H; CH3); 
13
C NMR (400 MHz; 
CDCl3): =205.8 (C), 109.2 (C), 99.1 (C), 77.4 (CH), 76.8 (CH2), 72.2 (CH), 65.4 (CH2), 26.6 (CH3), 25.2 (CH3), 
15.3 (CH3); IR 3457, 2931, 1060, 700, 611 (film) cm
-1
; HRMS (EI): m/z:[M-CH3]
+
 calcd for C9H13O3: 169.0865, 
found: 169.0864. 
9a 
 
(2R)-1,2-O-Isopropylidenehept-5-yne-1,2,3-triol (9b): Spectroscopical data: A. McCluskey, I. W. Muderawan,
 
 
Muntari, D. J. Young; J. Org. Chem. 2001, 66, 7811-7817. 
9b 
 
6-Bromohexa-2,4-diyn-1-ol (10): To a solution of hexa-2,4-diyne-1,6-diol
[3]
 (2.2 g, 0.02 mol) in anhydrous 
CH2Cl2 (40 mL), CBr4 (7.3 g, 0.022 mol) was added and cooled to 0°C. In small portions PPh3 (5.73 g, 0.022 mol) 
was added over a period of 30 minutes and the reaction mixture was further stirred at room temperature until TLC 
monitoring showed conversion of PPh3. MeOH (5mL) was added and the solvent were evaporated under reduced 
pressure. The crude product was purified by silica gel column chromatography (hexane/ethyl acetate = 5/1) to 
yield 6-bromohexa-2,4-diyn-1-ol 10 (1.9 g, 56 %). 
1
H NMR (400 MHz; CDCl3): =4.34 (bs, 2H; CH2) 3.96 (t, 
7
J 
= 1.0 Hz, 2H; CH2) 2.55 (bs, 1H; OH); 
13
C NMR (400 MHz; CDCl3): =79.0 (C), 74.1 (C), 70.6 (C), 69.6 (C), 
51.4 (CH2), 14.1 (CH2); IR (film) 3317, 2917, 2048, 1198, 1021 cm
-1
; HRMS (EI): m/z: [M]
+
 calcd for C6H5OBr: 
171.9524, found: 171.9519.  
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10 
 
(2R,3S)-4-Ethenylidene-1,2-O-isopropylidene-hept-5-yne-1,2,3,7-tetrol (10a): Analogously to method A, 2,3-
O-isopropylidene-D-glyceraldehyde 1 (65 mg, 0.5 mmol) was added to a suspension of LiI (67 mg, 0.5 mmol), 
indium (32 mg, 0.275 mmol) and 6-bromohexa-2,4-diyn-1-ol 10 (87 mg, 0.5 mmol) in THF (4 mL). The crude 
product was purified by silica gel column chromatography (hexane/ethyl acetate = 4/1) to yield compound 10a (45 
mg, 40 %).  = +18.0° (c 0.2, CH2Cl2);
1
H NMR (400 MHz; CDCl3): =5.17-5.13 (m, 2H; CH2) 4.40 (t, J = 
1.1 Hz, 2H; CH2) 4.31-4.22 (m, 2H; 2xCH) 4.07-4.02 (m, 2H; CH2) 1.44 (s, 3H; CH3) 1.37 (s, 3H; CH3); 
13
C NMR 
(400 MHz; CDCl3): =213.6 (C), 109.8 (C), 92.2 (C), 90.3 (C), 86.3 (C) 79.6 (CH2), 77.2 (CH), 72.0 (CH), 65.2 
(CH2), 51.7 (CH2), 26.8 (CH3), 25.3 (CH3); IR (film) 3385, 2926, 1936, 1065 cm
-1
; HRMS (ESI): m/z: [M+Na]
+ 
calcd for C12H16O4Na: 247.0946, found: 247.0950.  
10a 
 
3-((Benzyloxy)methyl)-6,10-dimethylundeca-1,2,9-trien-4-ol (11a): Analogously to method A, (+/-)-citronellal 
(72 mg, 1 mmol) was added to a suspension of LiI (134 mg, 1 mmol), indium (63 mg, 0.55 mmol) and 1-
(benzyloxy)-4-bromo-2-butyne 2 (240 mg, 1 mmol) in THF (8 mL). The crude product was separated by silica gel 
column chromatography (hexane/ethyl acetate = 7/1) to yield compounds 11a (142 mg, 45 %) and 11b (40 mg, 
13 %) in an diasteromeric mixture. 
1
H NMR (400 MHz; CDCl3): δ
major
=7.40-7.26 (m, 5H; ArH) 5.09 (tt, 
3
J = 3.5 
Hz, 
5
J = 1.4 Hz, 1H; CH) 4.92-4.87 (m, 2H; CH2) 4.55 (s, 2H; CH2) 4.35–4.28 (m, 1H; CH) 4.22 (dt, 
2
J = 12.2 Hz, 
5
J = 1.5 Hz, 1H; CH2) 4.14 (dt, 
2
J = 11.2 Hz, 
5
J = 2.1 Hz, 1H; CH2) 2.60-2.19 (m, 1H; OH) 2.13-1.85 (m, 2H; 
CH2) 1.73-1.56 (m, 1H; CH) 1.68 (s, 3H; CH3) 1.60 (s, 3H; CH3) 1.53-1.28 (m, 3H; CH2) 1.25-1.09 (m, 1H; CH2) 
0.918 (d, 
3
J =  6.6 Hz, 3H; CH3); 
1
H NMR (400 MHz; CDCl3): δ
minor
=7.40-7.26 (m, 5H; ArH) 5.09 (tt, 
3
J = 3.5 Hz, 
5
J = 1.4 Hz, 1H; CH) 4.92-4.87 (m, 2H; CH2) 4.55 (s, 2H; CH2) 4.35–4.28 (m, 1H; CH) 4.13 (dt, 
2
J = 11.2 Hz, 
5
J 
= 2.2 Hz, 1H; CH2) 4.14 (dt, 
2
J = 11.2 Hz, 
5
J = 2.1 Hz, 1H; CH2) 2.60-2.19 (m, 1H; OH) 2.13-1.85 (m, 2H; CH2) 
1.73-1.56 (m, 1H; CH) 1.68 (s, 3H; CH3) 1.60 (s, 3H; CH3) 1.53-1.28 (m, 3H; CH2) 1.25-1.09 (m, 1H; CH2) 0.92 
(d, 
3
J = 6.7 Hz, 3H; CH3); 
13
C NMR (400 MHz; CDCl3): δ=206.4, 206.2, 137.9, 137.8, 131.3, 131.2, 128.6 (4x), 
128.1 (4x), 128.0 (2x), 125.0, 124.9, 103.8, 103.1, 77.6, 77.4, 72.5, 72.4, 69.9, 69.8, 69.0, 43.2, 43.1, 37.8, 37.0, 
29.5, 29.0, 25.9 (2x), 25.6, 25.5, 20.1, 19.2, 17.8 (2x); IR (film) 3400, 2917, 1959, 1069, 737, 697 cm
-1
; HRMS 
(ESI): m/z: [M+Na]
+
 calcd for C21H30O2Na: 337.2144, found: 337.2152. 
11a 
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 1-Benzyloxy-7,11-dimethyldodeca-10-en-2-yn-5-ol (11b): δmajor=7.41-7.26 (m, 5H; ArH) 5.16-5.02 (m, 1H; CH) 
4.59 (s, 2H; CH2) 4.18 (t, 
5
J = 2.1 Hz, 2H; CH2) 3.92-3.76 (m, 1H; CH) 2.57-2.20 (m, 2H; CH2) 2.13-1.79 (m, 3H; 
CH, CH2) 1.68 (s, 3H; CH3) 1.60 (s, 3H; CH3) 1.54-1.35 (m, 2H; CH2) 1.33-1.06 (m, 2H; CH2) 0.93 (d, 
3
J = 6.6 
Hz, 3H; CH3);
 13
C NMR (400 MHz; CDCl3): δ=137.6, 131.5, 128.6 (2x), 128.2 (2x), 128.0, 124.8, 83.5, 78.8, 71.2, 
68.3, 57.8, 44.0, 36.8, 29.5, 28.2, 25.8, 25.5, 20.3, 19.3; IR (film) 3430, 2922, 2342, 1070, 746, 697 cm
-1
; HRMS 
(ESI): m/z: [M+Na]
+
 calcd for C21H30O2Na: 337.2144, found: 337.2150. 
11b 
 
2-((Benzyloxy)methyl)-1-phenylbuta-2,3-dien-1-ol (12a): Analogously to method A, benzaldehyde (106 mg, 1 
mmol) was added to a suspension of LiI (134 mg, 1 mmol), indium (63 mg, 0.55 mmol) and 1-(benzyloxy)-4-
bromo-2-butyne 2 (240 mg, 1 mmol) in THF (8 mL). The crude product was separated by silica gel column 
chromatography (hexane/ethyl acetate = 6/1) to yield compounds 12a (182 mg, 68 %) and 12b (58 mg, 22 %). 
1
H 
NMR (400 MHz; CDCl3): =7.42–7.26 (m, 10H; ArH) 5.38 (dt, 
3
J = 5.0 Hz, 
5
J = 2.5 Hz, 1H; CH) 4.96–4.93 (m, 
2H; CH2) 4.49 (s, 2H; CH2) 4.08 (dt, 
2
J = 11.1 Hz, 
5
J = 2.0 Hz, 1H; CH2) 3.99 (dt, 
2
J = 11.1 Hz, 
5
J = 1.9 Hz, 1H; 
CH2) 3.09 (d, 
3
J = 5.5 Hz, 1H; OH); 
13
C NMR (400 MHz; CDCl3) =206.6 (C), 142.2 (C), 137.7 (C), 128.6 
(2xCH), 128.4 (2xCH), 128.1 (2xCH), 128.0 (CH), 127.7 (CH), 126.4 (2xCH2), 103.8 (C), 78.1 (CH2), 73.8 (CH), 
72.5 (CH2), 69.4 (CH2); IR (film) 3424, 3062, 2864, 1068, 740, 699 cm
-1
; HRMS (ESI): m/z: [M+Na]
+
 calcd for 
C18H18O2Na: 289.1204, found: 289.1201. 
 12a 
 
5-(Benzyloxy)-1-phenylpent-3-yn-1-ol (12b): (400 MHz; CDCl3): =7.45–7.26 (m, 10H; ArH) 4.87 (t, 
3
J = 6.2 
Hz, 1H; CH) 4.53 (s, 2H; CH2) 4.16 (t, 
5
J = 2.1 Hz, 2H; CH2) 2.71 (dt, 
3
J = 6.34 Hz, 
5
J = 2.0 Hz, 2H; CH2) 2.38 
(bs, 1H; OH); 
13
C NMR (400 MHz; CDCl3) =142.6 (C), 137.5 (C), 128.5 (4xCH), 128.4 (2xCH), 127.9 (2xCH), 
127.8 (CH), 125.8 (CH), 83.1 (C), 78.7 (C), 72.5 (CH), 71.5 (CH2), 57.6 (CH2), 29.8 (CH2); IR (film) 3411, 3031, 
2926, 2327, 1058, 748, 698 cm
-1
; HRMS (ESI): m/z: [M+Na]
+
 calcd for C18H18O2Na: 289.1204, found: 289.1200. 
12b 
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2-((Benzyloxy)methyl)-1-(4-hydroxyphenyl)buta-2,3-dien-1-ol (13a): Analogously to method A, 4-
hydroxybenzaldehyde (122 mg, 1 mmol) was added to a suspension of LiI (134 mg, 1 mmol), indium (63 mg, 0.55 
mmol) and 1-(benzyloxy)-4-bromo-2-butyne 2 (240 mg, 1 mmol) in THF (8 mL). The crude product was 
separated by silica gel column chromatography (hexane/ethyl acetate = 2/1) to yield compounds 13a (129 mg, 
46 %) and 13b (41 mg, 14 %). 
1
H NMR (400 MHz; CDCl3): =7.38 (m, 7H; ArH) 6.79-6.74 (m, 2H; ArH) 
5.34-5.22 (m, 1H; CH2) 4.96-4.93 (m, 2H; CH2) 4.53 (m, 2H; CH2) 4.07 (dt, 
2
J = 11.3 Hz, 
5
J = 1.9 Hz, 1H; CH2) 
3.97 (dt, 
2
J = 11.3 Hz, 
5
J = 2.0 Hz, 1H; CH2) 3.05 (d, 
3
J = 3.9 Hz, 1H; OH); 
13
C NMR (400 MHz; CDCl3): 
=206.4 (C), 155.4 (C), 137.7 (C), 134.2 (C), 128.6 (2xCH), 128.1 (2xCH), 128.0 (CH), 127.9 (2xCH), 115.3 
(2xCH), 104.0 (C), 78.3 (CH), 73.2 (CH2), 72.4 (CH2), 69.4 (CH2); IR (film) 3318, 3030, 2923, 1056, 743, 698 
cm
-1
; HRMS (ESI): m/z: [M+Na]
+
 calcd for C18H18O3Na: 305.1154, found: 305.1160. 
13a 
 
1-Benzyloxy-5-(4-hydroxyphenyl)-pent-2-yn-5-ol (13b): (400 MHz; CDCl3): =7.39–7.24 (m, 7H; ArH) 
6.83-6.76 (m, 2H; ArH) 4.91 (bs, 1H; OH) 4.82 (t, 
3
J = 6.3 Hz, 1H; CH) 4.53 (s, 2H; CH2) 4.16 (t, 
5
J = 2.1 Hz, 
2H; CH2) 2.72-2.64 (m, 2H; CH2) 2.29 (bs, 1H; OH); 
13
C NMR (400 MHz; CDCl3): =155.3 (C), 137.5 (C), 134.9 
(C), 128.4 (2xCH), 128.1 (2xCH), 127.8 (CH), 127.3 (2xCH), 115.3 (2xCH), 83.3 (C), 78.6 (C), 72.1 (CH), 71.5 
(CH2), 57.6 (CH2), 29.8 (CH2); IR (film) 3330, 3030, 2925, 2351, 1056, 748, 698 cm
-1
; HRMS (ESI): m/z: 
[M+Na]
+
 calcd for C18H18O3Na: 305.1154, found: 305.1160. 
13b 
 
(E)-4-((Benzyloxy)methyl)-1-phenylhexa-1,4,5-trien-3-ol (14a): Analogously to method A, cinnamaldehyde 
(133 mg, 1 mmol) was added to a suspension of LiI (134 mg, 1 mmol), indium (63 mg, 0.55 mmol) and 1-
(benzyloxy)-4-bromo-2-butyne 2 (240 mg, 1 mmol) in THF (8 mL). The crude product was separated by silica gel 
column chromatography (hexane/ethyl acetate = 7/1) to yield compounds 14a (161 mg, 55 %, 69 % brsm.
[4]
) and 
14b (46 mg, 16 %, 19 % brsm.
[4]
). 
1
H NMR (400 MHz; CDCl3): =7.43-7.21 (m, 10H; ArH) 6.67 (d, 
3
J = 15.8 Hz, 
1H; CH) 6.30 (dd, 
3
J = 15.9 Hz, 
3
J = 6.3 Hz, 1H; CH) 5.01–4.91 (m, 3H; CH, CH2) 4.56 (s, 2H; CH2) 4.25 (dt, 
2
J 
= 11.2 Hz, 
5
J = 1.9 Hz, 1H; CH2) 4.17 (dt, 
2
J = 11.2 Hz, 
5
J = 1.9 Hz, 1H; CH2) 2.77 (d, 
3
J = 5.1 Hz, 1H; OH); 
13
C 
NMR (400 MHz; CDCl3): 206.4 (C), 137.8 (C), 136.8 (C), 131.0 (CH), 129.9 (CH), 128.7 (2xCH), 128.6 (2xCH), 
128.1 (2xCH), 128.0 (CH), 127.8 (CH), 126.7 (2xCH), 102.9 (C), 78.2 (CH2), 72.4 (CH2), 71.9 (CH), 69.4 (CH2); 
IR (film) 3411, 3031, 2925, 1962, 1452, 1065, 747, 696 cm
-1
; HRMS (EI): m/z: [M-H2O]
+ 
calcd for C20H18O: 
274.1358, found: 274.1362. 
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14a 
 
(E)-7-(Benzyloxy)-1-phenylhept-1-en-5-yn-3-ol (14b):
 1
H NMR (400 MHz; CDCl3): =7.37-7.13 (m, 10H; ArH) 
6.60 (d, 
3
J = 15.9 Hz, 1H; CH) 6.21 (dd, 
3
J = 15.9 Hz, 
3
J = 6.2 Hz, 1H; CH) 4.51 (s, 2H; CH2) 4.44-4.35 (m, 1H; 
CH) 4.11 (t, 
5
J = 2.1 Hz, 2H; CH2) 2.57 (ddt, 
2
J = 16.9 Hz, 
3
J = 5.4 Hz,
 5
J = 2.3 Hz, 1H; CH2) 2.52 (ddt, 
2
J = 16.6 
Hz, 
3
J = 6.3 Hz,
 5
J = 2.1 Hz, 1H; CH2) 2.77 (d, 
3
J = 4.6 Hz, 1H; OH); 
13
C NMR (400 MHz; CDCl3): 137.9 (C), 
136.8 (C), 131.7 (CH), 130.6 (CH), 129.0 (2xCH), 128.8 (2xCH), 128.4 (2xCH), 128.3 (CH), 128.2(CH), 127.0 
(2xCH), 83.1 (C), 79.3 (C), 71.9 (CH2), 71.3 (CH), 58.0 (CH2), 28.6 (CH2); IR (film) 3396, 3063, 2926, 2328, 
1455, 1070, 749, 698 cm
-1
; HRMS (EI): m/z: [M-H2O]
+ 
calcd for C20H18O: 274.1358, found: 274.1360. 
14b 
 
4-((Benzyloxy)methyl)-2-phenylhexa-4,5-dien-3-ol (15a): Analogously to method A, 2-phenylpropanal (134 mg, 
1 mmol) was added to a suspension of LiI (134 mg, 1 mmol), indium (63 mg, 0.55 mmol) and 1-(benzyloxy)-4-
bromo-2-butyne 2 (240 mg, 1 mmol) in THF (8 mL). The crude product was separated by silica gel column 
chromatography (hexane/ethyl acetate = 6/1) to yield compounds 15a (171 mg, 58 %, 83% de) and 15b (73 mg, 
25 %). 
1
H NMR (400 MHz; CDCl3): =7.39-7.23 (m, 7H; ArH), 7.22-7.16 (m, 3H; ArH) 4.83-4.72 (m, 2H; CH2) 
4.56 (s, 2H; CH2) 4.35 (m, 1H; CH) 4.09 (dt, 
2
J =  11.4 Hz, 
5
J = 2.0 Hz, 1H; CH2) 3.93 (dt, 
2
J = 11.4 Hz, 
5
J = 1.9 
Hz, 1H; CH2) 3.01 (m, 1H; CH) 2.52 (s, 1H; OH) 1.37 (d, 
3
J = 7.0 Hz, 3H; CH3); 
13
C NMR (400 MHz; CDCl3): 
=207.1 (C), 144.6 (C), 137.8 (C), 128.6 (2xCH), 128.3 (2xCH), 128.1 (CH), 128.0 (2xCH), 127.9 (CH), 126.4 
(2xCH), 102.2 (C), 77.8 (CH2), 75.6 (CH), 72.3 (CH2), 70.0 (CH2), 44.7 (CH), 17.1 (CH3); IR (film) 3424, 2928, 
1955, 1064, 749, 698 cm
-1
; HRMS (EI): m/z: [M-H2O]
+ 
calcd for C20H20O: 276.1514, found: 276.1519. 
15a 
 
1-Benzyloxy-6-phenylhept-2-yn-5-ol (15b): 
1
H NMR (400 MHz; CDCl3) =7.44-7.16 (m, 10H; ArH), 4.83 (s, 
2H; CH2) 4.19 (t, 
5
J = 2.12 Hz, 2H; CH2) 3.81 (m, 1H; CH) 2.89 (dq, 
3
J = 7.1 Hz, 
3
J = 7.0 Hz, 1H; CH) 2.37 (ddt, 
2
J =  16.9 Hz, 
3
J = 4.4 Hz, 
5
J = 2.1 Hz ,1H; CH2) 2.23 (ddt, 
2
J = 16.9 Hz, 
3
J = 4.4 Hz, 
5
J = 2.1 Hz ,1H; CH2) 1.97 
(d, 
3
J = 3.76 Hz, 1H; OH); 1.38 (d, 
3
J = 6.8 Hz, 3H; CH3); 
13
C NMR (400 MHz; CDCl3):=144.0 (C), 137.7 (C), 
128.8 (2xCH), 128.6 (2xCH), 128.2 (2xCH), 128.0 (CH), 127.8 (2xCH), 126.8 (CH), 83.5 (C), 79.0 (C), 74.6 
(CH), 71.7 (CH2), 57.8 (CH2), 45.1 (CH), 25.9 (CH2), 17.1 (CH3); IR (film) 3432, 2927, 1068, 745, 698 cm
-1
; 
HRMS (EI): m/z: [M]
+ 
calcd for C20H22O2: 294.1620, found: 294.1632. 
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15b 
 
1-O-Benzyl-4-(tert-butyloxycarbonyl)amino-2,4-dideoxy-2-C-ethenylidene-4,5-N,O-isopropylidene-L-
erythro-pentitol (16a): Analogously to method A, garner’s aldehyde[5] (230 mg, 1 mmol) was added to a 
suspension of LiI (134 mg, 1 mmol), indium (115 mg, 1 mmol) and 1-(benzyloxy)-4-bromo-2-butyne 2 (240 mg, 1 
mmol) in THF (8 mL). The crude product was separated by silica gel column chromatography (hexane/ethyl 
acetate = 6/1) to yield compounds 16a (95 mg, 24%, 27 % brsm.
[4]
) and 16b (177 mg, 45%, 50 % brsm.
[4]
). (16a): 
 = -37.4° (c 0.85, CH2Cl2); 
1
H NMR (400 MHz; DMSO, 330 K) =7.39–7.22 (m, 5H; ArH) 5.03 (d, 3J = 5.8 
Hz, 1H; OH) 4.96-4.81 (m, 2H; CH2) 4.48 (s, 2H; CH2) 4.44-4.38 (m, 1H; CH) 4.15-3.90 (m, 4H; CH, CH2) 3.84 
(dd, 
3
J = 8.3 Hz, 
3
J = 6.8 Hz, 1H; CH2) 1.50 (s, 3H; CH3) 1.45-1.38 (m, 12H; CH3); 
13
C-NMR (400 MHz; DMSO, 
330 K): =205.9 (C), 138.9 (C), 127.8 (2xCH), 127.2 (2xCH), 127.0 (CH), 102.2 (C), 94.1 (C), 78.8 (C), 77.0 
(CH2), 70.8 (CH2), 67.9 (CH), 67.4 (CH2), 63.0 (CH2), 59.7 (CH), 27.8 (4xCH3), 25.8 (CH3); IR (film) 3429, 2977, 
1961, 1698, 1390, 1098, 747, 698 cm
-1
; HRMS (ESI): m/z:[M+Na]
+
 calcd for C22H31O5NNa: 412.2100, found: 
412.2114. 
16a 
 
(2S)-7-O-Benzyl-2-(tert-butyloxycarbonyl)amino-1,2-O,N-isopropylidene-hept-5-yne-1,3,7-triol (16b):
 1
H 
NMR (400 MHz; CDCl3) =7.40–7.26 (m, 5H; ArH) 4.59 (s, 2H; CH2) 4.26-4.05 (m, 3H; CH, CH2) 4.05-3.79 (m, 
3H; CH, CH2) 2.58 (ddt, 
2
J = 16.9 Hz, 
3
J = 4.1 Hz, 
5
J = 2.2 Hz, 1H; CH2) 2.43 (ddt, 
2
J = 17.1 Hz, 
3
J = 6.3 Hz, 
5
J 
= 2.1 Hz, 1H; CH2) 1.59 (s, 3H; CH3) 1.49 (s, 9H; CH3) 1.48 (s, 3H; CH3); 
13
C-NMR (400 MHz; CDCl3): =137.7 
(C), 128.5 (2xCH), 128.2 (2xCH), 127.9 (CH), 94.6 (C), 94.5 (C), 83.0 (C), 78.8 (C), 72.2 (CH), 71.9 (CH2), 64.7 
(CH2), 61.4 (CH), 57.8 (CH2), 28.5 (4xCH3), 26.8 (CH3) 24.4 (CH2); IR (film) 3424, 2980, 2327, 1698, 1367, 
1068, 746, 698 cm
-1
; HRMS (ESI): m/z:[M+Na]
+
 calcd for C22H31O5NNa: 412.2100, found: 412.2117. 
16b 
 
2-((Benzyloxy)methyl)buta-2,3-dien-1-ol (17a): Analogously to method A, a freshly prepared aqueous solution 
(2 ml) of formaldehyde (120 mg, 4 mmol) was added to a suspension of LiI (134 mg, 1 mmol), indium (76 mg, 
0.66 mmol) and 1-(benzyloxy)-4-bromo-2-butyne 2 (240 mg, 1 mmol) in THF (4 mL). The crude product was 
separated by silica gel column chromatography (hexane/ethyl acetate = 4/1) to yield compounds 17a (123 mg, 
65 %) and 17b (43 mg, 22 %). 
1
H NMR (400 MHz; CDCl3): =7.39–7.26 (m, 5H; Ar-H) 4.93–4.88 (m, 2H; CH2) 
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4.54 (s, 2H; CH2) 4.23 (t, 
5
J = 2.5 Hz, 2H; CH2) 4.16 (t, 
5
J = 2.1 Hz, 2H; CH2) 2.4 (s, 1H; OH); 
13
C NMR (400 
MHz; CDCl3): =206.4 (C), 137.9 (C), 128.6 (2xCH), 128.0 (2xCH), 127.9 (CH), 100.5 (C), 77.3 (CH2), 72.3 
(CH2), 69.5 (CH2), 62.2 (CH2); IR (film) 3386, 3064, 2927, 1961, 1069, 747, 698 cm
-1
; HRMS (EI): m/z: calcd for 
C12H14O2: 190.0994, found: 190.0987. 
17a 
 
5-(Benzyloxy)pent-3-yn-1-ol (17b):
 1
H NMR (400 MHz; CDCl3): =7.40–7.26 (m, 5H; Ar-H) 4.59 (s, 2H; CH2) 
4.17 (t, 
5
J = 2.2 Hz, 2H; CH2) 3.72 (t, 
3
J = 6.3 Hz, 2H; CH2) 2.55-2.47 (m, 2H; CH2) 1.85 (bs, 1H; OH); 
13
C NMR 
(400 MHz; CDCl3) =137.6 (C), 128.6 (2xCH), 128.1 (2xCH), 128.0 (CH), 83.7 (C), 78.1 (C), 71.8 (CH2), 61.1 
(CH2), 57.8 (CH2), 23.3 (CH2); IR (film) 3316, 3064, 2857, 2239, 1043, 747, 698 cm
-1
; HRMS (EI): m/z: calcd for 
C12H14O2: 190.0994, found: 190.0989. 
 
17b 
 
3-((Benzyloxy)methyl)-penta-3,4-dien-1,2-diol (18a): Analogously to method A, an aqueous solution (2ml) of 
glycolaldehyde (60 mg, 1 mmol) was added to a suspension of LiI (134 mg, 1 mmol), indium (63 mg, 0.55 mmol) 
and 1-(benzyloxy)-4-bromo-2-butyne 2 (240 mg, 1 mmol) in THF (4 mL). The crude product was separated by 
silica gel column chromatography (hexane/ethyl acetate = 3/1) to yield compounds 18a (116 mg, 53 %) and 18b 
(74 mg, 34 %). 
1
H NMR (400 MHz; CDCl3): =7.40–7.26 (m, 5H; ArH) 4.97–4.91 (m, 2H; CH2) 4.54 (s, 2H; 
CH2) 4.37–4.28 (m, 1H; CH) 4.17 (dt, 
3
J = 11.1 Hz, 
5
J = 1.9 Hz, 1H; CH2) 4.13 (dt, 
2
J = 11.2 Hz, 
5
J = 1.8 Hz, 
1H; CH2) 3.73 (dd, 
2
J = 11.4 Hz, 
3
J = 4.1 Hz, 1H; CH2) 3.67 (dd, 
2
J = 14.4 Hz, 
3
J = 6.0 Hz, 1H; CH2) 2.90 (s, 
1H ; OH) 2.60 (s, 1H; OH); 
13
C NMR (400 MHz; CDCl3): =206.7 (C), 137.5 (C), 128.7 (2xCH), 128.6 (CH), 
128.1 (2xCH), 100.8 (C), 78.0 (CH2), 72.5 (CH), 71.0 (CH2), 69.2 (CH2), 65.6 (CH2); IR (film) 3351, 3064, 2924, 
1955, 1058, 737, 697 cm
-1
; HRMS (ESI): m/z: [M+Na]
+
 calcd for C13H16O3Na: 243.0997, found: 243.0998. 
18a 
 
6-(Benzyloxy)-hex-4-yne-1,2-diol (18b):
 1
H NMR (400 MHz; CDCl3): =7.4–7.26 (m, 5H; ArH) 4.58 (s, 2H; 
CH2) 4.17 (t, 
5
J = 2.2 Hz, 2H; CH2) 3.92-3.83 (m, 1H; CH) 3.74 (dd, 
2
J = 11.2 Hz, 
3
J = 3.5 Hz, 1H; CH2) 3.59 (dd, 
2
J = 11.2 Hz, 
3
J = 6.4 Hz, 1H; CH2) 2.56-2.37 (m, 2H; CH2) 1.84-1.53 (bs, 2H; 2xOH); 
13
C NMR (400 MHz; 
CDCl3): =137.5 (C), 128.6 (2xCH), 128.2 (2xCH), 128.1 (CH), 82.7 (C), 78.8 (C), 71.9 (CH2), 70.4 (CH), 65.7 
(CH2), 57.8 (CH2), 24.0 (CH2); IR (film) 3411, 3063, 2925, 2237, 1069, 747, 698 cm
-1
; HRMS (ESI): m/z: 
[M+Na]
+
 calcd for C13H16O3Na: 243.0997, found: 243.0996. 
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18b 
 
3-((Benzyloxy)methyl)-1-chloropenta-3,4-dien-2-ol (19a-chloride): Analogously to method A, an aqueous 
solution (2ml) of chloroacetaldehyde (~50% solution in water, 127µl, 1 mmol) was added to a suspension of LiI 
(134 mg, 1 mmol), indium (63 mg, 0.55 mmol) and 1-(benzyloxy)-4-bromo-2-butyne 2 (240 mg, 1 mmol) in THF 
(4 mL). The crude product was separated by silica gel column chromatography (hexane/ethyl acetate = 7/1) to 
yield compounds 19a (chloride) (29 mg, 12 %) and 19a (iodide) (119 mg, 36 %) and 19b (24 mg, 10 %). 
1
H NMR 
(400 MHz; CDCl3) =7.39-7.27 (m, 5H; ArH), 5.03-4.98 (m, 2H; CH2) 4.56-4.52 (s, 2H, CH2) 4.51-4.41 (m, 1H; 
CH) 4.25-4.10 (m, 2H; CH2) 3.73 (dd, 
2
J = 11.2 Hz, 
3
J = 4.6 Hz, 1H; CH2) 3.67 (dd, 
2
J = 11.2Hz, 
3
J = 6.7Hz, 1H; 
CH2) 2.84 (s, 1H; OH); 
13
C NMR (400 MHz; CDCl3): =206.6 (C), 137.7 (C), 128.7 (2xCH), 128.06 (CH), 128.06 
(2xCH), 100.6 (C), 78.8 (CH2), 72.4 (CH2), 70.5 (CH), 69.4 (CH2), 48.2 (CH2); HRMS (EI): m/z:[M]
+
 calcd for 
C13H15O2Cl: 238.0761, found: 238.0756. 
19a (chloride) 
 
3-((Benzyloxy)methyl)-1-iodopenta-3,4-dien-2-ol (19a-iodide): 
1
H NMR (400 MHz; CDCl3): =7.39-7.27 (m, 
5H; ArH) 5.03-4.98 (m, 2H; CH2) 4.56-4.52 (s, 2H; CH2) 4.51-4.41 (m, 1H; CH) 4.25-4.10 (m, 2H; CH2) 3.46 (dd, 
2
J = 10.2 Hz, 
3
J = 5.0 Hz, 1H; CH2) 3.40 (dd, 
2
J = 10.2 Hz, 
3
J = 6.3 Hz, 1H; CH2) 2.84 (s, 1H; OH); 
13
C NMR 
(400 MHz; CDCl3): =206.5 (C), 137.6 (C), 128.7 (CH), 128.1 (4xCH), 101.8 (C), 79.2 (CH2), 72.5 (CH2), 70.2 
(CH), 69.4 (CH2), 12.7 (CH2); IR (film) 3411, 3063, 2925, 1069, 748, 699 cm
-1
; HRMS (EI): m/z: [M]
+
 calcd for 
C13H15O2INa: 353.0014, found: 353.0017. 
19a (iodide) 
 
6-(Benzyloxy)-1-chlorohex-4-yn-2-ol (19b): 
1
H NMR (400 MHz; CDCl3) =7.40-7.26 (m, 5H; ArH), 4.58 (s, 
2H; CH2) 4.17 (t, 
5
J = 2.2 Hz, 2H; CH2) 4.05-3.92 (m, 1H; CH) 3.71 (dd, 
2
J = 11.2 Hz, 
3
J = 4.4 Hz, 1H; CH2) 
3.64 (dd, 
2
J = 11.2 Hz, 
3
J = 6.1 Hz, 1H; CH2) 2.73-2.51 (m, 2H; CH2) 2.38 (bs, 1H; OH); 
13
C NMR (400 MHz; 
CDCl3): =137.5 (C), 128.6 (2xCH), 128.2 (2xCH), 128.0 (CH), 81.7 (C), 79.3 (C), 71.9 (CH2), 69.9 (CH), 57.7 
(CH2), 48.5 (CH2), 24.8 (CH2); IR (film) 3411, 3031, 2924, 1071, 748, 698 cm
-1
; HRMS (EI): m/z:[M]
+
 calcd for 
C13H15O2Cl: 238.0761, found: 238.0756. 
19b 
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3,4,5-Tri-O-acetyl-1-O-benzyl-2-deoxy-2-C-ethenylidene-D-erythro-pentitol (20a): To a suspension of 2,3-O-
isopropylidine-D-glyceraldehyde (156 mg, 1.2 mmol) in 2,5 mL of a mixture of water/THF (4:1), 0.75 g of 
DOWEX 50 W (H
+
) were added and the mixture was stirred at room temperature. After TLC monitoring showed 
conversion of the starting material, the pH was adjusted to ~6.5 by addition of a 0.5 N NaOH solution. 
Analogously to method A, this solution was added a suspension of LiI (134 mg, 1 mmol), indium (115 mg, 1 
mmol) and 1-(benzyloxy)-4-bromo-2-butyne 2 (240 mg, 1 mmol) in THF (4 mL). After sonication of the reaction 
mixture for 12 hours, the pH was readjusted to ~6.5 by addition of a 0.5 N NaOH solution. The reaction mixture 
was filtered over a pad of zelite and the solvent was evaporated. To the dried reaction mixture, pyridine (1 mL), 
acetic anhydride (550 µL) and 4-dimethylaminopyridine (DMAP) were added. After 12 hours the solvents were 
removed by codestillation with toluene at reduced pressure. The crude product was carefully separated by silica 
gel column chromatography (hexane/ethyl acetate = 8:1) to yield compounds 20a (76 mg, 20 %) and 20b (124 mg, 
33 %). (20a):  = -1.8° (c 0.6, CH2Cl2);
 1
H-NMR (400 MHz, CDCl3): =7.38-7.26 (m, 5H; Ar-H) 5.57 (dt, 
3
J 
= 6.3 Hz,
 5
J = 1.7 Hz, 1H; CH)
 
5.43 (ddd, 
3
J = 6.2 Hz, 
3
J = 6.2 Hz, 
3
J = 3.9 Hz, 1H; CH)
 
4.98-4.94 (m, 2H; CH2) 
4.53 (d, 
2
J = 11.9 Hz, 1H; CH2)
 
4.55 (d, 
2
J = 11.7 Hz, 1H; CH2) 4.48 (d, 
2
J = 11.7 Hz, 1H; CH2) 4.33 (dd, 
2
J = 
12.0 Hz, 
3
J = 3.8 Hz, 1H; CH2) 4.15 (dd, 
2
J = 11.9, 
3
J = 6.0 Hz, 1H; CH2) 4.14 (dt, 
2
J = 11.6 Hz, 
5
J = 2.2 Hz, 1H; 
CH2) 4.04 (dt, 
2
J = 11.6 Hz, 
5
J = 1.9 Hz, 1H; CH2) 2.06 (s, 3H; CH3), 2.05 (s, 3H; CH3), 2.02 (s, 3H; CH3); 
13
C 
NMR (400 MHz; CDCl3): =208.0 (C), 170.7 (C), 170.2 (C), 170.0 (C), 138.0 (C), 128.5 (2xCH), 128.1 (2xCH), 
127.8 (CH), 97.9 (C), 78.5 (CH2), 72.3 (CH2), 70.9 (CH), 70.1 (CH), 68.5 (CH2), 62.7 (CH2), 21.0 (CH3), 20.9 
(CH3), 20.8 (CH3); IR (film) 3063, 2926, 1962, 1742, 1216, 746, 699 cm
-1
; HRMS (ESI): m/z: [M+Na]
+ 
calcd for 
C20H24O7Na: 399, 1420, found: 399,1413. 
20a 
 
(2R,3R)-7-(Benzyloxy)-1,2,3-tri-O-acetyl-5-heptyne-1,2,3-triol (20b):  = -7.2° (c 0.25, CH2Cl2); 
1
H-NMR 
(400 MHz, CDCl3): =7.40-7.26 (m, 5H; Ar-H) 5.40 (ddd, 
3
J = 6.1 Hz,
 3
J = 4.6 Hz, 
3
J = 4.6 Hz, 1H; CH)
 
5.21 
(ddd, 
3
J = 6.4 Hz, 
3
J = 6.4 Hz, 
3
J = 4.4 Hz, 1H; CH)
 
4.57 (s, 2H; CH2) 4.32 (dd, 
2
J = 11.9 Hz, 
3
J = 4.8 Hz, 1H; 
CH2)
 
4.14 (t, 
5
J = 2.1 Hz, 2H; CH2) 4.08 (dd, 
2
J = 11.9 Hz, 
3
J = 6.2 Hz, 1H; CH2) 2.67-2.52 (m, 2H; CH2) 2.11 (s, 
3H; CH3), 2.10 (s, 3H; CH3), 2.05 (s, 3H; CH3); 
13
C NMR (400 MHz; CDCl3): =170.6 (C), 170.1 (C), 170.0 (C), 
137.6 (C), 128.5 (2xCH), 128.2 (2xCH), 128.0 (CH), 80.7 (C), 79.1 (C), 71.6 (CH2), 70.5 (CH), 69.7 (CH), 62.1 
(CH2), 57.6 (CH2), 21.2 (CH2), 20.9 (CH3), 20.87 (CH3), 20.83 (CH3); IR (film) 2932, 1747, 1219, 748, 699 cm
-1
; 
HRMS (ESI): m/z: [M+Na]
+ 
calcd for C20H24O7Na: 399, 1420, found: 399,1418. 
20b 
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1-O-Benzyl-2-deoxy-2-C-ethenylidene-D-gluco-heptitol (21a) and (2R,3R,4R,5S)-9-(Benzyloxy)non-7-yne-
1,2,3,4,5-pentaol (21b): Analogously to method A, an aqueous solution (2 ml) of arabinose (150 mg, 1 mmol) 
was added to a suspension of LiCl (85 mg, 2 mmol), indium (115 mg, 1 mmol) and 1-(benzyloxy)-4-bromo-2-
butyne 2 (240 mg, 1 mmol) in THF (4 mL). The crude product was separated by silica gel column 
chromatography (ethyl acetate/methanol = 8/1) to yield an inseperable mixture of compound 21a and 21b (16 mg, 
5 %, 21a:21b=50:50) and the sideproducts 30a (21 mg, 16 %), 30b (13 mg, 12 %), and 31a (19 mg, 11 %) 
together with 31b (15 mg, 7 %). (21a): 
1
H NMR (400 MHz; CDCl3): =7.26–7.17 (m, 5H; ArH) 4.87–4.84 (m, 
2H; CH2) 4.44 (s, 2H; CH2) 4.24 (dt, 
2
J = 5.5 Hz, 
5
J = 1.7 Hz, 1H; CH) 4.10–4.04 (m, 2H; CH2) 3.86–3.79 (m, 
1H; CH) 3.71 (s, 5H; OH) 3.68–3.52 (m, 4H; CH, CH2) (21b): 
1
H NMR (400 MHz; CDCl3): =7.27–7.17 (m, 5H; 
ArH) 4.47 (s, 2H; CH2) 4.10–4.04 (m, 2H; CH2) 3.86–3.79 (m, 1H; CH) 3.79-3.75 (m, 1H; CH) 3.71 (s, 5H; OH) 
3.68-3.52 (m, 4H; CH, CH2) 2.50 (ddt, 
2
J = 16.7 Hz, 
3
J = 6.4 Hz, 
5
J = 2.1 Hz, 1H; CH2), 2.43 (ddt, 
2
J = 16.6 Hz, 
3
J = 6.6 Hz, 
5
J = 2.0 Hz, 1H; CH2); 
13
C NMR (400 MHz; CDCl3): 21a/21b: =207.4 (C-23a), 137.3 (C), 137.1 (C), 
128.4 (CH), 128.2 (CH), 128.1 (CH), 128.0 (CH), 127.94 (CH), 127.90 (CH), 100.5 (C-23a), 83.5 (C-23b), 77.6 
(CH2-23a), 77.5 (C-23b), 73.6 (CH), 72.34 (CH), 72.32 (CH), 72.3 (CH2), 71.8 (CH), 71.7 (CH), 71.69 (CH2), 71.4 
(CH), 71.1 (CH), 70.1 (CH), 68.7(CH2-23a), 63.57 (CH2), 63.55 (CH2), 57.7 (CH2-23b), 23.7 (CH2-23b); IR (film) 
3339, 2926, 2351, 1955, 1064, 743, 698 cm
-1
; HRMS (ESI): m/z: [M+Na]
+
 calcd for C16H22O6Na: 333.1314, 
found: 333.1312. 
21a  21b 
 
5-((Benzyloxy)methyl)hepta-5,6-dien-1,4-diol (30a): 
1
H NMR (600 MHz; CDCl3): =7.39-7.27 (m, 5H; Ar-H) 
4.93-4.90 (m, 2H; CH2) 4.55 (d, 
2
J = 11.8 Hz, 1H; CH2) 4.53 (d, 
2
J = 11.8 Hz, 1H; CH2) 4.29-4.24 (m, 1H; CH) 
4.20 (dt, 
2
J = 11.2 Hz, 
5
J = 1.9 Hz, 1H; CH2) 4.14 (dt,
2
 J = 11.2 Hz,
 5
J = 2.0 Hz, 1H; CH2) 3.71-3.61 (m, 2H; 
CH2) 2.75 (s, 2H; 2xOH) 1.83-1.75 (m, 1H; CH2) 1.73-1.64 (m, 3H; CH2); 
13
C NMR (400 MHz; CDCl3): =206.2 
(C), 137.7 (C), 128.6 (2xCH), 128.1 (2xCH), 128.0 (CH), 103.1 (C), 77.9 (CH), 72.4 (CH2), 70.9 (CH2), 69.9 
(CH), 63.0 (CH2), 32.7 (CH2), 29.3 (CH2); IR (film) 3385, 2927, 1956, 1066, 748, 699 cm
-1
; HRMS (ESI): m/z: 
[M+Na]
+ 
calcd for C15H20O3Na: 271.1310, found: 271.1308. 
30a 
 
8-(Benzyloxy)oct-6-yne-1,4-diol (30b): 
1
H NMR (600 MHz; CDCl3): =7.37-7.32 (m, 4H; Ar-H) 7.32-7.27 (m, 
1H; Ar-H) 4.59 (s, 2H; CH2) 4.18 (t, 
5
J = 2.13, 2H; CH2) 3.83-3.76 (m, 1H; CH) 3.75-3.62 (m, 2H; CH2) 2.48 (ddt, 
2
J = 16.6 Hz, 
3
J = 6.8 Hz, 
5
J = 2.1 Hz, 1H; CH2) 2.42 (ddt, 
2
J = 16.6 Hz, 
3
J = 5.1 Hz, 
5
J = 2.2 Hz, 1H; CH2) 
1.78-1.65 (m, 3H; CH2) 1.65-1.51 (m, 1H; CH2); 
13
C-NMR (600 MHz; CDCl3): =137.6 (C), 128.6 (2xCH), 128.2 
(2xCH), 128.0 (CH), 83.5 (C), 78.7 (C), 71.8 (CH2), 70.2 (CH), 63.0 (CH2), 57.8 (CH2), 33.5 (CH2), 29.2 (CH2), 
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28.1 (CH2); IR (film) 3342, 2924, 2237, 1066, 748, 699 cm
-1
; HRMS (ESI): m/z: [M+Na]
+ 
calcd for C15H20O3Na: 
271.1310, found: 271.1308. 
30b 
 
1-O-Benzyl-2,3-butadien-1-ol (31a): 
1
H NMR (600 MHz; CDCl3): =7.38-7.26 (m, 5H; Ar-H) 5.28 (m, 1H; CH) 
4.81 (dt, 
4
J = 6.6 Hz; 
5
J = 2.5 Hz, 2H; CH2) 4.54 (s, 2H; CH2) 4.07 (dt, 
4
J = 6.9 Hz, 
5
J = 2.4 Hz, 2H; CH2); 
13
C 
NMR (600 MHz; CDCl3): =209.5 (C), 137.7 (C), 128.6 (2xCH), 127.9 (CH), 127.8 (2xCH), 87.8 (CH), 75.8 
(CH2), 71.6 (CH2), 68.0 (CH2);  
1-O-Benzyl-but-2-yn-1-ol (31b): 
1
H NMR (600 MHz; CDCl3): =7.38-7.26 (m, 5H; Ar-H) 4.59 (s, 2H; CH2) 4.14 
(q, 
5
J = 2.3Hz, 2H; CH2) 1.88 (t, 
5
J = 2.3Hz, 3H; CH3);
13
C NMR (600 MHz; CDCl3): =138.2 (C), 128.5 (2xCH), 
128.2 (CH), 128.0 (2xCH), 82.8 (C), 75.2 (C), 71.9 (CH2), 57.9 (CH2), 3.8 (CH3); (33a + 33b): IR (film) 3064, 
2922, 1956, 747, 698 cm
-1
; HRMS (EI): m/z: [M-H]
- 
calcd for C11H11O: 159.0810 found: 159.0809. 
31a  +  31b 
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 1-O-Benzyl-2-deoxy-2-C-ethenylidene-4,5-O-isopropylidene-D-erythro-pentitol (3a): 
1.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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(2R)-7-(Benzyloxy)-1,2-O-isopropylidene-hept-5-yne-1,2,3-triol (3b):  
1.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
1
.
3
6
1
.
3
8
1
.
4
2
1
.
4
5
1
.
5
5
2
.
1
3
2
.
1
4
2
.
5
4
2
.
5
5
2
.
5
6
2
.
5
6
2
.
5
7
2
.
5
7
3
.
7
7
3
.
9
7
3
.
9
8
4
.
0
0
4
.
0
6
4
.
0
7
4
.
0
8
4
.
0
8
4
.
0
9
4
.
0
9
4
.
1
6
4
.
1
7
4
.
1
7
4
.
1
8
4
.
1
8
4
.
5
9
5
.
3
0
7
.
2
6
7
.
3
0
7
.
3
1
7
.
3
1
7
.
3
2
7
.
3
5
7
.
3
6
3
.4
8
1
.1
5
3
.1
3
0
.9
6
1
.0
0
0
.3
6
2
.7
6
0
.3
7
1
.0
9
0
.3
7
1
.0
9
2
.3
4
2
.6
0
2
.5
7
6
.3
1
 
220 200 180 160 140 120 100 80 60 40 20 0 ppm
2
4
.
1
4
2
4
.
4
7
2
5
.
3
2
2
6
.
6
6
2
6
.
8
1
5
7
.
7
9
6
6
.
0
4
6
6
.
1
9
7
0
.
4
1
7
0
.
5
4
7
1
.
7
9
7
1
.
8
5
7
6
.
8
4
7
7
.
1
6
7
7
.
4
7
7
7
.
5
4
7
7
.
5
6
7
9
.
2
0
8
2
.
3
2
8
8
.
5
3
1
0
9
.
5
4
1
2
8
.
0
1
1
2
8
.
0
4
1
2
8
.
1
9
1
2
8
.
6
1
1
3
7
.
6
0
 
132
Supporting Information - Eur. J. Org. Chem.
2-Deoxy-2-C-ethenylidene-4,5-O-isopropylidene-1-O-methyl-D-erythro-pentitol (4a):  
1.52.02.53.03.54.04.55.05.56.06.57.0 ppm
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2-Deoxy-2-C-ethenylidene-4,5-O-isopropylidene-D-erythro-pentitol (5a):  
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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1-O-Acetyl-4-bromo-but-2-yn-1-ol (6): 
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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1-O-Acetyl-2-deoxy-2-C-ethenylidene-4,5-O-isopropylidene-D-erythro-pentitol (6a): 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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1-O-Benzyloxycarbonyl-4-bromobut-2-yn-1-ol (7): 
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1-O-Carbonyloxybenzyl-2-deoxy-2-C-ethenylidene-4,5-O-isopropylidene-D-erythro-pentitol (7a):  
1.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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1-O-tert-Butyldiphenylsilyl-4-bromobut-2-yn-1-ol (8): 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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1-O-tert-Butyldiphenylsilyl-2-deoxy-2-C-ethenylidene-4,5-O-isopropylidene-D-erythro-pentitol (8a): 
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(2R,3S)-1,2-O-Isopropylidene-4-methyl-hexa-4,5-dien-1,2,3-triol (9a): 
1.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Supporting Information - Eur. J. Org. Chem.
6-Bromohexa-2,4-diyn-1-ol (10): 
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(2R,3S)-4-Ethenylidene-1,2-O-isopropylidene-hept-5-yne-1,2,3,7-tetrol 
(10a)
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Supporting Information - Eur. J. Org. Chem.
3-((Benzyloxy)methyl)-6,10-dimethylundeca-1,2,9-trien-4-ol (11a): 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Supporting Information - Eur. J. Org. Chem.
2-((Benzyloxy)methyl)-1-phenylbuta-2,3-dien-1-ol (12a): 
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Supporting Information - Eur. J. Org. Chem.
2-((Benzyloxy)methyl)-1-(4-hydroxyphenyl)buta-2,3-dien-1-ol (13a): 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Supporting Information - Eur. J. Org. Chem.
(E)-4-((Benzyloxy)methyl)-1-phenylhexa-1,4,5-trien-3-ol (14a): 
1.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Supporting Information - Eur. J. Org. Chem.
4-((Benzyloxy)methyl)-2-phenylhexa-4,5-dien-3-ol (15a): 
1.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Supporting Information - Eur. J. Org. Chem.
1-O-Benzyl-4-(tert-butyloxycarbonyl)amino-2,4-dideoxy-2-C-ethenylidene-4,5-N,O-isopropylidene-L-
erythro-pentitol (16a):  
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Supporting Information - Eur. J. Org. Chem.
2-((Benzyloxy)methyl)buta-2,3-dien-1-ol (17a): 
2.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Supporting Information - Eur. J. Org. Chem.
3-((Benzyloxy)methyl)penta-3,4-dien-1,2-diol (18a): 
2.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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Supporting Information - Eur. J. Org. Chem.
Mixture of 3-((Benzyloxy)methyl)-1-chloropenta-3,4-dien-2-ol and 3-((benzyloxy) methyl)-1-iodopenta-3,4-
dien-2-ol (19a): chloride : iodide = 1.0 : 0.77 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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Supporting Information - Eur. J. Org. Chem.
3-((Benzyloxy)methyl)-1-iodopenta-3,4-dien-2-ol (19a-iodide): 
2.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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3,4,5-Tri-O-acetyl-1-O-benzyl-2-deoxy-2-C-ethenylidene-4,5-O-isopropylidene-D-erythro-pentitol (20a): 
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1-O-Benzyl-2-deoxy-2-C-ethenylidene-D-gluco-heptitol (21a) and (2R,3R,4R)-9-(benzyloxy)non-7-yne-
1,2,3,4,5-pentaol (21b): 
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1-O-Benzyl-4,5-O-isopropylidene-D-erythro-2-pentulose (22):  
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
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1-Deoxy-4,5-O-isopropylidene-D-erythro-2-pentulose (23): 
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4,5-O-Isopropylidene-D-erythro-2-pentulose (24): 
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D-erythro-2-Pentulose (25): 
3.63.73.83.94.04.14.24.34.44.54.64.74.8 ppm
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13
C NMR(JMOD): For the carbonyl carbon of D-erythro-2-pentulose and the quaternary carbon of -D-erythro-2-
pentulose see above. 
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1-O-Benzyl-2-deoxy-2-C-ethenylidene-D-erythro-pentitol (26):  
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5 ppm
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(2R,3S)-4-Methylhexa-4,5-dien-1,2,3-triol (27): 
1.52.02.53.03.54.04.55.0 ppm
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1-O-Benzyl-D-erythro-2-pentulose (28): 
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1-Deoxy-D-erythro-2-pentulose (29):  
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13
C NMR(JMOD): For the quaternary carbons of - and -1-deoxy-D-erythro-2-pentulose see above. 
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5-((Benzyloxy)methyl)hepta-5,6-dien-1,4-diol (30a): 
1.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
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8-(Benzyloxy)oct-6-yne-1,4-diol (30b):  
1.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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1-O-Benzyl-buta-2,3-dien-1-ol (31a) and 1-O-Benzyl-but-2-yn-1-ol (31b): 
2.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
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PART C: Indium-Mediated Allenylation of Aldehydes with 4-Bromo-2-butyn-1-ols: Versatile -Hydroxyacetyl Anion Equivalents 
 
Unpublished Work: 
 
Dibenzyl (4-bromobut-2-yn-1-yl) phosphate (171b): 
 
 
To a solution of 2-butyne-1,4-diol (86 mg, 1 mmol) in dry pyridine (2 mL), freshly prepared 
dibenzyl phosphorylchloride (0.356 g, 1.2 mmol) was added at 0°C. After 1 houre the 
reaction was quenched by addition of a water (1 mL) and the solvent was removed under 
reduced pressure. The product was re-dispended in ethyl acetate (5 mL) and water (1 mL). 
The aqueous phase was separated and extracted with ethyl acetate (3 x 5 mL). The 
combined organic layers were washed with brine, dried over MgSO4 and evaporated. The 
crude product was separated twice by silica gel column chromatography (hexane/ethyl 
acetate = 2:1 and hexane/ethyl acetate = 1:2) to yield dibenzyl (4-hydroxybut-2-yn-1-yl) 
phosphate (132 mg, 38%). 1H-NMR (400 MHz; CDCl3)  = 7.68-7.12 (m, 10H, CH), 5.18-5.00 
(m, 4H, CH2), 4.73-4.56 (m, 2H, CH2), 4.31-4.19 (m, 2H, CH2), 3.82-3.71 (m, 1H, OH). 
13C-NMR 
(400 MHz; CDCl3)  = 135.5 (d, J = 7.1 Hz), 128.63, 128.61, 128.0, 87.1, 78.8 (d, J = 7.0 Hz), 
69.6 (d, J = 5.8 Hz), 55.6 (d, J = 5.0 Hz), 50.4. The phosphate was re-dissolved in anhydrous 
CH2Cl2 (1 mL), CBr4 (149 mg, 0.45 mmol) and PPh3 (118 mg, 0.45) were added at 0°. The 
reaction was quenched by addition of methanol (1 mL) after 2 hours and the solvent was 
removed under reduced pressure. The crude product was purified by silica gel column 
chromatography (hexane/ethyl acetate = 2/1) to yield dibenzyl (4-bromobut-2-yn-1-yl) 
phosphate (171b) (103 mg, 67%). 1H-NMR (400 MHz; CDCl3)  = 7.47-7.29 (m, 10H, CH), 5.16-
5.01 (m, 4H, CH2), 4.66 (dt, J = 10.4, J = 2.1 Hz, 2H, CH2), 3.83 (t, J = 2.0 Hz, 2H, CH2).  
 
1-Benzyloxy-2-bromo-but-2,3-diene (176): 
 
 
To a solution of 2-butyne-1,4-diol (21.5 g, 0.25 mol) in anhydrous DMF (250 mL), TBAI (0.46 
g, 0.0125 mol) and sodium hydride (60%, 3.6 g, 0.125 mol) were added at 0°C. Benzyl 
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bromide (25.7 g, 0.15 mol) was added slowly under stirring and after 12 hours the reaction 
was quenched by addition of ice-cold water (75 mL) and 3N HCl-solution (75 mL). The 
aqueous phase was extracted with diethyl ether (3 x 150 mL). The combined organic layers 
were washed with brine, dried over MgSO4 and evaporated. A part of the crude product (10 
g) was dissolved in anhydrous CH2Cl2 (65 mL), CBr4 (16.1 g, 0.048 mol) and PPh3 (12.7 g, 
0.048) were added at 0°C. The reaction was quenched by addition of methanol (20 mL) after 
5 hours and the solvent was removed under reduced pressure. The crude product was 
purified by silica gel column chromatography (hexane/ethyl acetate = 50/1) to yield 1-O-
benzyl-4-bromo-2-butyn-1-ol (4.12 g) and 1-benzyloxy-2-bromo-but-2,3-diene (176) (1.89 g). 
(176): 1H-NMR (400 MHz; CDCl3)  = 7.41-7.28 (m, 5H, CH), 4.99 (t, J = 2.4 Hz, 2H, CH2), 4.59 
(s, J = 2H, CH2), 4.22 (t, J = 2.4 Hz, 2H, CH2); 
13C-NMR (400 MHz; CDCl3)  = 205.1, 137.6, 
128.6, 128.1, 128.0, 89.0, 82.6, 71.8, 71.7. 
 
1-O-Benzyl-4,5-O-isoproylidene-D-erythro-pent-2-ulose p-bromophenylhydrazone (179): 
 
 
To a solution of pentulose 184 (10 mg, 36 µmol) in dry methanol (0.8 mL) were added 
molecular sieves (3Å) and 4-bromophenylhydrazine hydrochloride (9 mg, 39 µmol). The 
reaction was quenched by addition of water (1 mL), after TLC monitoring showed conversion 
of the starting materials (~5 min). The aqueous phase was separated and extracted with 
ethyl acetate (2 x 3 mL). The combined organic layers were washed with brine, dried with 
MgSO4, filtered and concentrated. The crude product was purified by silica gel 
chromatography (hexane/ethyl acetate = 4/1) to give hydrazone 179 (16 mg, 99 %). 1H-NMR 
(400 MHz; CDCl3)  = 9.19 (s, 1H, NH), 7.41-7.28 (m, 7H, CH), 6.82-6.77 (m, 2H, CH), 4.56 (d, J 
= 11.3 Hz, 1H, CH2), 4.52 (d, J = 11.4 Hz, 1H, CH2), 4.50 (d, J = 14.0 Hz, 1H, CH2), 4.39 (d, J = 
14.0 Hz, 1H, CH2), 4.19-413 (m, 2H, CH), 4.12-4.02 (m, 2H, CH), 3.23 (d, J = 4.9 Hz, 1H, OH), 
1.42 (s, 3H, CH3), 1.35 (s, 3H, CH3); 
13C-NMR (400 MHz; CHCl3):  = 143.9, 147.2, 136.9, 132.2, 
132.1, 128.9, 128.6, 128.4, 114.8, 114.4, 112.3, 109.7, 78.7, 73.2, 73.1, 67.3, 67.1, 26.7, 25.2. 
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1-O-Benzyl-4-N-tert-butyloxycarbonyl-4,5-N,O-isoproylidene-L-erythro-pent-2-ulose (187): 
 
 
Pentulose (187) was synthesized according to method B as published the European Journal 
of Organic Chemistry. Method B was applied to compound 186 (20 mg, 0.051 mmol) to yield 
pentulose (187) (17 mg, 87 %). []D
20= +14.9 (c = 0.85, CH2Cl2); 
1H NMR (400 MHz; CHCl3)  = 
7.41–7.26 (m, 5H; ArH), 4.63(d, J = 12.0 Hz, 1H; CH2), 4.58 (d, J = 12.0 Hz, 1H; CH2), 4.53-4.45 
(m, 1H; CH) 4.40-4.13 (m, 3H) 4.10-3.84 (m, 2H) 1.46 (bs, 15H; CH3); 
13C-NMR (400 MHz; 
CHCl3):  = 208.3, 153.7, 132.3, 128.7, 128.6, 128.2, 94.6, 81.4, 75.6, 75.1, 73.9, 73.7, 64.5, 
60.8, 28.4, 26.4, 24.8. 
 
Procedure A: Typical procedure for benzylidene protection – Synthesis of 2-
((benzyloxy)methyl)-1-((2R,4R)-2-phenyl-1,3-dioxolan-4-yl)buta-2,3-dien-1-ol (181) and 2-
((benzyloxy)methyl)-1-((2S,4R)-2-phenyl-1,3-dioxolan-4-yl)buta-2,3-dien-1-ol (182): 
 
 
To a solution of 1-O-benzyl-2-deoxy-2-C-ethenyliden-D-erythro-pentitol (16 mg, 63.9 µmol) 
in dry DMF (1 mL), benzaldehyde dimethyl acetal (24 mg, 143 µmol) and p-toluenesulfonic 
acid (2.7 mg, 16 µmol) were added. After heating the reaction mixture at 48°C under 
reduced pressure (39 mbar) for 4 ½ hours, H2O (1 mL) and ethyl acetate (5 mL) were added. 
The aqueous phase was separated and extracted with ethyl acetate (3 x 3 mL). The 
combined organic layers were washed with brine, dried with MgSO4, filtered and 
concentrated. The crude product was purified by silica gel column chromatography 
(hexane/ethyl acetate = 4/1) to yield five membered dioxolane ring (181) and (182) 
(combined yield: 8 mg, 37 %) in two conformations. 1H-NMR (600 MHz; CDCl3)  = 7.52-7.42 
(m, 4H, CH), 7.41-7.27 (m, 16H, CH), 5.99 (s, 1H, CH)182, 5.79 (s, 1H, CH)181, 4.99-4.92 (m, 4H, 
CH2), 4.57-4.51 (m, 5H, 2 x CH2, CH), 4.46-4.41 (m, 1H, CH)
181, 4.39-4.34 (m, 2H, CH), 4.30-
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4.25 (m, 3H, CH2), 4.24 (dd, J = 8.4 Hz, J = 6.6 Hz, 1H, CH2)
182, 4.17 (dt, J = 11.1 Hz, J = 1.9 Hz, 
1H, CH2)
182, 4.14 (dt, J = 11.2 Hz, J = 1.8 Hz, 1H, CH2)
181, 4.11 (dd, J = 8.5 Hz, J = 6.8 Hz, 1H, 
CH2)
182, 4.09 (dd, J = 8.4 Hz, J = 7.1 Hz, 1H, CH2)
181, 2.77 (s, 1H, OH)182, 2.72 (s, 1H, OH)181; 13C-
NMR (600 MHz; CDCl3)  =207.2, 206.8, 138.9, 137.7, 137.6, 137.2, 129.6, 129.3, 128.7, 
128.6, 128.5, 128.4, 128.1, 128.05, 128.02, 126.9, 126.5, 104.4, 104.2, 100.4, 100.3, 78.3, 
78.0, 77.98, 77.6, 72.6, 72.5, 71.5, 71.4, 70.0, 69.8, 67.1, 66.9, 29.8.  
 
(2R,4S,5R)-4-(buta-2,3-dien-2-yl)-2-phenyl-1,3-dioxan-5-ol (183): 
 
 
Procedure A was applied to allene 173e (24 mg, 0.166 mmol) for benzylidene protection to 
yield 1,3-dioxane 183 (14 mg, 34%). 1H-NMR (400 MHz; CDCl3)  = 7.53-7.44 (m, 2H, CH), 
7.42-7.30 (m, 3H, CH), 5.55 (s, 1H, CH), 4.95-4.78 (m, 2H, CH2), 4.36 (dd, J = 10.8 Hz, J = 5.3 
Hz, 1H, CH2), 4.04 (dt, J = 9.0 Hz, J = 1.7 Hz, 1H, CH2), 3.93-3.81 (m, 1H, CH), 3.67 (dd, J = 10.8 
Hz, J = 10.2 Hz, 1H, CH2), 1.88 (bs, 1H, OH), 1.84 (t, J = 3.3 Hz, 1H, CH3); 
13C-NMR (400 MHz; 
CDCl3)  = 201.5, 138.0, 129.1, 128.3, 126.2, 109.5, 101.2, 94.7, 78.9, 76.2, 76.1, 68.9, 65.2, 
26.5, 25.9. 
 
Synthesis of (2R,3S)-4-(((tert-butyldiphenylsilyl)oxy)methyl)hexa-4,5-diene-1,2,3-triol (189) 
and (2R,3S)-4-vinylidenepentane-1,2,3,5-tetraol (190): 
   
 
(2R, 3S)-4-(((tert-butyldiphenylsilyl)oxy)methyl)hexa-4,5-diene-1,2,3-triol (189) was 
synthesized according to method C as published the European Journal of Organic Chemistry. 
Method C was applied to compound 173f (50 mg, 0.114 mmol) to yield allene (189) (9 mg, 
20%) along with unreacted starting material (11mg) and tetrol 190 (9mg, 49 %). (189): 1H-
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NMR (400 MHz; CDCl3)  = 7.73-7.64 (m, 4H, CH), 7.50-7.35 (m, 6H, CH), 4.88-4.84 (m, 2H, 
CH2), 4.39-4.26 (m, 3H, CH, CH2), 3.85-3.78 (m, 3H, CH, CH2), 1.06 (s, 9H, CH3). (190): 5.11 (m, 
2H, CH2), 4.27-4.14 (m, 3H, CH, CH2), 3.91-3.78 (m, 2H, CH, CH2), 3.69 (dd, J = 11.7 Hz, J = 6.6 
Hz, 1H, CH2). 
 
4-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2-phenyl-5-vinylidene-1,3-dioxane (193): 
 
 
Procedure A was applied to allene 192 (10 mg, 0.05 mmol) for benzylidene protection to 
yield 1,3-dioxane 193 (5 mg, 34%). 1H-NMR (400 MHz; CDCl3)  = 7.55-7.45 (m, 2H, CH), 7.41-
7.30 (m, 3H, CH), 5.66 (s, 1H, CH), 5.04-4.85 (m, 2H, CH2), 4.67-4.61 (m, 1H, CH), 4.59-4.54 
(m, 2H, CH2), 4.41 (ddd, J = 6.6 Hz, J = 4.4 Hz, J = 0.1 Hz, 1H, CH), 4.16 (dd, J = 8.3 Hz, J = 6.6 
Hz, 1H, CH2), 4.11 (dd, J = 8.3 Hz, J = 6.6 Hz, 1H, CH2), 1.43 (s, 3H, CH3), 1.39 (s, 3H, CH3); 
13C-
NMR (400 MHz; CDCl3)  = 201.5, 138.0, 129.1, 128.3, 126.2, 109.5, 101.2, 94.7, 78.9, 76.2, 
76.1, 68.9, 65.2, 26.5, 25.9. 
 
(R)-4-((S)-3-((benzyloxy)methyl)-2,5-dihydrofuran-2-yl)-2,2-dimethyl-1,3-dioxolane (195): 
 
 
To a solution of allene 173d (30 mg, 0.104 mmol) in dry THF (2 mL) was added AuCl3 (1.5 mg, 
5 µmol). The solvent was removed under reduced pressure, after TLC monitoring showed 
consumption of the starting material. The crude product was purified by silica gel 
chromatography (hexane/ethyl acetate = 1/1) to yield furan 195 (9 mg, 30 %). 1H-NMR (400 
MHz; CDCl3)  = 7.40-7.27 (m, 5H, CH), 5.94-5.89 (s, 1H, CH), 4.78-4.70 (m, 1H, CH), 4.68-4.61 
(m, 2H, CH2), 4.59-4.50 (m, 2H, CH2), 4.25-4.11 (m, 2H, CH2), 4.11-4.06 (m, 1H, CH), 4.03 (dd, 
J = 8.2 Hz, J = 6.4, 1H, CH2), 3.92 (dd, J = 8.2 Hz, J = 5.6, 1H, CH2), 1.42 (s, 3H, CH3), 1.34 (s, 3H, 
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CH3); 
13C-NMR (600 MHz; CDCl3)  = 139.0, 128.6, 127.85, 127.80, 124.5, 109.6, 85.9, 78.2, 
75.3, 72.9, 66.6, 66.1, 26.7, 25.5. 
(2R,3S)-4-(((tert-butyldiphenylsilyl)oxy)methyl)-1-O-(p-nitrobenzoyl)hexa-4,5-diene-1,2,3-
triol: 
 
 
To a solution of allene 189 (7 mg, 17.6 µmol) in dry pyridine (1 mL) and dry CH2Cl2 (0.9 mL), 
p-nitrobenzoylchloride (20 mg, 105 µmol) and a catalytic amount of DMAP were added. The 
reaction was stirred for 18 hours at room temperature and quenched by addition of a 
saturated solution of ammonium chloride (1 mL). The aqueous phase was separated and 
extracted with CH2Cl2 (3 x 3 mL). The combined organic layers were washed with brine, dried 
with MgSO4, filtered and concentrated to give mono benzoyl protected allene 180c (9 mg, 
93%). 1H-NMR (400 MHz; CDCl3)  = 8.14 (bs, 3H, CH), 7.70-7.60 (m, 4H, CH), 7.49-7.29 (m, 
7H, CH), 4.85-4.84 (m, 2H, CH2), 4.53-4.38 (m, 1H, CH), 4.38-4.23 (m, 2H, CH2), 3.90 (m, 3H, 
CH, CH2), 3.69 (bs, 2H, OH) 1.04 (s, 9H, CH3). 
 
(2R,3S)-4-(Methyloxy)methyl)-1,2,3-tri-O-(m-chloro-p-nitrobenzoyl)hexa-4,5-diene-1,2,3-
triol: 
 
 
To a solution of allene 194 (13 mg, 0.075 mmol) in dry pyridine (1 mL) and dry CH2Cl2 (0.9 
mL), triethylamine (91 mg, 0.90 mmol) and m-chloro-p-nitrobenzoylchloride (98 mg, 0.448 
mmol) were added at 0°C. The reaction was stirred for 18 hours at room temperature and 
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was quenched by addition of 1 M HCl solution (1 mL) and ethyl acetate (3 mL). The aqueous 
phase was separated and extracted with ethyl acetate (3 x 3 mL). The combined organic 
layers were washed with brine, dried with MgSO4, filtered and concentrated to give benzoyl 
protected allene 180b (18 mg, 34%). 1H-NMR (400 MHz; CDCl3)  = 8.41 (d, J = 2.0 Hz, 1H, 
CH), 8.40 (d, J = 2.0 Hz, 1H, CH), 8.09 (dd, J = 8.4 Hz. J = 2.0 Hz, 1H, CH), 8.07 (dd, J = 8.4 Hz. J 
= 2.0 Hz, 1H, CH), 8.02 (dd, J = 8.4 Hz. J = 2.0 Hz, 1H, CH), 7.61 (d, J = 6.1 Hz, 1H, CH), 7.59 (d, 
J = 6.2 Hz, 1H, CH), 7.56 (d, J = 8.4 Hz, 1H, CH), 5.97-5.91 (m, 1H, CH), 5.88-5.81 (m, 1H, CH) 
5.07-4.94 (m, 2H, CH2), 4.86 (dd, J = 12.4 Hz. J = 2.9 Hz, 1H, CH2), 4.62 (dd, J = 12.3 Hz. J = 7.0 
Hz, 1H, CH2), 4.04 (dt, J = 11.3 Hz. J = 2.0 Hz, 1H, CH2), 4.00 (dt, J = 11.4 Hz. J = 1.7 Hz, 1H, 
CH2), 3.25 (s, 3H, CH3); 
 13C-NMR (400 MHz; CDCl3)  = 208.0, 163.5, 163.0, 162.7, 148.1, 
133.9, 133.8, 133.73, 133.70. 132.68, 132.56, 132.43, 129.34, 129.24, 127.0, 126.9, 126.8, 
97.3, 79.6, 72.8, 71.8, 71.4, 63.4, 58.3. 
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Selected spectra: 
 
1-O-Benzyl-4,5-O-isoproylidene-D-erythro-pent-2-ulose p-bromophenylhydrazone (179): 
 
 
 
 
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
1
.
3
5
1
.
4
2
1
.
5
2
1
.
5
7
4
.
0
5
4
.
0
7
4
.
1
0
4
.
1
5
4
.
1
6
4
.
1
7
4
.
3
8
4
.
4
1
4
.
4
8
4
.
5
2
4
.
5
4
4
.
5
5
6
.
7
9
6
.
8
1
7
.
2
6
7
.
3
1
7
.
3
2
7
.
3
2
7
.
3
2
7
.
3
3
7
.
3
3
7
.
3
4
7
.
3
4
7
.
3
6
7
.
3
6
7
.
3
6
7
.
3
7
7
.
3
7
7
.
3
8
9
.
1
9
3
.1
9
3
.0
8
0
.9
9
2
.3
5
2
.2
2
2
.2
9
2
.1
3
2
.0
0
8
.4
8
0
.9
9
O
O
OH
N
OBn
N
H
Br
179
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
2
5
.
2
8
2
6
.
7
5
6
7
.
0
7
6
7
.
3
4
7
3
.
1
6
7
3
.
2
1
7
6
.
8
4
7
7
.
1
6
7
7
.
4
8
7
8
.
7
4
1
0
9
.
6
5
1
1
2
.
2
5
1
1
4
.
4
3
1
1
4
.
8
0
1
2
8
.
3
6
1
2
8
.
6
0
1
2
8
.
8
9
1
3
2
.
0
8
1
3
2
.
1
5
1
3
6
.
9
4
1
4
2
.
1
9
1
4
3
.
8
7
O
O
OH
N
OBn
N
H
Br
179
176
PART C: Indium-Mediated Allenylation of Aldehydes with 4-Bromo-2-butyn-1-ols: Versatile -Hydroxyacetyl Anion Equivalents 
 
1-O-Benzyl-4-N-tert-butyloxycarbonyl-4,5-N,O-isoproylidene-L-erythro-pent-2-ulose (187): 
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(2R,4S)-4-(buta-2,3-dien-2-yl)-2-phenyl-1,3-dioxane-5-ol (183):  
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PART D: Synthesis of 4-Fluoro-2-oxo-butanoic acid  
 
 
 
D.1. Abstract 
 
An efficient synthesis of 4-fluoro-2-oxo-butanoic acid has been developed. In the key step of 
this synthesis the fluorine atom was introduced by a homoallylic fluorination in moderate 
yield. These types of fluorinations are known to be extremely difficult and seldom used in 
organic synthesis. In an earlier report by O’Leary, 4-fluoro-2-oxo-butanoic acid was claimed 
to be unstable in D2O solution with a half-life of decomposition to 2-oxo-3-butenoic acid of 
162 s at pH = 7.0. These findings are in contrast of our results since 4-fluoro-2-oxo-butanoic 
acid was stable in D2O solutions at pH = 7.0 for several hours. In our hands, 4-fluoro-2-oxo-
butanoic acid decomposed to 3-fluoro-propanoic acid in ten days by loss of one carbon 
atom. Maybe the fast decomposition of 4-fluoro-2-oxo-butanoic acid O’Leary et al. reported 
originates from unrecognized impurities in their synthesis which catalyzed the fast 
elimination of hydrogen fluoride. 
 
 
D.2. Introduction and Background 
 
Nucleophilic fluorination 
 
The most important route for the synthesis of fluorinated fine chemicals is by nucleophilic 
substitution of halogens or sulfonates by fluorine anions.90 This reaction type is hampered by 
the fact that the fluorine anion acts more likely as a base instead of a nucleophile due to its 
high electronegativity, very small size (1.36 Å) and a low polarizability. The nucleophilic 
reactivity of alkali metal fluorides decreases in order CsF > RbF > KF > NaF > LiF, because of 
the increasing lattice energy in the reverse order and the formation of tight ion pairs in 
aprotic solvents.Fehler! Textmarke nicht definiert.,91 Sterically demanding cations like CsF 
reduce ion paring by delocalizing the positive charge, making the fluoride anion more 
179
PART D: Synthesis of 4-Fluoro-2-oxo-butanoic acid 
 
nucleophilic.92 In addition, crown ethers (KF/18-crown-6)93 and especially lipophilic cations 
like TBAF94 are employed to enhance the nucleophilic character of fluoride anions (“naked 
fluorine”). Recently, DiMagno et al. reported a novel preparation of “truly” anhydrous TBAF 
(201) with a better reaction profile for nucleophilic substitution reactions than traditionally 
used TBAF (Scheme 69).95 
 
Scheme 69. Preparation of “truly“ anhydrous TBAF by DiMagno et al.Fehler! Textmarke nicht definiert. 
 
Another highly selective protocol for the substitution of hydroxyl functionalities into fluorine 
atoms applied a combination of n-perfluorobutanesulfonyl fluoride (PBSF) (206) with 
tetrabutyl-ammonium triphenyldifluoro-silicate (TBAT) (205).96 This strategy suppressed 
significantly elimination sidereactions in case of primary and secondary alcohols 202 
(Scheme 70). 
 
Scheme 70. Synthesis of primary and secondary alkyl fluorides by Zhao et al.Fehler! Textmarke nicht definiert. 
 
Chi et al. published a remarkably enhanced reactivity for nucleophilic fluorinations with 
alkali fluorides using sterically demanding protic solvents like tert-butanol and amylalcohol.97 
Normally, protic solvents reduce the nucleophilicity of anions by hydrogen bonding and by 
interactions with their partial positive charges.98 Chi et al. showed that the combination of 
CsF or TBAF in tert-butanol belong to the best nucleophilic fluorination methodologies to 
date.99 According to Chi et al.,99 tert-butanol enhances the reactivity for nucleophilic 
fluorination by four different effects (Figure 14): (i) The strength of the cesium fluoride ionic 
bond might be reduced by hydrogen bonding of the hydroxyl group of tert-butanol with the 
fluoride in the CsF lattice, resulting in selective solvation of the fluoride; (ii) The limited 
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coordination of bulky tBuOH molecules to fluoride anions might make the fluorine a good 
nucleophile; (iii) Hydrogen bonding of the tBuOH molecules of the sulfonate oxygen 
enhances their leaving group ability; (iv) The protic environment of the tert-butyl alcohol 
reduces the basicity of the fluoride anion avoiding side reaction as elimination and 
intramolecular alkylations.  
 
Figure 14. Chi’s rationalizations for nucleophilic fluorination of CsF in tert-butanol
99
 
 
Alternatively the nucleophilicity of fluorine can be enhanced by the combination of the 
fluoride anion (hard base) with a soft acid like sulfur as in the case of well known 
fluorodehydroxylation reagents DAST (207) and Deoxofluor (208) (Figure 16).100 However, 
these two reagents are highly reactive (elimination as common side reaction), thermally 
unstable and highly explosive. Because of these hazardous properties, these reagents are 
considered to be unsafe for large scale application. 
In the year 2010, a new class of deoxyfluorination reagents (aminodifluorosulfinium salts) 
have been reported by Couturier et al.101 These salts (XtalFluor 209 and 210), which can be 
synthesized directly from DAST are more selective, thermally stable and easier to handle 
that the former one’s (Figure 15).  
 
Figure 15. Deoxyfluorination reagents
100,101 
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Homoallylic Fluorination 
 
Volume 34 of Houben-Wiley’s Science of Synthesis, published in 2005, covers the synthesis 
of compounds containing a single fluorine atom bonded to a sp3 carbon.102 One section of 
this reference book deals solely with homoallylic fluorides,103 where the general introduction 
starts as following: 
 
“There are very few examples of this class of compound in the literature, although the 
important corticosteroid analogues betamethasone [1 ]and diflucortolone valerate [2]contain 
homoallylic fluoride functional groups.  
Scheme 1 Corticosteroids Containing the Homoallyl Fluoride Motif 
 
… This section will examine the extremely limited range of methods available for molecules 
which are strictly homoallylic fluorides …”103 
 
This statement clearly points out that the synthesis of homoallylic fluorides belongs to one 
of the severe problems in fluorine chemistry. Normally hydrogen fluoride elimination and 
etherification are preferred to the desired fluorination. Unexpected rearrangements have 
been reported for this type of reaction as well.104 
Two methods for the synthesis of strictly homoallylic fluorides were cited in the above 
mentioned Science of Synthesis Volume 34. A DAST mediated fluorodehydroxylation in low 
yield (Scheme 71) and ring opening reactions of cyclopropylmethanols 215 with Olah’s 
reagent (70 % hydrogen fluoride/pyridine) were reported for the synthesis of homoallylic 
fluorides (Scheme 72).  
 
Scheme 71. DAST mediated fluorodehydroxylation for the synthesis of homoallylic fluorides (Ishikawa’s reagent and 
TBAF-MsF did not yield any fluorinated product)
105
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Scheme 72. Ring opening reactions of cyclopropylmethanols with Olah’s reagent
105
 
 
For the synthesis of secondary and tertiary homoallylic fluorides, ring-opening reactions of 
epoxides with hydrogen fluoride or with tetrabutylammonium dihydrogen trifluoride were 
used for the preparation of betasome and secondary fluoride 218 (Scheme 72).106  
 
Scheme 73.
106
 
 
Furthermore, homoallylic deoxofluorinations have been published for following other 
systems. The preparations of two secondary homoallylic fluorides 219 in moderate yields 
were reported by Cossy using three equivalents of DAST.107 The bulky silyl protecting group 
TBDPS was tolerated under these reaction conditions (Scheme 74). 
 
Scheme 74.
107 
 
Addition of various Lewis acids for the regioselectivity epoxide opening of 221 with 
ammonium hydrogen fluoride H2F3NBu4 shifted the ratio of 222 to 223 towards allylic 
fluoride 222 (Scheme 74).108 
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Scheme 75
108
 
 
Alternatively a one-pot procedure using thionylchloride and potassium fluoride gave 
secondary homoallylic fluorine 225 in low yield (Scheme 76).109  
 
Scheme 76
109 
 
Primary homoallylic fluorides for positron emission tomography imaging of cyclooxygenase-2 
expression in pathological disease were synthesized by nucleophilic displacement of p-
nitrobenzenesulfonyl by potassium fluoride.110 However, the major product 228 (60 %) 
formed was derived from elimination of hydrogen fluoride (Scheme 77). 
 
Scheme 77.
110
 
 
Recently Zhao et al. described an efficient method for the conversion of primary or 
secondary alcohols into fluorides with PBSF-TBAT.Fehler! Textmarke nicht definiert. This 
procedure was efficient for the synthesis of one homoallylic fluoride 230 as well (Scheme 
78).  
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Scheme 78. Synthesis of homoallylic fluoride 230 by Zhao et al.Fehler! Textmarke nicht definiert.
 
 
 
Previous Synthesis 
 
As depicted in scheme 79, 4-fluoro-2-oxo-butanoic acid (236) was previously prepared by 
O’Leary et al. as an intermediate in their synthesis of (Z)-3-(fluoromethyl)phosphenol-
pyruvate (237).111 Commercially available glycolic acid 231 was azeotropically thioacetalized 
with 1,3-propanthiol and the acid functionality was protected as tert-butyl ester. The sodium 
anion of this dithiane 233 was alkylated with 1-bromo-2-fluoroethane in high yield. Cleavage 
of the dithianyl protecting group by NBS and the tert-butyl ester afforded 4-fluoro-2-oxo-
butanoic acid (236).  
 
Scheme 79. Synthesis of4-fluoro-2-oxo-butanoic acid (236) by O’Leary et al. 
111
 
 
Stability of 4-fluoro-2-oxo-butanoic acid (236) 
 
O’Leary et al.111 observed a rapid decomposition of 4-fluoro-2-oxo-butanoic acid (236) to 2-
oxo-3-butenoate (238) in D2O with a half-life of decomposition of 162 s at pH = 7.0 (25°C) 
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and of 52 s at pH = 8.0 (Scheme 80). At pH = 2.1, decomposition occurred with a half-life of 
several hours. 
 
Scheme 80. Decomposition of 4-fluoro-2-oxo-butanoic acid reported by O’Leary.111 
 
Concept and Strategy 
 
From experiences of my diploma thesis,112 we thought that the reported instability of 4-
fluoro-2-oxobutanoate (236) might originate in mistakes in experimental setups. In this 
previous work113 we synthesized tert-butyl 4-S-acetyl-2-oxobutanoate, a compound which is 
expected to eliminate more likely thioacetic acid than 4-fluoro-2-oxobutanoate (236) 
hydrogen fluoride. Therefore we believed 4-fluoro-2-oxobutanoate (236) to be more stable 
and potentially a useful compound for the incorporation of fluorine into proteins. 
 
Scheme 81. Retrosynthetic analysis 
 
In our retrosynthetic analysis we took the well documented general instability of free -keto 
acids into account.114 As a consequence, the acid and keto functionality has to be liberated 
as late as possible in the synthesis (Scheme 81). The fluorine atom was planned to be 
introduced by a homoallylic fluorination either via nucleophilic displacement of a sulfonate 
by a fluorine anion or by deoxofluorination of compound 240 with DAST. (The more selective 
XtalFluor reagents and the PBSF-TBAT system were not known to that time). Homoallylic 
alcohol 240 is accessible by our commonly used precursor 124 for the synthesis of isotope 
labeled -keto acids.113 
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D.3. Results and Discussion 
 
Starting form easily accessible ethyl -bromomethylacrylate (124)27, homoallylic alcohol 
240a was obtained by an indium mediated allylation between 124 and an aqueous solution 
of formaldehyde (Scheme 82).113 Primary alcohol 240a was transformed into the 
corresponding mesylate or tosylate under standard conditions.113 
 
Scheme 82. Attempted synthesis of 4-fluoro-2-oxo-butanoic acid. 
 
Nucleophilic displacement of the mesylate by KF with 18-crown-6 in acetonitrile did not yield 
any product. Interestingly this condition has been very efficient for synthesis of allylic 
fluoride 52. Homoallylic fluoride 239a was obtained by nucleophilic displacement of the 
mesylate or tosylate 241a in good yield by using Chi’s CsF/tBuOH system. This experiment 
was the first example that these conditions are efficient for the synthesis of homoallylic 
fluorides. Subsequently the double bond of compound 239a was cleaved by ozonolysis to 
yield -keto ester 242. Unexpectedly the ozonide destroying reagent was crucial to isolate 
pure products or any product at all. Appling triphenylphosphine no products containing a 
fluorine atom could be purified. Dimethylsulfide gave the desired -keto ester 242 along 
with seven percent 2-oxo-3-butenoate (238) and DMSO. A chromatographic purification was 
hampered by a concomitant elimination of hydrogen fluoride. Furthermore the boiling point 
of DMSO and the product was too similar to remove the solvent. Cleavage of the ethyl ester 
was unfortunately under all applied conditions unsuccessfully. No product could be isolated 
either by saponification under acid conditions (Dowex 50 H+, 0.025 M HCl, CH3CN) or by SN2-
type dealkylations (6.5 eq. LiI, DMFabs., reflux or 6.5 eq. LiI, dimethylpryidine, reflux). As a 
consequence, we protected the acid functionality by a tert-butyl ester which should be 
cleavable under slightly acidic conditions. 
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Scheme 83. Synthesis of 4-fluoro-2-oxo-butanoic acid. 
 
Surprisingly the tert-butyl ester had a strong influence on the yield of the homoallylic 
fluorination (Scheme 83). The yield was diminished by two side reactions. A partial cleavage 
of the tert-butyl ester yielded -lactone 243 as major side product. A possible mechanism is 
depicted in scheme 84. The fluorine anion may act as a base, removing a proton of the tert-
butyl ester and liberating isoprene. Subsequently the acid functionality attacks the leaving 
group and cyclize to the -lactone 243. The other side product, the homoallylic alcohol 240b 
originated from nucleophilic attack of hydroxide ions onto the tosylate 241b.  
 
Scheme 84. Possible mechanism for -lactone formation. 
 
A screening of nucleophilic fluorination methods revealed that only the CsF/tBuOH system 
gave the desired homoallylic fluoride 239b (Table 3). All other methodologies yielded 
quantitatively the -lactone 243. These findings may be rationalized by the unique 
nucleophilic behavior of CsF in tBuOH as described above. Obviously under the other applied 
fluorination conditions the fluorine anion was less nucleophilic and acted as a strong base. 
It became apparent that the work-up of the ozonolsyis is crucial for the synthesis of 
compound 235 as well. Triphenylphosphine gave no fluorinated product once again. In 
addition, using dimethylsulfide was hampered by removing the resulting DMSO. This severe  
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Table 3. Nucleophilic fluorination of compound 241b. 
Conditions    
KF/18-crown-6  quant.  
KF/ionic liquid  quant.  
CsF/tBuOH 39 % 40 % 19 % 
CsF/ionic liquid  quant.   
DAST  quant.  
 
problem could be solved by addition of thiourea to the intermediate formed ozonide. The 
resulting precipitate which is insoluble in methanol can be filtered off via normal filter paper. 
Using celite substantial amounts of elimination products were formed. The tert-butyl ester 
was cleaved off by two different methods. Primarily, the ester moiety was removed by 
gaseous HCl in an ether/dichloromethane solution. Interestingly, beside the desired -keto 
acid 236, the major product was 3-fluoropropionic acid (244) as shown by 1H-NMR in D2O. 
Only minor amounts (< 5%) of the elimination product 2-oxobut-3-enoic acid (238) were 
formed. Prolonged standing of the reaction solution simplified the spectra and after ten days 
4-fluoro-2-oxo-butanoic (236) acid was fully converted into 3-fluoropropionic acid (244) 
(Scheme 85). In contrast to O’Leary et al., we observed a slow decarbonylation instead of HF-
elimination of 4-fluoro-2-oxo-butanoic acid (236). Furthermore this loss of carbon prolonged 
over ten days compared to extremely fast elimination reaction (162 s at pH = 7) O’Leary has 
published. 
 
Scheme 85. Decomposition of 4-fluoro-2-oxobutanoate 236. 
 
Using dry TFA at 0°C, the tert-butyl ester was cleanly removed to yield 4-fluoro-2-oxo-
butanoic acid (236).111 The corresponding 1H-NMR spectrum in D2O is depicted in figure 16, 
demonstrating that the keto functionality is hydrated to a large excess (keto/gem-diol = 
1/2.4).  
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Figure 16. 
1
H-NMR spectrum of 4-fluoro-2-oxo-butanoic acid in D2O. 
 
 
D.4. Experimental Procedures 
 
Following compounds were synthesized according to literature procedures: 
 Ethyl 4-hydroxy-2-methylenebutanoate (240a)112 
 Ethyl 2-methylene-4-(tosyloxy)butanoate (241a)112 
 tert-Butyl 4-hydroxy-2-methylenebutanoate (240b)112 
 tert-Butyl 2-methylene-4-(tosyloxy)butanoate (241b)112 
 4-Fluoro-2-oxobutanoic acid (236)111 
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Ethyl 2-methylene-4-(mesyloxy)butanoate (241a’): 
 
 
To a solution of ethyl 4-hydroxy-2-methylenebutanoate (240a) (446 mg, 3.09 mmol) in dry 
CH2Cl2 (10 mL), triethylamine (1.03 mL, 7.4 mmol) and p-meyslchloride (425 mg, 3.7 mmol) 
were added under an argon-atmosphere at 0 °C. After 1 hour of stirring at room 
temperature (TLC: toluene/ethyl acetate 2:1; stain solution: aqueous KMnO4 -solution) 
CH2Cl2 (15 mL) and 2M NH4Cl-solution (5 mL) were added. The aqueous phase was separated 
and extracted with CH2Cl2 (3 x 20mL) and the combined organic layers were washed with 
water, dried over MgSO4, filtered and the solvent was evaporated. Subsequent column 
chromatography over silica gel (toluene/ethyl acetate 2:1) provided ethyl 2-methylene-4-O-
mesyl-butanoate (241a’) (658 mg, 96 %). 1H NMR (250 MHz; CDCl3)  = 6.31 (s, 1H, CH) 5.74-
5.70 (m, 1H, CH), 4.37 (t, J = 6.7 Hz, 2H, CH2), 4.22 (q, J = 7.0 Hz, 2H, CH2) 2.98 (s, 3H, CH3) 
2.76 (dt, J = 6.6 Hz, J = 0.8 Hz, 2H, CH2), 1.31 (t, J = 7.1 Hz, 3H, CH3). 
 
Typical procedure for homoallylic fluorination: Synthesis of ethyl 4-fluoro-2-methylene-
butanoate (239a): 
 
 
To a solution of ethyl 2-methylene-4-(tosyloxy)butanoate (241a) (1.69 g, 5.66 mmol) in dry 
tBuOH (40 mL), cesium fluoride (2.58 g, 17 mmol) was added at room temperature. The 
reaction mixture turned into a white gel and was stirred for two days at 80°C. The reaction 
was quenched by addition of a half saturated chloride solution and the aqueous phase was 
extracted with diethyl ether. The product was carefully concentrated under reduced 
pressure (the product co-evaporated with tBuOH) and was purified by distillation over a 
Vigreux column (75°C, 750 mbar) to give ethyl 4-fluoro-2-methylenebutanoate (239a) (605 
mg, 69%). Using ethyl 2-methylene-4-(mesyloxy)butanoate (241a’) as an educt gave identical 
yields. 1H-NMR (400 MHz; CDCl3)  = 6.29 (s, 1H, CH), 5.71-5.69 (m, 1H, CH), 4.56 (dt, J = 47.2 
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Hz, J = 6.1 Hz, 2H, CH2), 4.22 (q, J = 7.1 Hz, 2H, CH2) 2.71 (dtd, J = 21.4 Hz, J = 6.1 Hz, J = 1.1 
Hz, 2H, CH2), 1.30 (t, J = 7.4 Hz, 3H, CH3); 
13C-NMR (400 MHz; CDCl3):  = 166.7, 136.0 (J = 5.0 
Hz), 127.7, 82.1 (J = 167.4 Hz), 61.0, 33.3 (J = 21.0 Hz), 14.3. 
 
tert-Butyl 4-fluoro-2-methylenebutanoate (239b): 
 
Starting from tert-butyl 2-methylene-4-(tosyloxy)butanoate (241b) (2.13 g, 6.53 mmol), tert-
butyl 4-fluoro-2-methylenebutanoate (239b) (455 mg, 40 %;) was synthesized like described 
for 239a. 1H-NMR (400 MHz; CDCl3)  = 6.19 (s, 1H, CH), 5.64-5.60 (m, 1H, CH), 4.55 (dt, J = 
47.2 Hz, J = 6.2 Hz, 2H, CH2), 2.71 (dtd, J = 21.2 Hz, J = 5.9 Hz, J = 0.7 Hz, 2H, CH2), 1.50 (s, 9H, 
CH3); 
13C-NMR (400 MHz; CDCl3):  = 166.6, 137.4 (J = 5.1 Hz), 82.3 (J = 167.2 Hz), 81.1, 33.4 
(J = 21.0 Hz), 28.2; 19F-NMR (400 MHz; CDCl3):  = -218.4 (tt, J = 47.1 Hz, J= 24.3 Hz). 
Sideproducts: tert-butyl 4-hydroxy-2-methylenebutanoate (240b) (238 mg); 3-
methylenedihydrofuran-2(3H)-one (243) (552 mg) (Spectroscopical data were identical with 
Nakatsu et al.115). 
 
Ethyl 4-fluoro-2-oxobutanoate (242): 
 
 
Ozone was bubbled through a solution of ethyl 4-fluoro-2-methylenebutanoate (239a) (20 
mg, 0.137 mmol) in CH2Cl2 (2 mL) at -78°C until the color of the mixture turned blue. Dry air 
was bubbled through the solution until the blue color disappeared. After addition of 
dimethylsulfide (32 mg, 0.55 mmol), the mixture was allowed to reach room temperature 
over night. The solvent was carefully removed under reduced pressure (300 mbar at 30°C) to 
yield ethyl 4-fluoro-2-oxobutanoate (242) (approximately: 16 mg, 78 % after subtraction of 
DMSO and 2-oxo-3-butenoate (238) by integration of 1H-NMR resonances). A complete 
removed of DMSO was not possible due to co-evaporation of the product and DMSO. A 
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chromatographic purification over silica gave more elimination product. 1H-NMR (400 MHz; 
CDCl3)  = 4.75 (dt, J = 46.4 Hz, J = 5.7 Hz, 2H, CH2), 4.32 (q, J = 7.1 Hz, 2H, CH2) 3.23 (dt, J = 
24.0 Hz, J = 5.7 Hz, 2H, CH2), 1.35 (t, J = 7.1 Hz, 3H, CH3); 
13C-NMR (400 MHz; CDCl3):  = 
191.2 (J = 4.3 Hz), 160.7, 136.0 (J = 5.0 Hz), 78.2 (J = 167.0 Hz), 63.2, 40.2 (J = 22.1 Hz), 14.3. 
 
tert-Butyl 4-fluoro-2-oxobutanoate (235) 
 
 
Ozone was bubbled through a solution of tert-Butyl 4-fluoro-2-methylenebutanoate (239b) 
(10 mg, 0.057 mmol) in methanol (0.5 mL) at -30°C for two minutes. Dry air was bubbled 
through the solution for three minutes. After addition of thiourea (2.5 mg, 0.032 mmol) the 
mixture was allowed to reach room temperature and a white solid precipitated. After 
filtration over paper, the solvent was removed under reduced pressure to yield tert-butyl 4-
fluoro-2-oxobutanoate (242) (7 mg, 70 %). 1H-NMR (400 MHz; CDCl3)  = 4.76 (dt, J = 46.4 Hz, 
J = 5.8 Hz, 2H, CH2), 3.20 (dt, J = 23.7 Hz, J = 5.8 Hz, 2H, CH2), 1.55 (s, 9H, CH3); 
13C-NMR (400 
MHz; CDCl3):  = 192.0 (J = 4.4 Hz), 159.9, 84.6, 78.1 (J = 166.8 Hz), 39.8 (J = 22.1 Hz), 27.9. 
19F-NMR (600 MHz; CDCl3):  = -221.6 (tt, J = 46.4 Hz, J = 23.5 Hz). 
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Selected spectra: 
 
Ethyl 4-fluoro-2-methylenebutanoate (239a):  
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tert-Butyl 4-fluoro-2-methylenebutanoate (239b): 
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Ethyl 4-fluoro-2-methylenebutanoate (242): 
 
  
9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
1
.3
4
1
.3
6
1
.3
7
2
.6
8
3
.2
0
3
.2
1
3
.2
6
4
.3
0
4
.3
1
4
.3
3
4
.3
5
4
.7
0
4
.8
2
7
.2
6
3
.7
2
9
.1
9
2
.0
3
2
.3
7
1
.0
6
1
.0
0
O
O
O
F
242
DMSO
220 200 180 160 140 120 100 80 60 40 20 0 ppm
1
4
.
3
3
3
0
.
0
6
4
0
.
0
6
4
0
.
2
8
4
0
.
5
1
4
3
.
0
4
6
3
.
1
8
7
7
.
1
3
7
7
.
3
7
7
7
.
4
5
7
7
.
7
7
7
9
.
0
3
1
6
0
.
7
3
1
9
1
.
2
4
1
9
1
.
2
8
O
O
O
F
242
196
PART D: Synthesis of 4-Fluoro-2-oxo-butanoic acid 
 
tert-Butyl 4-fluoro-2-oxobutanoate (235): 
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4-Fluoro-2-oxobutanoic acid (236) (1H-NMR): 1H-NMR spectra after deprotection of tert-
butyl 4-fluoro-2-oxobutanoate (235) with gaseous HCl in CH2Cl2/diethyl ether (1/1) – 
prolonged standing of the reaction mixture in the NMR tube at room temperature 
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4-Fluoro-2-oxobutanoic acid (235) (13C-NMR) after three hours: 
 
 
4-Fluoro-2-oxobutanoic acid (235) (19F-NMR; coupled) after three hours: 
 
 
30405060708090100110120130140150160170180190200210220230240 ppm
3
5
.
3
2
3
5
.
4
6
3
9
.
4
2
3
9
.
5
4
4
0
.
2
8
5
6
.
3
1
5
7
.
1
5
6
6
.
6
3
6
9
.
2
6
6
9
.
3
3
7
8
.
7
2
7
9
.
7
9
8
0
.
0
3
8
0
.
2
4
8
1
.
0
9
8
1
.
3
0
8
2
.
0
9
9
3
.
1
0
1
1
9
.
3
4
1
3
1
.
9
3
1
3
6
.
4
7
1
7
4
.
8
0
1
7
5
.
6
3
1
7
5
.
6
5
F
O
OD
OD
OD
O
F
DO
OD
O
F
O
+ +
-218.6 -218.8 -219.0 -219.2 -219.4 -219.6 -219.8 -220.0 ppm
-
2
2
0
.
0
4
-
2
1
9
.
9
9
-
2
1
9
.
9
6
-
2
1
9
.
9
5
-
2
1
9
.
9
4
-
2
1
9
.
9
1
-
2
1
9
.
9
1
-
2
1
9
.
9
0
-
2
1
9
.
8
8
-
2
1
9
.
8
7
-
2
1
9
.
8
6
-
2
1
9
.
8
3
-
2
1
9
.
8
2
-
2
1
9
.
7
8
-
2
1
9
.
7
8
-
2
1
9
.
7
3
-
2
1
8
.
7
7
-
2
1
8
.
7
2
-
2
1
8
.
6
9
-
2
1
8
.
6
7
-
2
1
8
.
6
4
-
2
1
8
.
6
1
-
2
1
8
.
5
9
-
2
1
8
.
5
6
-
2
1
8
.
5
1
OD
O
F
O
OD
OD
O
F
DO
F
O
OD
199
PART D: Synthesis of 4-Fluoro-2-oxo-butanoic acid 
 
3-Fluoropropanoic acid (244) (1H-NMR and 19F-NMR; coupled) after ten days: 
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PART E: Preliminary Experiments Regarding the Synthesis of 
Selectively Labeled Imidazol-5-yl Pyruvic Acid 
 
 
 
E.1. Abstract 
 
The aim of this project was the development of a selectively 13C and deuterium labeled 
precursor compound for the synthesis of histidine labeled proteins. The -keto acid 
imidazol-5-yl pyruvic acid, usually involved in the degradation of histidine, was chosen as a 
possible precursor for the in vivo E. coli mediated synthesis of histidine. A convergent 
synthesis of imidazol-5-yl pyruvic acid was attempted to label the imidazole ring and the 
resulting peptide backbone from cheap carbon-13 enriched precursors.  
 
 
E.2. Introduction and Background 
 
Histidine adopts a unique position among the 20 proteinogenic amino acids because of the 
chemical properties of the imidazole side chain. The possibility of the imidazole moiety to 
switch between the protonation states is essential for the catalytic function of many 
enzymes which rely on a general acid/base mechanism. As a consequence, histidine residues 
are often found in the active site of enzymes such as proteases and ribonuclease A. Another 
general function of the nitrogen atoms of the imidazolium ring is the chelation of metal ions 
like zinc, copper, iron and cobalt in metalloenzymes.116 In addition, in past decade an 
increasing number of publications described the importance of phosphorylation and 
dephosphorylation of the imidazole nitrogen moiety for signal transduction.117 To study 
these manifold properties of histidine it is essential to provide special isotope labeled 
histidine for protein expression by bacteria or by cell-free methods.118 Besides isotope 
labeled amino acids, suitable isotope labeled biosynthetic precursors were used for the 
overexpression of selectively labeled proteins and enzymes by E. coli. Among these groups of 
compounds the most versatile precursors have been the -keto acids.119 The in situ 
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transformation of -keto acids into the corresponding -amino acid by E. Coli circumvents 
the necessary multistep asymmetric synthesis of the L-amino acid.  
 
Protein Labeling with -Keto Acids120 
 
The first -keto acid applied for protein labeling was pyruvate in D2O.
121 Protein expression 
resulted in complete deuteration at C and 80% deuteration at C position of nearly all 
amino acids. The methyl groups of Ala, Val, Leu and Ile (2 only) remained highly protonated. 
Unfortunately the protons of the methyl group of pyruvate exchanged with the solvent D2O 
leading to isotopomers (CH2D, CHD2 and CD3) which were transferred to the methyl groups 
of the biosynthesized protein. Wang et al. used [3-13C]-pyruvate122 for the labeling (>90 %) of 
Leu, Val, Ile and Ala methyl groups. In a more precise study Tugarinov at al. applied [1,2-
13C2]-pyruvate
123 for selective backbone labeling. Since pyruvate is metabolized in the citric 
acid cycle twelve of the 20 amino acids were labeled. High labeling efficiency was obtained 
for Ala, Val, Lys, Tyr, Phe, Trp, Ser, Gly (50-100%) and low efficiency for Thr, Met, Asn and 
Asp (20-40 %).  
A more effective strategy for the labeling of Val, Leu and Ile applied the direct biosynthetic 
precursors for these amino acids. Isotope labeled -ketoisovalerate was used for the 
labeling of Leu and Val124 and -ketobutyrate for Ile.125 Recently, an efficient and versatile 
synthetic concept for these compounds was published by Lichtenecker et al.126 Additionally 
the methyl group of methionine was labeled via its corresponding isotope labeled -keto 
acid.113 
 
Isotope Labeling of Histidine Residues of Proteins 
 
[ring-2-13C]-Histidine was incorporated in vivo into the galactose-H+ symport protein by 
overexpression in histidine auxotrophic strain of E. Coli. A detailed MS analysis showed that 
the 13C-label was selectively incorporated into the membrane transport protein to an extent 
of 80 %.127 Uniformly labeled 13C6-histidine was used to monitor side-chain dynamics and 
protonation of histidine in A. variabilis plastocyanin by 13C NMR relaxation dispersion 
measurement.128  
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Alternatively the aromatic amino acids Phe, Tyr, His and Trp can be simultaneously labeled 
with [1-13C]-glucose to a theoretical extent of 50% at specific positions.129 
 
The Biosynthesis of Histidine 
 
The amino acid histidine is synthesized by an extremely complex sequence of nine enzyme-
catalyzed transformations starting from adenosine triphosphate (ATP) (246) and phosphor-
ribosylpyrophosphate (PRPP) (247) (Scheme 86). For the de novo synthesis of histidine (245) 
approximately 41 molecules of ATP (246) are necessary,130 emphasizing its extraordinary 
importance among the 20 proteinogenic amino acids. In the first step, a transferase 
catalyzes the displacement on C1 of PRPP (247) by N1 of the purine ring of ATP (246) under 
liberation of pyrophosphate. The ribose moiety derived from PRPP (247) is inverted from the 
 to the  configuration. Subsequently the triphosphate 250 is irreversible hydrolyzed to the 
N’-5’-phosphoribosyl-adenosin monophosphate (PR-AMP) (251) which is ring-opened by a 
PR-AMP cyclohydrolase. In the next step, an isomerase catalyzes the interconversion of the 
phosphoribosyl moiety into a phosphoribulosyl unit by an Amadori rearrangement. The 
imidazol ring of imidazoleglycerol phosphate (IGP) (254) and 5-aminoimidazole-4-
carboxamide ribonucleotide (AICAR) are generated from phosphoriboslyl formino-5-
aminoimidazole-4-carboxamide ribonucleotide (PRFAR) (253) by a synthetase. A Mn2+ ion-
dependent dehydratation of IGP (254) combined with a keto-enol tautomerisation produces 
imidazolacetol phosphate (IAP) (255). The final precursor histidinol (257) is synthesized by a 
reversible transamination of IAP (255) with glutamate, followed by a dephosphorylation of 
histidinol phosphate (256).  
 
Figure 17. Biosynthetic precursors of histidine
130
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In the last step histidine (245) is generated by a NAD+- and Zn2+-dependent oxidation of the 
primary alcohol functionality to the carboxylic acid. For the sake of clarity the origin of the 
nitrogen and carbon atoms of histidine are summarized in figure 17.  
 
Scheme 86. Biosynthesis of L-histidine (245)
130
 
 
As depicted in Scheme 85, a suitable precursor for protein labeling might be the last 
intermediate L-histidinol (257). All the other biosynthetic intermediates are either more 
204
PART E: Preliminary Experiments Regarding the Synthesis of selectively labeled Imidazol-5-yl pyruvic acid 
 
complicated to synthesize than histidine (245) or are probably too polar for cell-wall 
permeation. Compared to histidine (245), the synthesis of histidinol (257) might be as 
complicated since both compounds constitute out of one chiral center. Alternatively it might 
be possible to use an intermediate of the degradation pathways of histidine for protein 
labeling. 
 
Histidine Degradation 
 
The main degradation pathway of histidine (245) leads to urocanate (258) by elimination of 
ammonium (Scheme 87).131 In two further enzyme catalyzed steps urocanic acid (258) is 
converted into L-glutamate (261). From a synthetic point of view only urocanate (258) is a 
valuable precursor for the synthesis of isotope labeled proteins. Unfortunately the 
elimination of ammonium from histidine (245) is practically irreversible in the bacterium and 
therefore urocanate (258) is not suitable for protein labeling. 
 
Scheme 87. Histidine degradation (Path B)
132 
 
Alternatively, the minor degradation pathway of histidine (245) starts with the 
transamination of histidine (245) to imidazol-5-yl pyruvic acid (262) which is further reduced 
to imidazol-5-yl lactate (263). These two reactions are the only ones that have been 
elucidated of this degradation pathway (Scheme 88).132 
205
PART E: Preliminary Experiments Regarding the Synthesis of selectively labeled Imidazol-5-yl pyruvic acid 
 
 
Scheme 88. Histidine degradation (Path B)
132
 
Concept and Strategy 
 
In our opinion, considering the synthetic accessibility and biological production of histidine 
(245), the most promising precursor for protein labeling might be imidazol-5-yl pyruvic acid 
(262) (Scheme 89). As described above, -keto acids have been used successfully as 
precursors for several other amino acids for protein labeling and showed similar or higher 
incorporation values than the corresponding labeled amino acids. Subsequently, the 
previous reported strategies for the synthesis of multi-labeled histidine133 (245a-245g) are 
discussed which were the basis for our retrosynthetic considerations towards imidazol-5-yl 
pyruvic acid (262).  
 
Scheme 89. Strategy for the synthesis of selectively isotope labeled histidines in proteins (one possible isotope pattern is 
indicated) 
 
Previous Syntheses of Multi-Labeled Histidine 
 
The first isotope labeled synthesis of histidine (245a) was reported by SooHoo et al. in 1976 
(Scheme 90).134 Histidine (245a) was synthesized carbon-13 labeled at the -carbon, N-15 
labeled at the N1 and deuterium labeled at C2 and C4 of the imidazole ring. This sequence of 
seven steps afforded racemic multi-labeled histidine (245a) in 3% overall yield. 
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Scheme 90. Synthesis of multi-labeled histidine 245a by SooHoo et al.134 
 
One year later Silks et al. published a short and efficient synthesis of racemic multi-labeled 
histidine (245b).135 Imidazol-4-ylmethanol (270) was isolated as a water insoluble copper salt 
after condensation of dihydroxyacetone with ammonia (Scheme 91). Copper sulfide 
precipitation with hydrogensulfide afforded primary alcohol (270) in 59% yield based on 
dihydroxyacetone (15) or 37% on 15NH4OH. Conversion of imidazole (270) was performed 
identical to SooHoo et al. and gave racemic multi-labeled histidine (245b) in 47 % overall 
yield based on dihydroxyacetone or 30% on 15NH4OH. 
 
Scheme 91. Synthesis of multi-labeled histidine 245b by Silks III et al.
135
 
 
Furuta et al. synthesized multi-labeled L-histidine (245e) after enzymatic resolution of (245d) 
in 4% overall yield (Scheme 92).136 The N1 of the imidazolium ring was nitrogen-15 labeled 
via a Gabriel synthesis, C2 and N3 of the imidazolium ring were labeled via KS13C15N and 
deuteration was performed in D2O at elevated temperatures.  
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Scheme 92. Synthesis of multi-labeled histidine 245c-e by Furuta et. al.
136
  
 
The first enantioselective synthesis of multi-labeled histidine was published by Cappon et al. 
in 1994 (Scheme 94).137 The imidazole ring was constructed by the Van-Leusen Three 
Component Reaction.138 The reactants for this imidazole synthesis were synthesized from 
isotope labeled methylammonium chloride, N-methylformamide, acetonitrile and 
ammonium chloride (Scheme 93). After transformation of 279 in three steps into benzyl 
protected chloromethylimidazole (281), histidine (245f) was enantioselective synthesized by 
the Schöllkopf bislactim ether method.139 This strategy virtually allows a selective 
incorporation of several carbon-13 and nitrogen-15 atoms at each desired position and 
afforded multi-labeled histidine (245f) in 35% overall yield based on tosylmethyl isocyanide 
(275). 
 
Scheme 93. Reactants for the Van Leusen Three-Component Reaction.
137
  
 
Nishiyama et al. reported a general methodology for the synthesis of L-threo and L-erythro-
[1-13C, 2,3-2H2]amino acids (Scheme 95).
140 Methyl N-acetyl-2-(dimethoxy-
phosphoryl)glycinate141 (284) was condensed with 1-tritylimidazole-4-carbaldehyde (283) to 
afford compound (285) in 49% yield. Stereoselective incorporation of deuterium was 
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accomplished by catalytic deuteration. Enzymatic resolution after cleavage of the methoxy 
ester gave multi-labeled histidine (285g) in 24% overall yield. 
 
 
Scheme 94. Synthesis of multi-labeled histidine by Cappon et al.
137
 
 
 
Scheme 95. Synthesis of multi-labeled histidine by Nishiyama et al.
140
 
 
Retrosynthetic Analysis 
 
The same retrosynthetic considerations which had been regarded in the synthesis of 4-
fluoro-2-oxobutanoate (236) have been taken as a basis for the synthesis of imidazol-5-yl 
pyruvic acid (262). The -keto functionality was planned to be liberated at the same time as 
the carboxylic acid from hydantoin derivative 286 (Scheme 96). Compound 286 is accessible 
via the condensation of hydantoin (287) with imidazole-4-carbaldehyde (288).142,143 
Hydantoin (287) can be prepared from glycine (289) and potassium cyanate by a slight 
modification of the Bucherer-Bergs reaction.144 Imidazole-4-carbaldehyde (288) is accessible 
by an oxidation of the cyclization products from 2-oxopropanal145 (290) or dihydroxyacetone 
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(15) with formaldehyde and ammonia.146,147 These approaches would allow the labeling of 
histidine (245) from cheap carbon-13 and nitrogen-15 sources (glycine, formaldehyde and 
NH4Cl).  
 
Scheme 96. Retrosynthetic analysis 
 
Deuterium labels can be introduced by D2O at elevated temperatures at C2 and C4 of the 
imidazolium ring136 and under slightly basic conditions at the  carbon of imidazol-5-yl 
pyruvic acid (262) (Figure 18). A very similar strategy was used for the synthesis of 4-
hydroxyphenyl- and phenylpyruvic acid by R. Lichtenecker.148 
 
 
Figure 18. Possible isotope label patterns of imidazol-5-yl pyruvic acid (262) 
 
 
 
 
 
210
PART E: Preliminary Experiments Regarding the Synthesis of selectively labeled Imidazol-5-yl pyruvic acid 
 
E.3. Results and Discussion 
 
According to literature procedures, the hydantoin (287) was synthesized form glycine and 
potassium cyanate in high yield.144 The optimum pH-value for the cyclization is below pH 1 
(Scheme 97).  
 
Scheme 97. Hydantoin synthesis
144
 
 
For the synthesis of imidazole-4-carbaldehyde (288) two different approaches were tested. A 
cyclization of 2-oxopropanal (290) with ammonium sulfate or ammonium chloride and 
freshly prepared formaldehyde under acidic conditions (pH = 0-1) afforded 4-methyl-
imidazol (291) in excellent yield (Scheme 98).145 The literature known FeSO4 and CuSO4 
catalyzed oxidation of a methyl group with permonosulfonic acid did not yield any product. 
According to Hamazaki et al.,149 this oxidation gives imidazole-4-carbaldehyde (288) in 95 % 
yield.  
 
Scheme 98. First approach towards imidazole-4-carbaldehyde (288) or 4-(bromomethyl)imidazole (292). 
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A iron(III)-carboxylate catalyzed oxidation with hydrogen peroxide gave the desired product 
(288) only in trace amounts. The original procedure described by Schmid et al.,150 which was 
developed for the oxidation of unactivated cycloalkanes, was used. For further studies lower 
reaction temperatures may be beneficial. Cer(IV)ammonium nitrate in nitric acid did not 
yield the desired product.151 A radical bromination with NBS or bromine with MnO2
152 of the 
methyl group only led to a decomposition of the imidazole ring system.  
In the second approach, imidazole-4-carbaldehyde (288) was synthesized by oxidation of 
imidazol-4-ylmethanol (294) with manganese dioxide in excellent yield (Scheme 99). The 
alcohol 294 was prepared in low yield by cyclization of dihydroxyacetone 15 with 
formaldehyde and copper(II)acetate in ammoniacalic solution.135 The resulting imidazolium 
copper complex 293 was filtered and freed from copper by bubbling hydrogen sulfide 
through the reaction mixture. The low yield may be enhanced by further experimentation 
and by heating the reaction mixture under microwave conditions.  
 
Scheme 99. Second approach towards imidazole-4-carbaldehyde (288) 
After obtaining hydantoin (287) and imidazole-4-carbaldehyde (288), various literature 
known coupling procedures which were successful for aldehyde 288 or benzaldehyde 
derivatives were performed. All initial attempts, even the conditions from Deulofeu et al. 
(Ac2O, NaOAc, 135°C) for exactly the same coupling were unsuccessful (Scheme 100).
142  
 
Scheme 100. Attempted condensation of hydantoin (287) with aldehyde 288 
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Applying ammonium acetate instead of sodium acetate, which was beneficial for the 
coupling of hydantoin with p-methoxybenzaldehyde did not give any product (Scheme 
100).148  
For a successful coupling, the quality of the acetic anhydride proved to be essential. The 
desired coupling product was exclusively obtained by using freshly distilled acetic anhydride 
in combination with sodium acetate at elevated temperatures. The acetyl protecting groups 
were easily cleaved during work-up with methanol (Scheme 101).  
 
 
Scheme 101. Primarily studies towards the synthesis of imidazol-5-yl pyruvic acid (262) 
 
The final opening of the hydantoin ring system could not be solved. Reaction conditions 
which have been very efficient for the opening 5-(p-hydroxybenzal)hydantoin were 
uneffective.148,153 In the original procedure, the -keto acid was continuously extracted 
under acidic conditions in an atmosphere of argon for several hours. In our case no product 
isolation was possible, since under acidic conditions the imidazole ring is protonated and the 
free -keto acid displays extraordinarily good water solubility. Changing the work-up 
conditions from hydrochloric acid to an ion exchange chromatography did not enhance the 
procedure. Imidazol-5-yl-pyruvate (262) is presumably too unstable for these reaction 
conditions and has to be synthesized by a different procedure. Furthermore, the generation 
of the imidazole ring has to be improved for an isotope label synthesis.  
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E.4. Experimental Procedures 
 
 
Following compounds were synthesized according to literature procedures: 
 Hydantoin (287)144 
 4-Methylimidazole (291)145 
 Imidazol-4-ylmethanol (294)134 
 Imidazole-4-carbaldehyde (288)135b (Solvent: MeOH) 
 
5-(Imidazol-5-yl)methylenehydantoin (286):  
 
 
5-(Imidazol-5-yl)methylenehydantoin was prepared very similar to Doulofeu et al.142 
Imidazoyl-4-carbaldehyde (50 mg, 0.52 mmol) and dry sodium acetate (53 mg, 0.65 mmol) 
were suspended in freshly distilled acetanhydride (206 µL) and hydantoin (52 mg, 0.52 
mmol) was added. The reaction mixture was heated to 135°C, until a yellow solid 
precipitated. The mixture was cooled to 0°C and after 12 hours the precipitate was filtered. 
The solid was dissolved in a mixture of CH3OH/CHCl3 (1/1) and heated to 50°C. After 1 
minute a yellow solid precipitated, the mixture was cooled to 0°C and after 12 hours the 
precipitate was filtered to yield 5-(Imidazol-5-yl)methylenehydantoin (286) (37 mg, 40%).1H-
NMR (400 MHz, DMSO):  = 7.84 (s, 1H, CH) 7.57 (s, 1H, CH) 6.40 (s, 1H, CH); 13C-NMR (400 
MHz, DMSO):  =165.2, 154.4, 137.0, 134.6, 126.1, 120.3, 101.1. 
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Selected spectra: 
 
5-(Imidazol-5-yl)methylenehydantoin: (286): 
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